<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">90943</article-id><article-id pub-id-type="doi">10.7554/eLife.90943</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>The vaginal immunoproteome for the prediction of spontaneous preterm birth: A retrospective longitudinal study</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-334248"><name><surname>Shaffer</surname><given-names>Zachary</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-370528"><name><surname>Romero</surname><given-names>Roberto</given-names></name><email>romeror@mail.nih.gov</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-157739"><name><surname>Tarca</surname><given-names>Adi L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1712-7588</contrib-id><email>atarca@med.wayne.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-370529"><name><surname>Galaz</surname><given-names>Jose</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334250"><name><surname>Arenas-Hernandez</surname><given-names>Marcia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334251"><name><surname>Gudicha</surname><given-names>Dereje W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334252"><name><surname>Chaiworapongsa</surname><given-names>Tinnakorn</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334253"><name><surname>Jung</surname><given-names>Eunjung</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-334254"><name><surname>Suksai</surname><given-names>Manaphat</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-166295"><name><surname>Theis</surname><given-names>Kevin R</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8690-7599</contrib-id><email>ktheis@med.wayne.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-243267"><name><surname>Gomez-Lopez</surname><given-names>Nardhy</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3406-5262</contrib-id><email>nardhy@wustl.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="pa2">§</xref><xref ref-type="fn" rid="fn1">#</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04byxyr05</institution-id><institution>Pregnancy Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, US Department of Health and Human Services (NICHD/NIH/DHHS)</institution></institution-wrap><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01070mq45</institution-id><institution>Department of Obstetrics and Gynecology, Wayne State University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01070mq45</institution-id><institution>Department of Physiology, Wayne State University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jmfr291</institution-id><institution>Department of Obstetrics and Gynecology, University of Michigan</institution></institution-wrap><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05hs6h993</institution-id><institution>Department of Epidemiology and Biostatistics, Michigan State University</institution></institution-wrap><addr-line><named-content content-type="city">East Lansing</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01070mq45</institution-id><institution>Department of Computer Science, Wayne State University College of Engineering</institution></institution-wrap><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01070mq45</institution-id><institution>Center for Molecular Medicine and Genetics, Wayne State University</institution></institution-wrap><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04teye511</institution-id><institution>Division of Obstetrics and Gynecology, Faculty of Medicine, Pontificia Universidad Católica de Chile</institution></institution-wrap><addr-line><named-content content-type="city">Santiago</named-content></addr-line><country>Chile</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01070mq45</institution-id><institution>Department of Biochemistry, Microbiology and Immunology, Wayne State University School of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Detroit</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Simon</surname><given-names>Carlos</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043nxc105</institution-id><institution>Foundation Carlos Simon and Valencia University</institution></institution-wrap><country>Spain</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Yan</surname><given-names>Wei</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/025j2nd68</institution-id><institution>The Lundquist Institute</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>‡</label><p>Department of Obstetrics and Gynecology, Busan Paik Hospital, Inje University College of Medicine, Busan, South Korea</p></fn><fn fn-type="present-address" id="pa2"><label>§</label><p>Center for Reproductive Health Sciences, Department of Obstetrics and Gynecology &amp; Pathology and Immunology, Washington University School of Medicine, St. Louis, United States</p></fn><fn fn-type="other" id="fn1"><label>#</label><p>Lead contact</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>06</month><year>2024</year></pub-date><volume>13</volume><elocation-id>e90943</elocation-id><history><date date-type="received" iso-8601-date="2023-07-12"><day>12</day><month>07</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2024-05-28"><day>28</day><month>05</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-11-03"><day>03</day><month>11</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://dx.doi.org/10.2139/ssrn.4259790"/></event></pub-history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-90943-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-90943-figures-v1.pdf"/><abstract><sec id="abs1"><title>Background:</title><p>Preterm birth is the leading cause of neonatal morbidity and mortality worldwide. Most cases of preterm birth occur spontaneously and result from preterm labor with intact (spontaneous preterm labor [sPTL]) or ruptured (preterm prelabor rupture of membranes [PPROM]) membranes. The prediction of spontaneous preterm birth (sPTB) remains underpowered due to its syndromic nature and the dearth of independent analyses of the vaginal host immune response. Thus, we conducted the largest longitudinal investigation targeting vaginal immune mediators, referred to herein as the immunoproteome, in a population at high risk for sPTB.</p></sec><sec id="abs2"><title>Methods:</title><p>Vaginal swabs were collected across gestation from pregnant women who ultimately underwent term birth, sPTL, or PPROM. Cytokines, chemokines, growth factors, and antimicrobial peptides in the samples were quantified via specific and sensitive immunoassays. Predictive models were constructed from immune mediator concentrations.</p></sec><sec id="abs3"><title>Results:</title><p>Throughout uncomplicated gestation, the vaginal immunoproteome harbors a cytokine network with a homeostatic profile. Yet, the vaginal immunoproteome is skewed toward a pro-inflammatory state in pregnant women who ultimately experience sPTL and PPROM. Such an inflammatory profile includes increased monocyte chemoattractants, cytokines indicative of macrophage and T-cell activation, and reduced antimicrobial proteins/peptides. The vaginal immunoproteome has improved predictive value over maternal characteristics alone for identifying women at risk for early (&lt;34 weeks) sPTB.</p></sec><sec id="abs4"><title>Conclusions:</title><p>The vaginal immunoproteome undergoes homeostatic changes throughout gestation and deviations from this shift are associated with sPTB. Furthermore, the vaginal immunoproteome can be leveraged as a potential biomarker for early sPTB, a subset of sPTB associated with extremely adverse neonatal outcomes.</p></sec><sec id="abs5"><title>Funding:</title><p>This research was conducted by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, <italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS) under contract HHSN275201300006C. ALT, KRT, and NGL were supported by the Wayne State University Perinatal Initiative in Maternal, Perinatal and Child Health.</p></sec></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Human pregnancies last 40 weeks on average. Preterm births, defined as live births before 37 weeks, occur in about one in ten pregnancies. Being born too early is the main cause of a number of diseases and death in newborn babies.</p><p>Preterm births are further divided into those that happen early – before 34 weeks – and those that happen late – between 34 and 37 weeks. There are also differences between preterm births in which the amniotic sac ruptures before or after the start of labor.</p><p>Although several factors can lead to spontaneous preterm birth, bacteria getting into the amniotic fluid around the fetus are a well-known trigger. These bacteria usually come from the vagina. In the past, researchers have studied the number and types of bacteria in the vagina of people who had a normal pregnancy and those that had a preterm birth to predict who is more at risk of preterm birth.</p><p>However, predictions based only on data about bacteria have been less useful so far. Instead, it might be better to investigate a person’s immune response during pregnancy. Shaffer et al. addressed this gap by asking whether measuring the levels of proteins involved in the immune response could help predict preterm births.</p><p>Shaffer et al. collected vaginal fluids from 739 individuals of predominately African American ethnicity with an average BMI of 28.7 – representing a population at high risk for spontaneous preterm birth. The swabs were taken at multiple points during their pregnancy, and 31 different immune-related proteins in those fluids were measured. The researchers further noted whether these individuals had a normal or a preterm birth.</p><p>The data showed that, compared to normal births, preterm births are associated with higher levels of proteins that attract white blood cells and promote inflammation, such as IL-6 and IL-1β. Vaginal fluids from individuals who went on to have an early preterm birth where the amniotic sac ruptured before labor, contained lower levels of proteins known as defensins, which defend the body from bacteria.</p><p>With these new data from vaginal swabs, Shaffer et al. could make better predictions about the likelihood of preterm birth in general and early preterm birth with the amniotic sac ruptured before labor. For the latter scenario, the predictions were not improved when combining immune protein data with other characteristics of the pregnant person, such as age.</p><p>These findings suggest that clinicians may be able to use measurements of immune-related proteins to help predict preterm births, so that pregnant individuals at high risk can receive extra care. Further research will have to validate the data and determine whether the findings apply more widely.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>preterm birth</kwd><kwd>immunology</kwd><kwd>vaginal ecosystem</kwd><kwd>obstetrics</kwd><kwd>great obstetrical syndromes</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009633</institution-id><institution>Eunice Kennedy Shriver National Institute of Child Health and Human Development</institution></institution-wrap></funding-source><award-id>HHSN275201300006C</award-id><principal-award-recipient><name><surname>Romero</surname><given-names>Roberto</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The vaginal immunoproteome in pregnancy is more predictive of spontaneous preterm birth (sPTB) than maternal characteristics alone, with sPTB cases showing heightened pro-inflammatory profiles accompanied by reduced levels of antimicrobial proteins/peptides.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Preterm birth, defined as live birth before 37 weeks of gestation (<xref ref-type="bibr" rid="bib5">American College of Obstetricians and Gynecologists, 2021</xref>), afflicts 1 of every 10 children born worldwide (<xref ref-type="bibr" rid="bib27">Chawanpaiboon et al., 2019</xref>; <xref ref-type="bibr" rid="bib131">Martin and Hamilton, 2021</xref>). The economic burden of preterm birth amounts to more than $25.2 billion in healthcare costs annually in the United States alone (<xref ref-type="bibr" rid="bib200">Waitzman et al., 2021</xref>). Two-thirds of preterm births occur spontaneously (i.e., spontaneous preterm birth [sPTB]) (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>), while the remainder are due to evident clinical conditions (e.g., preeclampsia and intrauterine growth restriction) that jeopardize maternal–fetal well-being and require medically indicated delivery (i.e., iatrogenic preterm birth) (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>; <xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>). sPTB can be further subdivided into spontaneous preterm labor with intact membranes (sPTL) and preterm prelabor rupture of membranes (PPROM) (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>). The pathogenesis of sPTL and PPROM can include local inflammatory processes (<xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>); yet, each is considered a syndrome with distinct underlying mechanisms of disease (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>; <xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>) and thus requiring different clinical managements (<xref ref-type="bibr" rid="bib4">American College of Obstetricians and Gynecologists, 2016</xref>; <xref ref-type="bibr" rid="bib43">Dvorakova and Ivankova, 2020</xref>). Therefore, research focused on the prediction and prevention of sPTB should account for the distinct inflammatory nature of sPTL and PPROM.</p><p>Multiple attempts have been made to predict sPTB using data from noninvasive sampling coupled with omics platforms such as genomics (<xref ref-type="bibr" rid="bib61">Frey et al., 2016</xref>; <xref ref-type="bibr" rid="bib136">Modi et al., 2017</xref>; <xref ref-type="bibr" rid="bib137">Modi et al., 2018</xref>; <xref ref-type="bibr" rid="bib108">Jain et al., 2022</xref>), transcriptomics (<xref ref-type="bibr" rid="bib142">Ngo et al., 2018</xref>; <xref ref-type="bibr" rid="bib109">Jehan et al., 2020</xref>; <xref ref-type="bibr" rid="bib148">Peterson et al., 2020</xref>; <xref ref-type="bibr" rid="bib185">Tarca et al., 2021</xref>; <xref ref-type="bibr" rid="bib20">Camunas-Soler et al., 2022</xref>), and proteomics (<xref ref-type="bibr" rid="bib148">Peterson et al., 2020</xref>; <xref ref-type="bibr" rid="bib109">Jehan et al., 2020</xref>; <xref ref-type="bibr" rid="bib185">Tarca et al., 2021</xref>; <xref ref-type="bibr" rid="bib191">Tiensuu et al., 2022</xref>). Yet, to date, assessment of cervical length remains the strongest and most cost-effective predictor of sPTB: women with a sonographic short cervix (≤ 25 mm) are sixfold more likely to deliver a preterm neonate (<xref ref-type="bibr" rid="bib104">Iams et al., 1996</xref>), and tailored treatment with natural progesterone reduces such risk by half (<xref ref-type="bibr" rid="bib58">Fonseca et al., 2007</xref>; <xref ref-type="bibr" rid="bib95">Hassan et al., 2011</xref>; <xref ref-type="bibr" rid="bib166">Romero et al., 2014b</xref>; <xref ref-type="bibr" rid="bib167">Romero et al., 2016</xref>; <xref ref-type="bibr" rid="bib168">Romero et al., 2017</xref>; <xref ref-type="bibr" rid="bib32">Conde-Agudelo et al., 2018</xref>; <xref ref-type="bibr" rid="bib169">Romero et al., 2018</xref>). Indeed, personalized cervical length assessment that accounts for maternal characteristics and obstetrical history was shown to improve prediction relative to raw cervical length data (<xref ref-type="bibr" rid="bib89">Gudicha et al., 2021</xref>); however, additional biomarkers are still needed to further increase prediction performance. Growing evidence has fostered the hypothesis that cervical disease is associated with changes in the vaginal ecosystem (<xref ref-type="bibr" rid="bib119">Kindinger et al., 2017</xref>; <xref ref-type="bibr" rid="bib208">Witkin et al., 2019</xref>; <xref ref-type="bibr" rid="bib37">Di Paola et al., 2020</xref>; <xref ref-type="bibr" rid="bib68">Gerson et al., 2020</xref>). Thus, intensive investigation has focused on the vaginal microbiome and its potential utility for predicting sPTB (<xref ref-type="bibr" rid="bib39">Donders et al., 2009</xref>; <xref ref-type="bibr" rid="bib36">DiGiulio et al., 2015</xref>; <xref ref-type="bibr" rid="bib119">Kindinger et al., 2017</xref>; <xref ref-type="bibr" rid="bib60">Freitas et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Fettweis et al., 2019</xref>; <xref ref-type="bibr" rid="bib143">Odogwu et al., 2021</xref>; <xref ref-type="bibr" rid="bib146">Payne et al., 2021</xref>; <xref ref-type="bibr" rid="bib56">Flaviani et al., 2021</xref>; <xref ref-type="bibr" rid="bib153">Pruski et al., 2021</xref>; <xref ref-type="bibr" rid="bib123">Kumar et al., 2021</xref>). However, models utilizing vaginal microbiome data alone have displayed weak predictive power (<xref ref-type="bibr" rid="bib60">Freitas et al., 2018</xref>; <xref ref-type="bibr" rid="bib123">Kumar et al., 2021</xref>; <xref ref-type="bibr" rid="bib153">Pruski et al., 2021</xref>), potentially due to sample size, sequencing depth, and ethnicity-driven differences in microbial community profile. Recent models, however, have leveraged vaginal host–microbe interactions by incorporating the determination of immune mediators, which improved the prediction of sPTB (<xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>; <xref ref-type="bibr" rid="bib55">Fettweis et al., 2019</xref>; <xref ref-type="bibr" rid="bib153">Pruski et al., 2021</xref>; <xref ref-type="bibr" rid="bib123">Kumar et al., 2021</xref>). Nonetheless, an extensive interrogation of the vaginal soluble immune response (i.e., the vaginal immunoproteome), with consideration of the distinction between sPTL and PPROM cases, has not been undertaken.</p><p>Herein, we conducted the largest assessment, based on the study’s scale, longitudinal nature, and depth of immunological mediators evaluated, of the vaginal immunoproteome during uncomplicated and complicated pregnancies. Importantly, our determinations were performed in vaginal samples collected during all three trimesters and considered sPTB, including its two subsets (i.e., sPTL and PPROM), as well as the timing of delivery (i.e., early and late sPTB). Furthermore, the immunological mediators evaluated were selected for their relevance to key biological processes in the vaginal ecosystem. Additionally, we used machine learning approaches and cross-validation to generate and assess predictive models for sPTL and PPROM in our high-risk population.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characteristics of the study population</title><p>This study represents the largest (N = 739 women, n = 2819 samples) and most comprehensive (31 immune mediators) profiling of the soluble immune response in vaginal fluid throughout well-characterized pregnancies that culminated in the delivery of a term neonate (controls) or those that resulted in sPTB (sPTL and PPROM cases) (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Specifically, we enrolled pregnant women from whom vaginal swabs were collected at different points throughout gestation. Patients were followed until delivery, after which we selected women who underwent sPTL or PPROM with delivery before 37 weeks of gestation (preterm birth) and women with a normal term delivery as controls (matched by gestational age at sampling at a 2:1 ratio). All patients had a singleton pregnancy without fetal anomalies and had at least three vaginal samples available. Patients were classified into three study groups according to pregnancy outcome and diagnosis: (i) women who delivered at term (494 patients, 1907 samples); (ii) women who underwent sPTL (140 patients, 521 samples); and (iii) women who experienced PPROM (105 patients, 391 samples) (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). By design, gestational age at sampling was similar among the study groups (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). The clinical characteristics of the study population are shown in <xref ref-type="table" rid="table1">Table 1</xref>. As expected (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>), the prevalence of sPTL or PPROM was higher among women with a history of sPTB. Of note, this study addressed a high-risk population primarily composed of African-American women with an average body mass index (BMI) of 28.7 kg/m<sup>2</sup>. Hence, the current study represents the largest survey of the vaginal immunoproteome in a population at high risk for sPTB.</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Longitudinal vaginal sampling of women with a term or preterm delivery.</title><p>(<bold>A</bold>) Representative diagram showing the collection of vaginal swabs throughout gestation from women who underwent uncomplicated term birth (control; N = 494 subjects, n = 1907 swabs), spontaneous preterm labor with intact membranes (sPTL; N = 140, n = 521), or preterm prelabor rupture of membranes (PPROM; N = 105, n = 391) to quantify the concentrations of cytokines, chemokines, and other immune mediators in the cervico-vaginal fluid by immunoassay. (<bold>B</bold>) Plots showing the distribution of swabs collected throughout gestation (weeks) for each study group. Gray dots represent gestational ages when vaginal swabs were taken, and green triangles show the gestational age at delivery. (<bold>C</bold>) Violin plots showing sample frequency across gestational age (weeks) for each study group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig1-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 1A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Demographics and clinical characteristics of the study groups.</title><p>Demographics and clinical information are presented as a median (with interquartile ranges) or as proportions (n/N).</p><p>Differences between study groups and the control group were assessed by the Mann–Whitney <italic>U</italic> test for continuous data or the Fisher’s exact test for categorical data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2"/><th align="left" valign="bottom" rowspan="2">Term control(n = 494)</th><th align="left" valign="bottom" colspan="4">Spontaneous preterm birth (n = 245)</th></tr><tr><th align="left" valign="bottom">sPTL (n = 140)</th><th align="left" valign="bottom">p</th><th align="left" valign="bottom">PPROM (n = 105)</th><th align="left" valign="bottom">p</th></tr></thead><tbody><tr><td align="left" valign="bottom">Maternal age (years)</td><td align="left" valign="bottom">24 (21–27)</td><td align="left" valign="bottom">23.5 (21-27)</td><td align="left" valign="bottom">0.37</td><td align="left" valign="bottom">25 (22–30)</td><td align="left" valign="bottom">0.02</td></tr><tr><td align="left" valign="bottom">BMI (kg/m<sup>2</sup>)</td><td align="left" valign="bottom">27.5 (22.7–33.8)</td><td align="left" valign="bottom">26.4 (22.5–31.7)</td><td align="left" valign="bottom">0.05</td><td align="left" valign="bottom">28.2 (23.2–33.3)</td><td align="left" valign="bottom">0.79</td></tr><tr><td align="left" valign="bottom">Maternal race</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom">0.09</td><td align="left" valign="bottom"/><td align="left" valign="bottom">0.4</td></tr><tr><td align="left" valign="bottom"> African American</td><td align="left" valign="bottom">94.5% (467/494)</td><td align="left" valign="bottom">90% (126/140)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">98.1% (103/105)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> White</td><td align="left" valign="bottom">1.8% (9/494)</td><td align="left" valign="bottom">5% (7/140)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">1% (1/105)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom"> Other</td><td align="left" valign="bottom">3.7 (18/494)</td><td align="left" valign="bottom">5% (7/140)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">1% (1/105)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Nulliparity</td><td align="left" valign="bottom">20.4% (101/494)</td><td align="left" valign="bottom">12.9% (18/140)</td><td align="left" valign="bottom">0.02</td><td align="left" valign="bottom">19% (20/105)</td><td align="left" valign="bottom">0.79</td></tr><tr><td align="left" valign="bottom">History of preterm birth</td><td align="left" valign="bottom">11.1% (55/494)</td><td align="left" valign="bottom">39.3% (55/140)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">32.4% (34/105)</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom">Gestational age at delivery (weeks)</td><td align="left" valign="bottom">39.6 (39–40.4)</td><td align="left" valign="bottom">35.7 (33.7–36.6)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">35 (32.6–35.9)</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom">Birthweight (g)</td><td align="left" valign="bottom">3300 (3090–3593)</td><td align="left" valign="bottom">2363 (1995–2748)</td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">2235 (1760–2575)</td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom">Maternal Inflammatory response</td><td align="left" valign="bottom">0% (0/494)</td><td align="left" valign="bottom">21.1% (28/133)<xref ref-type="table-fn" rid="table1fn2">*</xref></td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">22.4% (22/98)<xref ref-type="table-fn" rid="table1fn2">*</xref></td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom">Fetal inflammatory response</td><td align="left" valign="bottom">4.3% (21/494)</td><td align="left" valign="bottom">20.3% (27/133)<xref ref-type="table-fn" rid="table1fn2">*</xref></td><td align="left" valign="bottom">&lt;0.001</td><td align="left" valign="bottom">28.5% (28/98)<xref ref-type="table-fn" rid="table1fn2">*</xref></td><td align="char" char="." valign="bottom">&lt;0.001</td></tr><tr><td align="left" valign="bottom">Early sPTB (&lt;34 weeks)</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">27.1% (38/140)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">36.2% (38/105)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Late sPTB (34–36<sup>+6</sup>) weeks</td><td align="left" valign="bottom">–</td><td align="left" valign="bottom">72.9% (102/140)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">63.8% (67/105)</td><td align="left" valign="bottom"/></tr></tbody></table><table-wrap-foot><fn><p>BMI = body mass index; sPTL = spontaneous preterm labor; sPTB = spontaneous preterm birth; PPROM = preterm prelabor rupture of membranes.</p></fn><fn id="table1fn2"><label>*</label><p>Seven missing data.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-2"><title>The vaginal immunoproteome is tightly regulated during normal gestation</title><p>First, by profiling 31 immune mediators, including two antimicrobial molecules, we established the gestational age-dependent changes in the vaginal immunoproteome during normal gestation. Given that the immunobiology of preterm birth is syndromic in nature (<xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>; <xref ref-type="bibr" rid="bib80">Gomez-Lopez et al., 2022a</xref>), in this study we classified the immune mediators measured in the vaginal fluid into six categories based on their established role and/or their potential cellular source: pro-inflammatory cytokines (IL-6, IL-1β, IL-16, CXCL8, TNF, IFN-γ, IL-1α, and LT-α), chemoattractants of monocytes (herein referred to as monocyte chemokines; CCL2, CCL3, and CCL4), macrophage cytokines (IL-12/IL-23p40, IL-12p70, and IL-15), T-cell cytokines and chemokines (IL-2, IL-4, IL-17A, IL-10, IL-13, IL-5, CXCL10, and CCL17), antimicrobial peptides (AMPs; β-defensin-2 and secretory leukocyte peptidase inhibitor [SLPI]), and growth factors (VEGF and GM-CSF). All immune mediators, except for CCL11, CCL13, CCL22, and CCL26, were present at detectable levels in the majority of our study samples (<xref ref-type="table" rid="table2">Table 2</xref>) and were included in our analyses. Importantly, one-third of these mediators showed an association with gestational age (<xref ref-type="fig" rid="fig2">Figure 2</xref>; <xref ref-type="supplementary-material" rid="fig2sdata1 fig2sdata2">Figure 2—source data 1 and 2</xref>), whereas the remaining were unaffected (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplements 1</xref> and <xref ref-type="fig" rid="fig2s2">2</xref> , <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1 and 2</xref> ). Specifically, the vaginal concentrations of IL-1β (<xref ref-type="fig" rid="fig2">Figure 2</xref>), IL-1α (<xref ref-type="fig" rid="fig2">Figure 2B</xref>), CXCL8 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>), IL-2 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>), IL-12/IL-23p40 (<xref ref-type="fig" rid="fig2">Figure 2E</xref>), GM-CSF (<xref ref-type="fig" rid="fig2">Figure 2F</xref>), and β-defensin-2 (<xref ref-type="fig" rid="fig2">Figure 2G</xref>) declined as gestation progressed. On the other hand, CCL17 (<xref ref-type="fig" rid="fig2">Figure 2H</xref>), CXCL10 (<xref ref-type="fig" rid="fig2">Figure 2I</xref>), and VEGF (<xref ref-type="fig" rid="fig2">Figure 2J</xref>) increased with gestational age. A tendency for increased concentrations of SLPI with advancing gestational age was also observed (<xref ref-type="fig" rid="fig2">Figure 2K</xref>). These data indicate that the vaginal immunoproteome undergoes specific changes during normal pregnancy, which involve a decline in pro-inflammatory mediators, an increase in T cell-associated chemokines, and the tight regulation of growth factors and defensins. Together, these findings suggest that the vaginal cytokine network in normal pregnancy is modestly modulated during gestation, which prompted us to investigate whether a deviation from these changes occurs in women who ultimately undergo sPTB.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The vaginal immunoproteome is finely regulated during normal gestation.</title><p>Linear mixed effects modeling was used to determine changes in (<bold>A</bold>) IL-1β, (<bold>B</bold>) IL-1α, (<bold>C</bold>) CXCL8, (<bold>D</bold>) IL-2, (<bold>E</bold>) IL-12/IL-23p40, (<bold>F</bold>) GM-CSF, (<bold>G</bold>) β-defensin-2, (<bold>H</bold>) CCL17, (<bold>I</bold>) CXCL10, (<bold>J</bold>) VEGF, and (<bold>K</bold>) SLPI throughout pregnancies, resulting in term birth. Immune mediator labels denote category: pro-inflammatory cytokines (red), T-cell cytokine response (blue), macrophage cytokine response (purple), chemokines (green), growth factors (orange), and antimicrobial peptides (AMPs) (teal). Each black circle represents the protein concentration of one sample. Blue lines represent the linear fit, with gray shaded areas representing the 95% confidence interval of the mean. Scatterplot trends were estimated using generalized additive models with spline transformations of gestational age. *p&lt;0.05 and q&lt;0.1, **p&lt;0.01 and q&lt;0.1, ***p&lt;0.001 and q&lt;0.1, <sup>a</sup>p&lt;0.05 and q&gt;0.1. Correlation coefficients are shown above each figure as rho-values (ρ).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Vaginal immune mediator shifts across gestational age in term uncomplicated pregnancies.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>The 10th, 50th, and 95th quantiles of vaginal immune mediator concentrations weekly across gestation, resulting in term birth.</title></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig2-data2-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Vaginal pro-inflammatory mediators, monocyte chemoattractants, and macrophage cytokines unaltered with gestational age in women who ultimately delivered at term.</title><p>Linear mixed effects modeling was used to determine changes in (<bold>A</bold>) IL-6, (<bold>B</bold>) CXCL8 (HA, high affinity), (<bold>C</bold>) IL-16, (<bold>D</bold>) LT-α, (<bold>E</bold>) TNF, (<bold>F</bold>) IFN-γ, (<bold>G</bold>) CCL2, (<bold>H</bold>) CCL3, (<bold>I</bold>) CCL4, (<bold>J</bold>) IL-12p70, and (<bold>K</bold>) IL-15 throughout pregnancy. Each black circle represents the protein concentration of one sample. Blue lines represent the linear fit, with gray shaded areas representing the 95% confidence interval of the mean. Scatterplot trends were estimated using generalized additive models with spline transformations of gestational age. Immune mediator labels denote their immunobiology category: pro-inflammatory cytokines (red), chemokines (green), and macrophage cytokine response (purple). NS, nonsignificant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Vaginal T-cell cytokines and the growth factor IL-7 that are unaltered with gestational age in women who ultimately delivered at term.</title><p>Linear mixed effects modeling was used to determine changes in (<bold>A</bold>) IL-4, (<bold>B</bold>) IL-5, (<bold>C</bold>) IL-10, (<bold>D</bold>) IL-13, (<bold>E</bold>) IL-17A, and (<bold>F</bold>) IL-7 throughout pregnancy. Each black circle represents the protein concentration of one sample. Blue lines represent the linear fit, with gray shaded areas representing the 95% confidence interval. Scatterplot trends were estimated using generalized additive models with spline transformations of gestational age. Immune mediator labels denote their immunobiology category: T-cell cytokine response (blue) and growth factors (orange). NS, nonsignificant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig2-figsupp2-v1.tif"/></fig></fig-group><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Immune mediator assay sensitivity and proportion outside of range of detection.</title><p>Vaginal immune mediator proportions below the limit of detection and greater than 2 * 99th percentile. Chemokines listed in red were excluded from analyses due to a majority of samples being below the limit of detection.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom" rowspan="2">Immune mediator</th><th align="left" valign="bottom" rowspan="2">Sensitivity of detection</th><th align="left" valign="bottom" colspan="4">Control</th><th align="left" valign="bottom" colspan="4">sPTL</th><th align="left" valign="bottom" colspan="4">PPROM</th></tr><tr><th align="left" valign="bottom">Below limit</th><th align="left" valign="bottom">Below limit %</th><th align="left" valign="bottom">Above limit</th><th align="left" valign="bottom">Above limit %</th><th align="left" valign="bottom">Below limit</th><th align="left" valign="bottom">Below limit %</th><th align="left" valign="bottom">Above limit</th><th align="left" valign="bottom">Above limit %</th><th align="left" valign="bottom">Below limit</th><th align="left" valign="bottom">Below limit %</th><th align="left" valign="bottom">Above limit</th><th align="left" valign="bottom">Above limit %</th></tr></thead><tbody><tr><td align="left" valign="bottom">IFN-γ</td><td align="left" valign="bottom">0.368  pg/mL</td><td align="left" valign="bottom">515.00</td><td align="left" valign="bottom">27.01</td><td align="left" valign="bottom">7.00</td><td align="left" valign="bottom">0.37</td><td align="left" valign="bottom">103.00</td><td align="left" valign="bottom">19.77</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">83.00</td><td align="left" valign="bottom">21.23</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td></tr><tr><td align="left" valign="bottom">IL-1β</td><td align="left" valign="bottom">0.152  pg/mL</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.05</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.77</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">IL-2</td><td align="left" valign="bottom">0.219  pg/mL</td><td align="left" valign="bottom">29.00</td><td align="left" valign="bottom">1.52</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">10.00</td><td align="left" valign="bottom">1.92</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">6.00</td><td align="left" valign="bottom">1.53</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">IL-4</td><td align="left" valign="bottom">0.028  pg/mL</td><td align="left" valign="bottom">147.00</td><td align="left" valign="bottom">7.71</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">30.00</td><td align="left" valign="bottom">5.76</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">30.00</td><td align="left" valign="bottom">7.67</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">IL-6</td><td align="left" valign="bottom">0.113  pg/mL</td><td align="left" valign="bottom">43.00</td><td align="left" valign="bottom">2.25</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">10.00</td><td align="left" valign="bottom">1.92</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">8.00</td><td align="left" valign="bottom">2.05</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.77</td></tr><tr><td align="left" valign="bottom">CXCL8</td><td align="left" valign="bottom">0.101  pg/mL</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.77</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">IL-10</td><td align="left" valign="bottom">0.054  pg/mL</td><td align="left" valign="bottom">34.00</td><td align="left" valign="bottom">1.78</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">10.00</td><td align="left" valign="bottom">1.92</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.58</td><td align="left" valign="bottom">5.00</td><td align="left" valign="bottom">1.28</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">IL-12p70</td><td align="left" valign="bottom">0.084  pg/mL</td><td align="left" valign="bottom">178.00</td><td align="left" valign="bottom">9.33</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">35.00</td><td align="left" valign="bottom">6.72</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">42.00</td><td align="left" valign="bottom">10.74</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">IL-13</td><td align="left" valign="bottom">0.119  pg/mL</td><td align="left" valign="bottom">55.00</td><td align="left" valign="bottom">2.88</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">9.00</td><td align="left" valign="bottom">1.73</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">16.00</td><td align="left" valign="bottom">4.09</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">TNF</td><td align="left" valign="bottom">0.108  pg/mL</td><td align="left" valign="bottom">94.00</td><td align="left" valign="bottom">4.93</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">14.00</td><td align="left" valign="bottom">2.69</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.77</td><td align="left" valign="bottom">23.00</td><td align="left" valign="bottom">5.88</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">GM-CSF</td><td align="left" valign="bottom">0.200  pg/mL</td><td align="left" valign="bottom">176.00</td><td align="left" valign="bottom">9.23</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.21</td><td align="left" valign="bottom">46.00</td><td align="left" valign="bottom">8.83</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">30.00</td><td align="left" valign="bottom">7.67</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">IL-1α</td><td align="left" valign="bottom">0.089  pg/mL</td><td align="left" valign="bottom">15.00</td><td align="left" valign="bottom">0.79</td><td align="left" valign="bottom">8.00</td><td align="left" valign="bottom">0.42</td><td align="left" valign="bottom">14.00</td><td align="left" valign="bottom">2.69</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">5.00</td><td align="left" valign="bottom">1.28</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.77</td></tr><tr><td align="left" valign="bottom">IL-5</td><td align="left" valign="bottom">0.162  pg/mL</td><td align="left" valign="bottom">324.00</td><td align="left" valign="bottom">16.99</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.21</td><td align="left" valign="bottom">102.00</td><td align="left" valign="bottom">19.58</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.58</td><td align="left" valign="bottom">82.00</td><td align="left" valign="bottom">20.97</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td></tr><tr><td align="left" valign="bottom">IL-7</td><td align="left" valign="bottom">0.124  pg/mL</td><td align="left" valign="bottom">772.00</td><td align="left" valign="bottom">40.48</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.16</td><td align="left" valign="bottom">190.00</td><td align="left" valign="bottom">36.47</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.77</td><td align="left" valign="bottom">141.00</td><td align="left" valign="bottom">36.06</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td></tr><tr><td align="left" valign="bottom">IL-12/IL-23p40</td><td align="left" valign="bottom">0.408  pg/mL</td><td align="left" valign="bottom">211.00</td><td align="left" valign="bottom">11.06</td><td align="left" valign="bottom">8.00</td><td align="left" valign="bottom">0.42</td><td align="left" valign="bottom">48.00</td><td align="left" valign="bottom">9.21</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">34.00</td><td align="left" valign="bottom">8.70</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">IL-15</td><td align="left" valign="bottom">0.111  pg/mL</td><td align="left" valign="bottom">707.00</td><td align="left" valign="bottom">37.07</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.21</td><td align="left" valign="bottom">159.00</td><td align="left" valign="bottom">30.52</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">142.00</td><td align="left" valign="bottom">36.32</td><td align="left" valign="bottom">6.00</td><td align="left" valign="bottom">1.53</td></tr><tr><td align="left" valign="bottom">IL-16</td><td align="left" valign="bottom">0.478  pg/mL</td><td align="left" valign="bottom">123.00</td><td align="left" valign="bottom">6.45</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.21</td><td align="left" valign="bottom">31.00</td><td align="left" valign="bottom">5.95</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">26.00</td><td align="left" valign="bottom">6.65</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td></tr><tr><td align="left" valign="bottom">IL-17A</td><td align="left" valign="bottom">0.381  pg/mL</td><td align="left" valign="bottom">247.00</td><td align="left" valign="bottom">12.95</td><td align="left" valign="bottom">10.00</td><td align="left" valign="bottom">0.52</td><td align="left" valign="bottom">42.00</td><td align="left" valign="bottom">8.06</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.77</td><td align="left" valign="bottom">46.00</td><td align="left" valign="bottom">11.76</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">1.02</td></tr><tr><td align="left" valign="bottom">LT-α</td><td align="left" valign="bottom">0.095  pg/mL</td><td align="left" valign="bottom">957.00</td><td align="left" valign="bottom">50.18</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.21</td><td align="left" valign="bottom">236.00</td><td align="left" valign="bottom">45.30</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.58</td><td align="left" valign="bottom">201.00</td><td align="left" valign="bottom">51.41</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">VEGF</td><td align="left" valign="bottom">0.264  pg/mL</td><td align="left" valign="bottom">7.00</td><td align="left" valign="bottom">0.37</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">9.00</td><td align="left" valign="bottom">1.73</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">12.00</td><td align="left" valign="bottom">3.07</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td></tr><tr><td align="left" valign="bottom"><styled-content style="color: #D50000;">CCL11/Eotaxin</styled-content></td><td align="left" valign="bottom">0.480 pg/mL</td><td align="left" valign="bottom">1504.00</td><td align="left" valign="bottom">78.87</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">379.00</td><td align="left" valign="bottom">72.74</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">294.00</td><td align="left" valign="bottom">75.19</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.26</td></tr><tr><td align="left" valign="bottom"><styled-content style="color: #D50000;">CCL26/Eotaxin-3</styled-content></td><td align="left" valign="bottom">1.099 pg/mL</td><td align="left" valign="bottom">1480.00</td><td align="left" valign="bottom">77.61</td><td align="left" valign="bottom">7.00</td><td align="left" valign="bottom">0.37</td><td align="left" valign="bottom">394.00</td><td align="left" valign="bottom">75.62</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.58</td><td align="left" valign="bottom">309.00</td><td align="left" valign="bottom">79.03</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">CXCL8 (HA)</td><td align="left" valign="bottom">22.575 pg/mL</td><td align="left" valign="bottom">84.00</td><td align="left" valign="bottom">4.40</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">11.00</td><td align="left" valign="bottom">2.11</td><td align="left" valign="bottom">1.00</td><td align="left" valign="bottom">0.19</td><td align="left" valign="bottom">23.00</td><td align="left" valign="bottom">5.88</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">CXCL10</td><td align="left" valign="bottom">0.119 pg/mL</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.21</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">CCL2</td><td align="left" valign="bottom">0.072 pg/mL</td><td align="left" valign="bottom">10.00</td><td align="left" valign="bottom">0.52</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">0.77</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">4.00</td><td align="left" valign="bottom">1.02</td></tr><tr><td align="left" valign="bottom"><styled-content style="color: #D50000;">CCL13/MCP-4</styled-content></td><td align="left" valign="bottom">0.230 pg/mL</td><td align="left" valign="bottom">1693.00</td><td align="left" valign="bottom">88.78</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">438.00</td><td align="left" valign="bottom">84.07</td><td align="left" valign="bottom">7.00</td><td align="left" valign="bottom">1.34</td><td align="left" valign="bottom">332.00</td><td align="left" valign="bottom">84.91</td><td align="left" valign="bottom">5.00</td><td align="left" valign="bottom">1.28</td></tr><tr><td align="left" valign="bottom"><styled-content style="color: #D50000;">CCL22/MDC</styled-content></td><td align="left" valign="bottom">1.740 pg/mL</td><td align="left" valign="bottom">985.00</td><td align="left" valign="bottom">51.65</td><td align="left" valign="bottom">3.00</td><td align="left" valign="bottom">0.16</td><td align="left" valign="bottom">245.00</td><td align="left" valign="bottom">47.02</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">197.00</td><td align="left" valign="bottom">50.38</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">CCL3</td><td align="left" valign="bottom">0.319 pg/mL</td><td align="left" valign="bottom">718.00</td><td align="left" valign="bottom">37.65</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">134.00</td><td align="left" valign="bottom">25.72</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">116.00</td><td align="left" valign="bottom">29.67</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">CCL4</td><td align="left" valign="bottom">0.226 pg/mL</td><td align="left" valign="bottom">221.00</td><td align="left" valign="bottom">11.59</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.10</td><td align="left" valign="bottom">33.00</td><td align="left" valign="bottom">6.33</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">32.00</td><td align="left" valign="bottom">8.18</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.51</td></tr><tr><td align="left" valign="bottom">CCL17</td><td align="left" valign="bottom">0.375 pg/mL</td><td align="left" valign="bottom">192.00</td><td align="left" valign="bottom">10.07</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">45.00</td><td align="left" valign="bottom">8.64</td><td align="left" valign="bottom">2.00</td><td align="left" valign="bottom">0.38</td><td align="left" valign="bottom">38.00</td><td align="left" valign="bottom">9.72</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">SLPI</td><td align="left" valign="bottom">20.336  pg/mL</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr><tr><td align="left" valign="bottom">β-defensin-2</td><td align="left" valign="bottom">0.007 ng/mL</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td><td align="left" valign="bottom">0.00</td></tr></tbody></table><table-wrap-foot><fn><p>sPTL = spontaneous preterm labor; PPROM = preterm prelabor rupture of membranes; HA = high affinity.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s2-3"><title>The vaginal immunoproteome of women with sPTB has a pro-inflammatory profile</title><p>To interrogate whether alterations in the vaginal immunoproteome are observed in women destined to undergo sPTB, immune mediator data were quantified in vaginal swabs collected longitudinally from early to late gestation (in the interval of 8–37 weeks) from women who ultimately delivered term or preterm. Linear mixed effects modeling controlling for gestational age at sampling, maternal age, BMI, parity, and history of preterm birth was used to compare the concentrations of immune mediators between cases and controls (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig4">Figure 4</xref>, <xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="fig" rid="fig6">Figure 6</xref><bold>,</bold> <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>, <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>, <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>). Using the same immune mediator categories defined previously, we first looked at the pro-inflammatory cytokines IL-6, IL-1β, IL-16, CXCL8, TNF, IFN-γ, IL-1α, and LT-α. Notably, two pro-inflammatory cytokines that have been considered master regulators of parturition, IL-6 (<xref ref-type="bibr" rid="bib162">Romero et al., 2006a</xref>; <xref ref-type="bibr" rid="bib157">Robertson et al., 2010</xref>; <xref ref-type="bibr" rid="bib82">Gomez‐Lopez et al., 2016</xref>) and IL-1β (<xref ref-type="bibr" rid="bib159">Romero et al., 1989</xref>; <xref ref-type="bibr" rid="bib160">Romero et al., 1992a</xref>), were increased in women who ultimately experienced sPTB compared to those who delivered at term (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Next, we divided cases of sPTB into sPTL and PPROM, as prior studies have suggested that there are distinct mechanisms of disease for PPROM and sPTL (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>; <xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>). We observed that IL-6 and IL-1β were increased in both sPTB subsets compared to women who delivered at term (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). As early and late preterm birth have differing pathophysiology (<xref ref-type="bibr" rid="bib70">Goldenberg et al., 2000</xref>), and adverse outcomes of prematurity are worsened with decreasing gestational age at delivery (<xref ref-type="bibr" rid="bib16">Blencowe et al., 2013</xref>; <xref ref-type="bibr" rid="bib46">Ely and Driscoll, 2020</xref>), we further subdivided cases of sPTL and PPROM into early (&lt;34 weeks) or late (34–36<sup>+6</sup> weeks) according to gestational age at delivery (<xref ref-type="bibr" rid="bib130">Martin and Osterman, 2018</xref>). While the increase in all and late sPTL cases was consistent across all elevated pro-inflammatory cytokines, an increase in both all PPROM and exclusively early PPROM groups was noted only for IL-6 and IL-1β (<xref ref-type="fig" rid="fig3">Figure 3A and B</xref>). Likewise, IL-16, a pro-inflammatory mediator (<xref ref-type="bibr" rid="bib29">Chupp et al., 1998</xref>) reported in the female reproductive tract (FRT) (<xref ref-type="bibr" rid="bib9">Athayde et al., 2000</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), was also increased in late sPTL and early PPROM (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). The vaginal concentrations of CXCL8 (high-affinity, HA), TNF, and IFN-γ, immune mediators previously reported in the vaginal fluid with conflicting results (<xref ref-type="bibr" rid="bib106">Imseis et al., 1997</xref>; <xref ref-type="bibr" rid="bib205">Wennerholm et al., 1998</xref>; <xref ref-type="bibr" rid="bib38">Donders et al., 2003</xref>; <xref ref-type="bibr" rid="bib113">Kalinka et al., 2005</xref>; <xref ref-type="bibr" rid="bib25">Chandiramani et al., 2012</xref>; <xref ref-type="bibr" rid="bib112">Kacerovsky et al., 2015</xref>; <xref ref-type="bibr" rid="bib111">Jung et al., 2016</xref>; <xref ref-type="bibr" rid="bib213">Yoo et al., 2017</xref>; <xref ref-type="bibr" rid="bib175">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib135">Mikołajczyk et al., 2020</xref>; <xref ref-type="bibr" rid="bib176">Short et al., 2021</xref>; <xref ref-type="bibr" rid="bib24">Chan et al., 2022</xref>; <xref ref-type="bibr" rid="bib87">Grewal et al., 2022</xref>), were also increased in women with sPTB compared to term controls (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>). Yet, such elevation appeared to be driven by late sPTL cases (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>). The vaginal concentrations of CXCL8 (low-affinity, LA), IL-1α, and LT-α were unchanged with sPTB (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A–C</xref>). Taken together, these results suggest that some sPTB cases are characterized by a pro-inflammatory milieu in the vaginal ecosystem, which may contribute to the pathophysiology of sPTB; yet, the nature of this inflammatory profile is distinct between clinically defined subsets, highlighting the importance of subcategorization of sPTB for obstetrical disease.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>The vaginal immunoproteome of women with spontaneous preterm birth (sPTB) displays a pro-inflammatory profile.</title><p>Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Violin plots showing the concentrations of (<bold>A</bold>) IL-6, (<bold>B</bold>) IL-1β, (<bold>C</bold>) IL-16, (<bold>D</bold>) CXCL8 (HA), (<bold>E</bold>) TNF, and (<bold>F</bold>) IFN-γ. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all sPTB, orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Pro-inflammatory immune mediator concentration differences between term and sPTB cases with and without adjustment for maternal characteristics, between term, sPTL, and PPROM cases, and between term, early sPTL, late sPTL, early PPROM, and late PPROM cases.</title><p>Red text values in cells indicate significance of the immune mediator both before and after adjustment for maternal characteristics. Gray highlighted cells indicate significance for immune mediators without adjustment for maternal characteristics. Yellow highlighted cells indicate significance of the immune mediator for the etiology of preterm birth and the gestational age period at delivery.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Specific pro-inflammatory cytokines in the vaginal fluid are unaltered with birth outcome.</title><p>Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Violin plots showing the concentrations of (<bold>A</bold>) CXCL8, (<bold>B</bold>) IL-1α, and (<bold>C</bold>) LT-α. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all spontaneous preterm births (sPTB), orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig3-figsupp1-v1.tif"/></fig></fig-group><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The vaginal immunoproteome of women with spontaneous preterm birth (sPTB) harbors a stereotypical monocyte response.</title><p>(<bold>A</bold>) Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Violin plots showing the concentrations of (<bold>B</bold>) CCL2, (<bold>C</bold>) CCL3, and (<bold>D</bold>) CCL4. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all sPTB, orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Monocyte chemokine and macrophage cytokine concentration differences between term and sPTB cases with and without adjustment for maternal characteristics between term, sPTL, and PPROM cases as well as between term, early sPTL, late sPTL, early PPROM, and late PPROM cases.</title><p>Red text values in cells indicate significance of the immune mediator both before and after adjustment for maternal characteristics. Gray highlighted cells indicate significance for immune mediators without adjustment for maternal characteristics. Yellow highlighted cells indicate significance of the immune mediator for the etiology of preterm birth and the gestational age period at delivery.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig4-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig4-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 4A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>The vaginal immunoproteome of women with spontaneous preterm birth (sPTB) includes altered macrophage cytokines.</title><p>(<bold>A</bold>) Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Violin plots showing the concentrations of (<bold>B</bold>) IL-12p70, (<bold>C</bold>) IL-12/IL-23p40, and (<bold>D</bold>) IL-15. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all sPTB, orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks). *p&lt;0.05, **p&lt;0.01, <sup>a</sup>p&gt;0.05 and q&lt;0.1.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig4-figsupp1-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 4—figure supplement 1A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig></fig-group><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The vaginal immunoproteome of women with spontaneous preterm birth (sPTB) is enriched for T-cell mediators.</title><p>(<bold>A</bold>) Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Violin plots showing the concentrations of (<bold>B</bold>) IL-2, (<bold>C</bold>) IL-10, (<bold>D</bold>) IL-4, and (<bold>E</bold>) IL-17A. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all sPTB, orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks). *p&lt;0.05, **p&lt;0.01.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>T-cell cytokine concentration differences between term and sPTB cases with and without adjustment for maternal characteristics, between term, sPTL, and PPROM cases, and between term, early sPTL, late sPTL, early PPROM, and late PPROM cases.</title><p>Red text values in cells indicate significance of the immune mediator both before and after adjustment for maternal characteristics. Gray highlighted cells indicate significance for immune mediators without adjustment for maternal characteristics. Yellow highlighted cells indicate significance of the immune mediator for the etiology of preterm birth and the gestational age period at delivery.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig5-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig5-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 5A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>T-cell cytokines/chemokines and the growth factor IL-7 in the vaginal fluid are unaltered with birth outcome.</title><p>Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Violin plots showing the concentrations of (<bold>A</bold>) IL-5, (<bold>B</bold>) IL-13, (<bold>C</bold>) CXCL10, (<bold>D</bold>) CCL17, and (<bold>E</bold>) IL-7. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all spontaneous preterm births (sPTB), orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks). Immune mediator labels denote their immunobiology category: T-cell cytokine response (blue) and growth factors (orange).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig5-figsupp1-v1.tif"/></fig></fig-group><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The vaginal immunoproteome of women with spontaneous preterm birth (sPTB) exhibits altered antimicrobial proteins and growth factors.</title><p>(<bold>A</bold>) Linear mixed effects modeling adjusted for gestational age at sampling, body mass index (BMI), parity, and history of preterm birth was used to compare the concentrations of proteins between groups. Immune mediator labels denote category: antimicrobial peptides (AMPs) (teal) and growth factors (orange). Violin plots showing the concentrations of (<bold>B</bold>) SLPI, (<bold>C</bold>) β-defensin-2, (<bold>D</bold>) GM-CSF, and (<bold>E</bold>) VEGF. Violin plots for early spontaneous preterm labor with intact membranes (sPTL) and early preterm prelabor rupture of membranes (PPROM) contain data &lt;34 weeks, all other violin plots contain data &lt;37 weeks. Light blue = controls, red = all sPTB, orange = sPTL, purple = PPROM, light orange = early sPTL (gestational age at delivery &lt;34 weeks), dark orange = late sPTL (gestational age at delivery 34–36<sup>+6</sup> weeks), light purple = early PPROM (gestational age at delivery &lt;34 weeks), dark purple = late PPROM (gestational age at delivery 34–36<sup>+6</sup> weeks). *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, <sup>b</sup>p&gt;0.05 and q&lt;0.1.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Antimicrobial peptide and growth factor concentration differences between term and sPTB cases with and without adjustment for maternal characteristics, between term, sPTL, and PPROM cases, and between term, early sPTL, late sPTL, early PPROM, and late PPROM cases.</title><p>Red text values in cells indicate significance of the immune mediator both before and after adjustment for maternal characteristics. Gray highlighted cells indicate significance for immune mediators without adjustment for maternal characteristics. Yellow highlighted cells indicate significance of the immune mediator for the etiology of preterm birth and the gestational age period at delivery.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig6-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig6-v1.tif"/><permissions><copyright-statement>© 2024, BioRender Inc</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>BioRender Inc</copyright-holder><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>Figure 6A was created using <ext-link ext-link-type="uri" xlink:href="https://www.biorender.com/">BioRender</ext-link>, and is published under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND</ext-link> license. Further reproductions must adhere to the terms of this license.</license-p></license></permissions></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Changes in the vaginal immunoproteome are correlated between spontaneous preterm labor with intact membranes (sPTL) and preterm prelabor rupture of membranes (PPROM).</title><p>Correlation of changes in the concentrations of vaginal immune mediators observed in PPROM vs. control (y-axis; coefficient PPROM vs. control) and in sPTL vs. control (coefficient sPTL vs. control). Proteins are categorized into pro-inflammatory cytokines (red), T-cell cytokine response (blue), macrophage cytokine response (purple), chemokines (green), growth factors (orange), and antimicrobial peptides (AMPs) (teal).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig6-figsupp1-v1.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>The trajectory of specific vaginal immune mediators across gestation is distinct with negative birth outcomes compared to gestations resulting in term birth.</title><p>Linear mixed effect modeling with an allowance for an interaction term between preterm birth subsets and gestational age at sampling was used to compare the trajectory of immune mediator concentrations across gestation in pregnancies resulting in black = term delivery, orange = spontaneous preterm labor with intact membranes (sPTL), purple = preterm prelabor rupture of membranes (PPROM). Modeling showed significant change in the trendline of sPTL and/or PPROM in (<bold>A</bold>) IL-1β, (<bold>B</bold>) IL-6, (<bold>C</bold>) VEGF, (<bold>D</bold>) CCL2, (<bold>E</bold>) CCL3, and (<bold>F</bold>) CCL4. Immune mediator labels denote their immunobiology category: pro-inflammatory cytokines (red), growth factors (orange), chemokines (green), and macrophage cytokine response (purple).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig6-figsupp2-v1.tif"/></fig><fig id="fig6s3" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 3.</label><caption><title>The trajectory of specific vaginal immune mediators across gestation is unaltered with birth outcome.</title><p>Linear mixed effect modeling with an allowance for an interaction term between preterm birth subsets and gestational age at sampling was used to compare the trajectory of immune mediator concentrations across gestation in pregnancies resulting in black = term delivery, orange = spontaneous preterm labor with intact membranes (sPTL), purple = preterm prelabor rupture of membranes (PPROM). Modeling showed significant change in the trendline of sPTL and/or PPROM in (<bold>A</bold>) IFNγ, (<bold>B</bold>) IL-10, (<bold>C</bold>) IL-12p70, (<bold>D</bold>) CXCL8, (<bold>E</bold>) IL-2, (<bold>F</bold>) IL-4 (<bold>G</bold>) β-defensin-2 (<bold>H</bold>) TNF, (<bold>I</bold>) IL-15, (<bold>J</bold>) IL-16, and (<bold>K</bold>) IL-17A. Immune mediator labels denote their immunobiology category: pro-inflammatory cytokines (red), T-cell cytokine response (blue), macrophage cytokine response (purple), and antimicrobial peptides (AMPs) (teal). NS, non-significant.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig6-figsupp3-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>The vaginal immunoproteome of women with sPTB harbors a stereotypical monocyte/macrophage response</title><p>The conventional sources of cytokines in an inflammatory response are monocytes and macrophages (<xref ref-type="bibr" rid="bib84">Gordon and Taylor, 2005</xref>; <xref ref-type="bibr" rid="bib197">van de Veerdonk and Netea, 2010</xref>; <xref ref-type="bibr" rid="bib90">Guilliams et al., 2018</xref>). Therefore, we first quantified chemokines responsible for monocyte recruitment such as CCL2, CCL3, and CCL4 (<xref ref-type="bibr" rid="bib173">Shi and Pamer, 2011</xref>; <xref ref-type="bibr" rid="bib158">Robinson et al., 2021</xref>; <xref ref-type="fig" rid="fig4">Figure 4A</xref>). Interestingly, each of these chemokines followed the same pattern: these mediators were increased in women with sPTB compared to those who delivered at term (<xref ref-type="fig" rid="fig4">Figure 4B–D</xref>). Specifically, CCL2 and CCL3 were increased in women with late sPTL and those with early PPROM (<xref ref-type="fig" rid="fig4">Figure 4B and C</xref>), and CCL4 was increased in early and late sPTL as well as in early PPROM (<xref ref-type="fig" rid="fig4">Figure 4D</xref>).</p><p>As a follow-up to the above findings, we also quantified cytokines that are typically produced by tissue-resident macrophages, such as IL-12 (<xref ref-type="bibr" rid="bib195">Trinchieri et al., 2003</xref>; <xref ref-type="bibr" rid="bib198">Vignali and Kuchroo, 2012</xref>) and IL-15 (<xref ref-type="bibr" rid="bib53">Fehniger and Caligiuri, 2001</xref>). We reasoned that the determination of such macrophage-associated cytokines (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>) could provide further insight into the role of the local immunological milieu in the pathophysiology of sPTB. Unlike monocyte chemokines, the vaginal concentrations of the macrophage cytokines did not follow a clear pattern. Specifically, the pro-inflammatory IL-12p70 (<xref ref-type="bibr" rid="bib50">Ethuin et al., 2003</xref>; <xref ref-type="bibr" rid="bib188">Taylor et al., 2013</xref>) was increased in both all and late sPTL cases, but not in other subsets of sPTB (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). By contrast, the anti-inflammatory IL-12/IL-23p40 (<xref ref-type="bibr" rid="bib132">Mattner et al., 1993</xref>; <xref ref-type="bibr" rid="bib114">Kato et al., 1996</xref>) was increased only in early PPROM among the sPTB subsets (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>). Yet, the vaginal concentrations of IL-15 were increased in late sPTL as well as in early PPROM (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>).</p><p>These data suggest that part of the pathophysiology of preterm birth may result in an increased recruitment of monocytes into the lower FRT due to elevated chemokines, a finding observed peripartum in mice (<xref ref-type="bibr" rid="bib192">Timmons et al., 2009</xref>) and in humans (<xref ref-type="bibr" rid="bib145">Osman, 2003</xref>). Similarly, an increase in pro-inflammatory cytokines in the vaginal milieu occurs, possibly contributing to monocyte infiltration and/or the activation of resident macrophages (<xref ref-type="bibr" rid="bib14">Benjelloun et al., 2020</xref>), as indicated by an increase in macrophage-associated cytokines. Together with prior studies implicating activated macrophages in the pro-inflammatory milieu accompanying preterm labor and birth (<xref ref-type="bibr" rid="bib209">Xu et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">Gomez-Lopez et al., 2021</xref>), our study further incriminates such an innate immune response in the pathophysiology of a subset of preterm births.</p></sec><sec id="s2-5"><title>The vaginal immunoproteome of women with sPTB is enriched for T-cell mediators</title><p>Important components of mucosal immunity in the vagina are T cells (<xref ref-type="bibr" rid="bib14">Benjelloun et al., 2020</xref>) and T-cell-associated mediators, such as IL-2 (<xref ref-type="bibr" rid="bib175">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Gandhi et al., 2020</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), IL-4 (<xref ref-type="bibr" rid="bib175">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>; <xref ref-type="bibr" rid="bib123">Kumar et al., 2021</xref>), IL-17A (<xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), IL-10 (<xref ref-type="bibr" rid="bib8">Ashford et al., 2018</xref>; <xref ref-type="bibr" rid="bib175">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), IL-13 (<xref ref-type="bibr" rid="bib175">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), IL-5 (<xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), CXCL10 (<xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), and CCL17 (<xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), the concentrations of which were determined in the current study (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The partial determination of such cytokines/chemokines has been previously reported in the vaginal fluid (<xref ref-type="bibr" rid="bib175">Short et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Ashford et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Gandhi et al., 2020</xref>; <xref ref-type="bibr" rid="bib123">Kumar et al., 2021</xref>); however, their combined evaluation across gestation had not been undertaken. The vaginal concentrations of IL-2 and IL-10 were increased in women with sPTB; specifically, in those with late sPTL, but not in women with PPROM (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). In addition, the vaginal concentrations of IL-4 and IL-17A were increased in specific subsets of sPTB (late sPTL and early PPROM) (<xref ref-type="fig" rid="fig5">Figure 5D and E</xref>). However, the concentrations of IL-5, IL-13, CXCL10, and CCL17 did not differ between sPTB cases and controls (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–D</xref>). These results suggest that certain T-cell-associated mediators are implicated in the pathogenesis of early PPROM and late sPTL. The finding of products from activated T cells expands on previous research implicating T-cell infiltration and increased markers of inflammation in the amniotic fluid of women experiencing PPROM before 34 weeks of gestation (<xref ref-type="bibr" rid="bib63">Galaz et al., 2020</xref>). Indeed, maternal anti-fetal rejection (infiltration of lymphocytes, including T cells, in the placental tissues; <xref ref-type="bibr" rid="bib117">Kim et al., 2015b</xref>) has been suggested as a mechanism of disease for late sPTB (<xref ref-type="bibr" rid="bib115">Kim et al., 2010</xref>), which is consistent with the increase in T-cell-associated cytokines and chemokines observed in this study.</p></sec><sec id="s2-6"><title>The vaginal immunoproteome of women with sPTB exhibits altered antimicrobial proteins and growth factors</title><p>Defensins are key players in vaginal host defense (<xref ref-type="bibr" rid="bib30">Cole, 2006</xref>; <xref ref-type="bibr" rid="bib174">Shimoya et al., 2006</xref>; <xref ref-type="bibr" rid="bib31">Cole and Cole, 2008</xref>; <xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>). Indeed, it was previously reported that reduced vaginal concentrations of β-defensin-2 were associated with sPTB (<xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>). Therefore, we next determined the concentrations of two canonical vaginal defensins: SLPI (<xref ref-type="bibr" rid="bib190">Thompson and Ohlsson, 1986</xref>) and β-defensin-2 (<xref ref-type="bibr" rid="bib93">Harder et al., 1997</xref>; <xref ref-type="bibr" rid="bib65">Ganz, 2003</xref>; <xref ref-type="fig" rid="fig6">Figure 6A</xref>). Notably, the vaginal concentrations of both SLPI and β-defensin-2 were decreased in early PPROM (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>). These results show that a specific subset of preterm births, early PPROM, is associated with reduced concentrations of antimicrobial proteins, indicating that a dampened or impaired antimicrobial response may be associated with its pathophysiology.</p><p>Besides cytokines, chemokines, and defensins, we also determined the vaginal concentrations of growth factors that are associated with immunobiological functions; namely, GM-CSF (<xref ref-type="bibr" rid="bib92">Hamilton, 2008</xref>; <xref ref-type="bibr" rid="bib13">Becher et al., 2016</xref>), VEGF (<xref ref-type="bibr" rid="bib54">Ferrara et al., 2003</xref>; <xref ref-type="bibr" rid="bib7">Apte et al., 2019</xref>), and IL-7 (<xref ref-type="bibr" rid="bib100">Henney, 1989</xref>; <xref ref-type="bibr" rid="bib11">Barata et al., 2019</xref>; <xref ref-type="fig" rid="fig6">Figure 6A</xref>). While the vaginal concentrations of GM-CSF were only increased in early PPROM (<xref ref-type="fig" rid="fig6">Figure 6D</xref>), VEGF was decreased in women with early and late sPTL and early PPROM (<xref ref-type="fig" rid="fig6">Figure 6E</xref>). The vaginal concentrations of IL-7 did not vary between sPTB cases and controls (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>). The differing patterns of association with preterm birth observed in the measured growth factors suggest that, rather than being concomitantly increased or decreased as part of a broad shift in the local inflammatory milieu, each carries out signaling functions that may play a distinct role in the context of different sPTB subsets.</p><p>A sub-analysis was performed to evaluate the degree to which adjustment for maternal characteristics affected the immune mediators found significantly different with birth outcome in our model. We compared the results of the adjusted model to a model constructed after adjusting only for gestational age but not for maternal characteristics (<xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Notably, the lack of adjustment for maternal characteristics confirmed the significance of the immune mediators found in the adjusted model as well as four additional immune mediators, suggesting that adjustment for maternal characteristics provides a more stringent model. In addition, a correlation analysis was also performed between the changes in concentrations of vaginal analytes in sPTL vs. controls and PPROM vs. controls (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Overall, the majority of analytes displayed consistent change between the two sPTB subsets, as demonstrated by positive correlation of fold changes (<italic>r</italic> = 0.87, p&lt;0.0001). VEGF and β-defensin-2 showed the largest decrease in sPTL and PPROM compared to controls, whereas CCL3, CCL4, and IL-6 displayed the largest increase. Yet, specific immune mediators (CXCL10, SLPI, and LT-α) displayed differing directions of change between sPTL and PPROM. This finding indicates that sPTB cases share a common inflammatory profile; yet, subtle differences may allow the distinction of its subsets.</p></sec><sec id="s2-7"><title>The trajectory of vaginal mediators across gestation differs with birth outcome</title><p>Vaginal immune mediators that were shown to be distinct among birth outcome groups in models controlling for gestational age were analyzed again to determine whether the trends of change across gestation varied among the different birth outcomes. Linear mixed effects models with adjustment for all the same covariates as the original analyses, as well as an allowance for an interaction term between sPTB subsets and gestational age at sampling, were constructed to answer this question (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplements 2 and</xref> <xref ref-type="fig" rid="fig6s3">3</xref>). IL-6, CCL2, CCL3, CCL4, and VEGF were shown to have a significant interaction between the disease outcome for sPTL and PPROM and for gestational age (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>). Specifically, the trendline for IL-6, CCL2, CCL3, and CCL4 was more positive for the disease groups than in pregnancies resulting in term birth, whereas for VEGF the trendlines for the disease groups were more negative than that for the term birth group. Notably, IL-1β was the only immune mediator that had a significant interaction term (increased trend) for sPTL but not PPROM (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>), whereas no mediators were significant for PPROM but not sPTL. These data further highlight the shared but subtly different mechanisms of disease underlying sPTL and PPROM.</p></sec><sec id="s2-8"><title>The vaginal immunoproteome can be leveraged as a biomarker for early sPTB</title><p>Up to this point, our data show that specific components of the vaginal immunoproteome are disrupted in women who ultimately undergo sPTB and that such disruption is distinct among different subsets of preterm birth. Therefore, as a proof of concept, we next evaluated whether the vaginal immunoproteome could serve to generate noninvasive biomarkers for preterm birth subsets with improved predictive value over maternal clinical and demographic information. Random forest modeling of the vaginal immunoproteome was used to establish a predictive tool for sPTB and its subtypes. First, using the last sample taken before 28 weeks of gestation, predictive models were created for sPTB subsets, resulting in delivery after 28 weeks: all sPTB cases (<xref ref-type="fig" rid="fig7">Figure 7A</xref>), all sPTL cases (<xref ref-type="fig" rid="fig7">Figure 7B</xref>), sPTL cases delivered before 34 weeks of gestation (sPTL &lt;34 or early sPTL) (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), all PPROM cases (<xref ref-type="fig" rid="fig7">Figure 7D</xref>), and PPROM cases delivered before 34 weeks of gestation (PPROM &lt;34 or early PPROM) (<xref ref-type="fig" rid="fig7">Figure 7E</xref>). When considering the vaginal concentrations of cytokines, chemokines, growth factors, and defensins without including maternal characteristics (black line), the vaginal immunoproteome has the highest potential predictive value for early PPROM &lt;34 (area under the curve [AUC] = 0.787) (<xref ref-type="fig" rid="fig7">Figure 7E</xref>), with the two most informative immune mediators for the prediction of early PPROM being VEGF and IL-1β. Importantly, limiting inclusion in our model to only the five most significant immunoproteins from a univariate analysis for early PPROM would have resulted in similar performance [AUC = 0.701 (0.6–0.802)]. Nonetheless, the combination of all analytes determined in the vaginal fluid resulted in a model with a lower predictive strength for early sPTL &lt;34 (AUC = 0.637) (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) compared to early PPROM. For early sPTL, concentrations of IL-1β, IL-16, and IL-13 were most informative. When maternal characteristics (maternal age, BMI, parity, and history of preterm birth) were included in the models with all vaginal analytes (red line), the prediction accuracy of models predicting sPTB, and the subsets of all sPTL cases and all PPROM cases, was improved (p&lt;0.05 for all) (<xref ref-type="fig" rid="fig7">Figure 7A, B, and D</xref>). On the other hand, the prediction of early sPTL (<xref ref-type="fig" rid="fig7">Figure 7C</xref>) and early PPROM (<xref ref-type="fig" rid="fig7">Figure 7E</xref>) was not improved with the addition of maternal characteristics to the predictive model. Similar conclusions about the significance of the predictions were derived using the area under the precision recall curve (AUPR) instead of the AUC (<xref ref-type="supplementary-material" rid="fig7sdata1">Figure 7—source data 1</xref>), and by determining empirical confidence intervals from permutations rather than relying on the DeLong confidence intervals for the AUC displayed in <xref ref-type="fig" rid="fig7">Figure 7</xref>. To show that the vaginal immunoproteome is capturing variations distinct from maternal characteristics, we compared our models, including the vaginal immunoproteome, to models generated from maternal characteristics alone. Immune mediator data and maternal characteristics resulted in significantly improved prediction of PPROM &lt;34 (DeLong test p&lt;0.023) and led to higher point estimates for all other outcomes when using the last sample before 28 weeks (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The vaginal immunoproteome allows for the prediction of early spontaneous preterm births (sPTB).</title><p>Random forest modeling including protein concentrations generated from the last swab before 28 weeks of gestation was used to generate models using the combination of all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules in this study (black line), maternal characteristics (blue line), or the combination of all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules in this study together with maternal characteristics (red line) for (<bold>A</bold>) all sPTB, (<bold>B</bold>) all spontaneous preterm labor with intact membranes (sPTL), (<bold>C</bold>) sPTL who delivered before 34 weeks of gestation, (<bold>D</bold>) all preterm prelabor rupture of membranes (PPROM), and (<bold>E</bold>) PPROM who delivered before 34 weeks of gestation. Area under the curve (AUC) values and 95% confidence intervals are given for each curve. P-values correspond to the comparisons between the curves of maternal characteristics alone and the curves of maternal characteristics together with all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules within each study group.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Comparison of AUC vs. AUPR statistics for vaginal immunoproteome predictive models of sPTB and subtypes.</title><p>AUC and AUPR calculations used preterm birth and related subgroups as the positive group while the reference (i.e., negative) group always constituted normal pregnancy group controls.</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-90943-fig7-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>The vaginal immunoproteome shows moderate predictive value for early spontaneous preterm labor with intact membranes (sPTL) and preterm prelabor rupture of membranes (PPROM) using swabs collected before 24 weeks.</title><p>The vaginal immunoproteome allows for the prediction of early sPTB. Random forest modeling including protein concentrations generated from the last swab before 24 weeks of gestation was used to generate models using the combination of all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules in this study (black line), maternal characteristics (blue line), or the combination of all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules in this study together with maternal characteristics (red line) for (<bold>A</bold>) all spontaneous preterm births (sPTB), (<bold>B</bold>) all sPTL, (<bold>C</bold>) sPTL who delivered before 30 weeks of gestation, (<bold>D</bold>) all PPROM, and (<bold>E</bold>) PPROM who delivered before 30 weeks of gestation. Area under the curve (AUC) values and 95% confidence intervals are given for each curve.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig7-figsupp1-v1.tif"/></fig><fig id="fig7s2" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 2.</label><caption><title>The vaginal immunoproteome provides increased value when combined with the quantitative cervical length measurement model for predicting early preterm prelabor rupture of membranes (PPROM).</title><p>The vaginal immunoproteome allows for the prediction of early spontaneous preterm births (sPTB). Random forest modeling including protein concentrations generated from the last swab before 28 weeks of gestation and cervical length measured during this time period was used to generate models using the combination of all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules in this study (black line), quantitative cervical length measurements (blue line), or the combination of all cytokines, chemokines, immune-related growth factors, and antimicrobial molecules in this study together with cervical length measurements (red line) for (<bold>A</bold>) all sPTB, (<bold>B</bold>) all spontaneous preterm labor with intact membranes (sPTL), (<bold>C</bold>) sPTL who delivered before 34 weeks of gestation, (<bold>D</bold>) all PPROM, and (<bold>E</bold>) PPROM who delivered before 34 weeks of gestation. Area under the curve (AUC) values and 95% confidence intervals are given for each curve.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-90943-fig7-figsupp2-v1.tif"/></fig></fig-group><p>In an effort to determine whether sPTB can be predicted earlier in the second trimester, a new set of models was developed by using samples collected before 24 weeks of gestation to predict preterm birth after 24 weeks (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Utilizing earlier data also allowed for the prediction of earlier sPTB, specifically for delivery before 30 weeks of gestation. When only considering cytokines, chemokines, growth factors, and defensins in the vaginal fluid (black line), an improved predictive value for sPTL &lt;30 (AUC = 0.743) (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C</xref>) and a similar value for PPROM &lt;30 (AUC = 0.755) (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E</xref>) were observed compared to predictive values for sPTL and PPROM &lt;34 weeks. Similar to our models for preterm birth &lt;34 weeks, the inclusion of maternal characteristics (red line) in predictive models generated from the samples collected before 24 weeks of gestation improved the prediction accuracy for sPTB, all sPTL cases, and all PPROM cases (p&lt;0.05 for all) (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A, B and D</xref>), but not early sPTL or early PPROM (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C and E</xref>). Likewise, the combination of immunoproteomic data and maternal characteristics resulted in higher point estimates than maternal characteristics alone for all outcomes considered, and significantly increased prediction of PPROM &lt;30 (DeLong test p&lt;0.04), when using the last sample before 24 weeks (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1E</xref>).</p><p>Next, we compared the prediction of sPTB by the vaginal immunoproteome against quantitative sonographic cervical length. This analysis was based on a subset of 439 controls and 220 sPTB cases who had one or more cervical length scans at the same time as, or at most within 1 week of, vaginal swab collection. As shown in <xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2</xref>, the vaginal immunoproteome and cervical length provide comparable predictive value for early PPROM; yet, cervical length alone was a better predictor of sPTB than the vaginal immunoproteome. Notably, for early PPROM, adding the immunoproteome data to cervical length increased the AUC point estimate from AUC = 0.727 (0.597–0.857) to AUC = 0.797 (0.678–0.917) (<xref ref-type="fig" rid="fig7s2">Figure 7—figure supplement 2E</xref>), suggesting that the incorporation of the vaginal immune response into predictive screening may bolster the strength of these models.</p><p>Taken together, these results demonstrate that the vaginal immunoproteome analyzed during the second trimester can generate noninvasive biomarkers with potential predictive value for early preterm birth cases, although the clinical utility of such models needs to be investigated further. Regardless, these data show that the vaginal immunoproteome has improved predictive value over maternal characteristics alone for a subset of early sPTB, highlighting that vaginal immune mediator changes in a subset of preterm birth are attributable to factors other than maternal characteristics.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>The vaginal ecosystem includes cellular and soluble components that maintain homeostasis and provide defense against potential pathogens (<xref ref-type="bibr" rid="bib38">Donders et al., 2003</xref>; <xref ref-type="bibr" rid="bib126">Lee et al., 2015</xref>; <xref ref-type="bibr" rid="bib178">Smith and Ravel, 2017</xref>; <xref ref-type="bibr" rid="bib133">Mei et al., 2019</xref>; <xref ref-type="bibr" rid="bib101">Hezelgrave et al., 2020</xref>; <xref ref-type="bibr" rid="bib138">Monin et al., 2020</xref>). While the cellular fraction has been poorly investigated, the soluble components have been well characterized during pregnancy (<xref ref-type="bibr" rid="bib205">Wennerholm et al., 1998</xref>; <xref ref-type="bibr" rid="bib38">Donders et al., 2003</xref>; <xref ref-type="bibr" rid="bib25">Chandiramani et al., 2012</xref>; <xref ref-type="bibr" rid="bib3">Amabebe et al., 2018</xref>; <xref ref-type="bibr" rid="bib8">Ashford et al., 2018</xref>; <xref ref-type="bibr" rid="bib55">Fettweis et al., 2019</xref>; <xref ref-type="bibr" rid="bib208">Witkin et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>; <xref ref-type="bibr" rid="bib24">Chan et al., 2022</xref>). The soluble fraction includes cytokines, chemokines, antimicrobial peptides/proteins, metabolites, antibodies, and complement components, among others, (<xref ref-type="bibr" rid="bib38">Donders et al., 2003</xref>; <xref ref-type="bibr" rid="bib204">Wei et al., 2010</xref>; <xref ref-type="bibr" rid="bib193">Tribe, 2015</xref>; <xref ref-type="bibr" rid="bib144">Oh et al., 2019</xref>; <xref ref-type="bibr" rid="bib153">Pruski et al., 2021</xref>; <xref ref-type="bibr" rid="bib35">Delgado-Diaz et al., 2022</xref>). It is likely that the vaginal soluble fraction mirrors the three inflammatory phases described at the maternal-fetal interface: a pro-inflammatory profile accompanies the process of implantation, an anti-inflammatory state is maintained throughout the majority of gestation, and an inflammatory milieu is associated with the onset of parturition (<xref ref-type="bibr" rid="bib72">Gomez-Lopez et al., 2010</xref>; <xref ref-type="bibr" rid="bib48">Erlebacher, 2013</xref>). Yet, such a concept has not been established and thus remains to be proven. Herein, we report the largest longitudinal investigation of the vaginal immunoproteome from 8 weeks (i.e., after implantation) to term (collected prior to the onset of parturition), showing that several immune mediators are modulated throughout normal gestation. Specifically, we report that, while multiple innate-derived pro-inflammatory mediators undergo a steady reduction, T cell-associated cytokines and the pro-angiogenic factor VEGF increase throughout gestation. These findings suggest that the vaginal immunoproteome undergoes a modest modulation to help ensure that a homeostatic microenvironment is maintained. Our results are consistent with the prevailing hypothesis that immune homeostasis is required to maintain a successful pregnancy until delivery, and that a breakdown of such homeostasis is implicated as a mechanism of disease for sPTB (<xref ref-type="bibr" rid="bib78">Gomez-Lopez et al., 2020</xref>; <xref ref-type="bibr" rid="bib79">Gomez-Lopez et al., 2021</xref>; <xref ref-type="bibr" rid="bib80">Gomez-Lopez et al., 2022a</xref>). Consistent with this hypothesis, systems biology approaches using proteomics, cytomics, and transcriptomics have conceptualized an immunological clock for pregnancy and have suggested that the early detection of its malfunction may allow for the prediction of sPTB (<xref ref-type="bibr" rid="bib1">Aghaeepour et al., 2017</xref>; <xref ref-type="bibr" rid="bib2">Aghaeepour et al., 2018</xref>; <xref ref-type="bibr" rid="bib77">Gomez-Lopez et al., 2019c</xref>; <xref ref-type="bibr" rid="bib69">Ghaemi et al., 2019</xref>; <xref ref-type="bibr" rid="bib148">Peterson et al., 2020</xref>; <xref ref-type="bibr" rid="bib185">Tarca et al., 2021</xref>; <xref ref-type="bibr" rid="bib180">Stelzer et al., 2021</xref>; <xref ref-type="bibr" rid="bib81">Gomez-Lopez et al., 2022b</xref>). Herein, we built upon this concept by longitudinally exploring the vaginal immunoproteome of women who ultimately underwent sPTB.</p><p>Our first set of results showed that multiple pro-inflammatory cytokines, particularly IL-6 and IL-1β, were upregulated in the vaginal fluid of women who ultimately underwent sPTL or PPROM compared to women who delivered at term. Interleukin-6 is a highly pleiotropic cytokine that participates in acute and chronic inflammation, hematopoiesis, and other developmental and physiological processes (<xref ref-type="bibr" rid="bib110">Jones and Jenkins, 2018</xref>). Importantly, IL-6 not only regulates the innate immune response but also participates in the transition to a sustained adaptive immune response, which has made this cytokine and its family attractive targets for immunotherapies (<xref ref-type="bibr" rid="bib110">Jones and Jenkins, 2018</xref>). Moreover, IL-6 regulates the recruitment and activity of leukocytes and may thus be an important upstream regulator of the vaginal chemokine response observed in women with sPTB in the current study. Interleukin-6 also plays a central role in antimicrobial/antiviral immunity (<xref ref-type="bibr" rid="bib110">Jones and Jenkins, 2018</xref>). Indeed, IL-6 is the established biomarker for the diagnosis of acute intra-amniotic inflammation (<xref ref-type="bibr" rid="bib214">Yoon et al., 2001</xref>), the most well-established causal link to preterm labor and birth (<xref ref-type="bibr" rid="bib163">Romero et al., 2006b</xref>; <xref ref-type="bibr" rid="bib164">Romero et al., 2007</xref>; <xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>; <xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>). Consistent with the pro-inflammatory functions of IL-6, IL-1β is also an acute inflammatory cytokine that may even precede the upregulation of IL-6 (<xref ref-type="bibr" rid="bib97">Hazuda et al., 1988</xref>; <xref ref-type="bibr" rid="bib18">Cahill and Rogers, 2008</xref>). Yet, IL-1β is synthesized as a zymogen and therefore requires processing via specific intracellular machinery (i.e., the NLRP3 inflammasome) to be released in its mature and bioactive form (<xref ref-type="bibr" rid="bib122">Kostura et al., 1989</xref>). Notably, we have provided in vivo and in vitro demonstrations that the tissues surrounding the amniotic cavity (i.e., the chorioamniotic membranes), as well as tissues of the upper FRT (e.g., uterine tissues), express the components of the NLRP3 inflammasome (<xref ref-type="bibr" rid="bib150">Plazyo et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Gomez-Lopez et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Gomez-Lopez et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Gomez-Lopez et al., 2019b</xref>; <xref ref-type="bibr" rid="bib75">Gomez-Lopez et al., 2019a</xref>; <xref ref-type="bibr" rid="bib52">Faro et al., 2019</xref>; <xref ref-type="bibr" rid="bib139">Motomura et al., 2020</xref>; <xref ref-type="bibr" rid="bib140">Motomura et al., 2021</xref>; <xref ref-type="bibr" rid="bib141">Motomura et al., 2022</xref>). In fact, in vivo administration of LPS or alarmins, pathogen-associated molecular patterns, and danger-associated molecular patterns that can activate the NLRP3 inflammasome (<xref ref-type="bibr" rid="bib182">Swanson et al., 2019</xref>) results in the processing of active caspase-1 and the subsequent release of mature IL-1β, leading to preterm labor and birth (<xref ref-type="bibr" rid="bib76">Gomez-Lopez et al., 2019b</xref>; <xref ref-type="bibr" rid="bib52">Faro et al., 2019</xref>; <xref ref-type="bibr" rid="bib139">Motomura et al., 2020</xref>; <xref ref-type="bibr" rid="bib140">Motomura et al., 2021</xref>; <xref ref-type="bibr" rid="bib141">Motomura et al., 2022</xref>). In line with these results, the intra-amniotic infusion of IL-1β triggers the common pathway of parturition and leads to preterm birth in non-human primates (<xref ref-type="bibr" rid="bib86">Gravett et al., 1994</xref>; <xref ref-type="bibr" rid="bib207">Witkin et al., 1994</xref>; <xref ref-type="bibr" rid="bib10">Baggia et al., 1996</xref>; <xref ref-type="bibr" rid="bib196">Vadillo-Ortega et al., 2002</xref>; <xref ref-type="bibr" rid="bib171">Sadowsky et al., 2006</xref>; <xref ref-type="bibr" rid="bib152">Presicce et al., 2015</xref>) and mice (<xref ref-type="bibr" rid="bib215">Yoshimura and Hirsch, 2005</xref>). Moreover, the blockade of either of these pro-inflammatory cytokines through natural inhibitors (e.g., IL-1RA [<xref ref-type="bibr" rid="bib161">Romero and Tartakovsky, 1992b</xref>]) or neutralizing antibodies (e.g., anti-IL-6R [<xref ref-type="bibr" rid="bib201">Wakabayashi et al., 2013</xref>; <xref ref-type="bibr" rid="bib51">Farias-Jofre et al., 2023</xref>]) rescues preterm labor and birth. Thus, given their stereotypical role in acute inflammation, the elevated vaginal concentrations of IL-6 and IL-1β described herein may therefore point to a local inflammatory response that precedes intra-amniotic inflammation that is conventionally associated with sPTB. Whether this local increase represents an aberrant host response to vaginal commensals, the sudden expansion of an opportunistic pathogen, or some other host–microbe interaction requires further investigation. Nonetheless, the above-described evidence further supports IL-6 and IL-1β as master regulators of the onset of preterm parturition, as has been previously demonstrated (<xref ref-type="bibr" rid="bib162">Romero et al., 2006a</xref>; <xref ref-type="bibr" rid="bib157">Robertson et al., 2010</xref>; <xref ref-type="bibr" rid="bib82">Gomez‐Lopez et al., 2016</xref>; <xref ref-type="bibr" rid="bib159">Romero et al., 1989</xref>; <xref ref-type="bibr" rid="bib160">Romero et al., 1992a</xref>). It is worth noting that we report distinct patterns of the vaginal immunoproteome between early and late preterm delivery for both sPTB subsets, with the most significant increases observed in women with early PPROM or late sPTL. Thus, these findings provide additional insight into the differing dynamics underlying these two sPTB subsets (<xref ref-type="bibr" rid="bib59">Fortunato et al., 1999</xref>; <xref ref-type="bibr" rid="bib47">Erez et al., 2009</xref>; <xref ref-type="bibr" rid="bib151">Polettini et al., 2014</xref>; <xref ref-type="bibr" rid="bib21">Capece et al., 2014</xref>; <xref ref-type="bibr" rid="bib41">Dutta et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Dvorakova et al., 2017</xref>; <xref ref-type="bibr" rid="bib134">Menon and Richardson, 2017</xref>). Furthermore, these findings could be partially explained by the genetic predisposition observed in the fetal cord blood of women who undergo PPROM, which displays rare mutations of genes involved in the negative regulation of innate immune activation (<xref ref-type="bibr" rid="bib136">Modi et al., 2017</xref>; <xref ref-type="bibr" rid="bib181">Strauss and Pearson, 2018</xref>); however, additional research is required to investigate the maternal contribution to such a predisposition to undergo PPROM. Regardless of the differing mechanisms that can drive sPTL and PPROM, our data support a shared vaginal immune signature that accompanies inflammation-associated sPTB, potentially reflecting the inflammatory status of the amniotic cavity. This observation is consistent with the concept of a ‘common pathway of labor’ (<xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>) and indicates that it is important to distinguish between changes in vaginal immune mediators that are driven by labor and those that are specific to the disease subset (i.e., sPTL vs. PPROM).</p><p>Another finding of the current study was the observed increase in the vaginal concentrations of chemokines implicated in leukocyte recruitment, i.e., CCL2, CCL3, and CCL4, in women who ultimately underwent sPTL or PPROM. The primary receptor for CCL2 is CCR2, which is predominantly expressed by inflammatory monocytes and controls the trafficking of such cells (<xref ref-type="bibr" rid="bib88">Griffith et al., 2014</xref>). CCL2 is rapidly produced by activated tissue or immune cells, and CCL2/CCR2 interactions are considered to be required for inflammatory monocyte migration into peripheral tissues (<xref ref-type="bibr" rid="bib124">Kuziel et al., 1997</xref>). CCL3 and CCL4 can signal through CCR1 and CCR5, which can be expressed by monocytes and T cells (<xref ref-type="bibr" rid="bib88">Griffith et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Dyer, 2020</xref>). CCR1 and CCR5 have been demonstrated to promote monocyte adhesion and transmigration in an in vitro setting (<xref ref-type="bibr" rid="bib203">Weber et al., 2001</xref>). Indeed, monocytes and macrophages are found in the lower reproductive tract in low numbers (<xref ref-type="bibr" rid="bib202">Wang et al., 2021</xref>), including during pregnancy (<xref ref-type="bibr" rid="bib192">Timmons et al., 2009</xref>), and their abundance is associated with inflammation (<xref ref-type="bibr" rid="bib202">Wang et al., 2021</xref>). In addition, the priming of CD8+ T cells also relies on CCL3/CCL4 signaling through CCR5 (<xref ref-type="bibr" rid="bib22">Castellino et al., 2006</xref>; <xref ref-type="bibr" rid="bib103">Hugues et al., 2007</xref>), thus the increased presence of these chemokines in the vaginal fluid of women who experience sPTB has interesting implications for the pathogenesis of preterm birth. In the context of prior findings, our results suggest that increased chemokine concentrations may contribute to a hostile vaginal milieu through enhanced infiltration of monocytes that could then activate local T cells, a considerable portion of the vaginal immune cell composition (<xref ref-type="bibr" rid="bib126">Lee et al., 2015</xref>). Our findings are in line with a prior report that demonstrated increased cervico-vaginal concentrations of CCL2 in women who underwent preterm birth compared to those who delivered at term (<xref ref-type="bibr" rid="bib55">Fettweis et al., 2019</xref>). Moreover, women who ultimately will develop a short cervix, which is a strong predictor of sPTB (<xref ref-type="bibr" rid="bib6">Andersen et al., 1990</xref>; <xref ref-type="bibr" rid="bib104">Iams et al., 1996</xref>; <xref ref-type="bibr" rid="bib98">Heath et al., 1998</xref>; <xref ref-type="bibr" rid="bib94">Hassan et al., 2000</xref>; <xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>; <xref ref-type="bibr" rid="bib165">Romero et al., 2014a</xref>), displayed a fivefold increase in their vaginal concentrations of CCL2 compared to controls (<xref ref-type="bibr" rid="bib25">Chandiramani et al., 2012</xref>). These data suggest that women destined to undergo sPTL and PPROM share a common signature of monocyte recruitment prior to disease onset; indeed, such infiltrating cells may represent a source of the acute vaginal cytokine response (i.e., elevated concentrations of IL-6 and IL-1β) that was also observed herein. However, the evaluation of individual mediator kinetics throughout pregnancy would require a substantially greater number of sampling points, making the determination of whether chemokine release precedes the acute inflammatory response nearly impossible. Nonetheless, the role of such mediators in the pathogenesis of each subset of sPTB requires further investigation.</p><p>AMPs, which include defensins, cathelicidins, whey acidic proteins, lysozymes, C-type lectins, and S100 proteins, among others, are soluble mediators that participate in the host innate immune response against pathogens in the FRT (<xref ref-type="bibr" rid="bib211">Yarbrough et al., 2015</xref>). Defensins are the largest family of AMPs found in humans, comprising small cationic peptides produced by a variety of immune and nonimmune cells, and are subdivided into α, β, and θ defensins (<xref ref-type="bibr" rid="bib127">Lichtenstein, 1991</xref>; <xref ref-type="bibr" rid="bib210">Yang et al., 2002</xref>; <xref ref-type="bibr" rid="bib129">Maisetta et al., 2003</xref>; <xref ref-type="bibr" rid="bib65">Ganz, 2003</xref>). Specifically, there are four human β-defensins (HBD-1–4) which are primarily expressed by epithelial cells and have been reported in the FRT (<xref ref-type="bibr" rid="bib120">King et al., 2003</xref>; <xref ref-type="bibr" rid="bib211">Yarbrough et al., 2015</xref>), including the vaginal fluid (<xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>) as well as in the gestational tissues (<xref ref-type="bibr" rid="bib49">Espinoza et al., 2003</xref>; <xref ref-type="bibr" rid="bib179">Soto et al., 2007</xref>; <xref ref-type="bibr" rid="bib121">King et al., 2007</xref>; <xref ref-type="bibr" rid="bib118">Kim et al., 2022</xref>). Indeed, the vaginal concentrations of β-defensin-2 were found to be decreased in women who ultimately underwent sPTB compared to those who delivered at term (<xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>). Consistently, in the current study we confirmed that the vaginal concentrations of β-defensin-2 are decreased in women with sPTB, particularly in those with early PPROM. Early PPROM has been previously associated with increased rates of neonatal morbidity (<xref ref-type="bibr" rid="bib85">Goya et al., 2013</xref>; <xref ref-type="bibr" rid="bib216">Yu et al., 2015</xref>; <xref ref-type="bibr" rid="bib149">Pinto et al., 2019</xref>) and mortality (<xref ref-type="bibr" rid="bib85">Goya et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">González-Mesa et al., 2021</xref>; <xref ref-type="bibr" rid="bib216">Yu et al., 2015</xref>), thus women at risk for this subset of sPTB represent a target population for the development of predictive and preventive clinical tools. Such a decrease in β-defensin-2 was mirrored by SLPI, another AMP that has also been reported in the FRT and vaginal fluid (<xref ref-type="bibr" rid="bib211">Yarbrough et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>). SLPI is a secreted inhibitor that protects host cells against damage from extracellular proteases and is a central player in the constitutive host response in the FRT (<xref ref-type="bibr" rid="bib99">Hein et al., 2002</xref>; <xref ref-type="bibr" rid="bib107">Itaoka et al., 2015</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>). We previously showed that SLPI is negatively correlated with <italic>Gemella</italic> spp. (<xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>), a member of the vaginal community state type (CST) IV (<xref ref-type="bibr" rid="bib154">Ravel et al., 2011</xref>) that is linked to increased risk for preterm birth (<xref ref-type="bibr" rid="bib36">DiGiulio et al., 2015</xref>; <xref ref-type="bibr" rid="bib183">Tabatabaei et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>; <xref ref-type="bibr" rid="bib102">Hočevar et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Chang et al., 2020</xref>; <xref ref-type="bibr" rid="bib143">Odogwu et al., 2021</xref>; <xref ref-type="bibr" rid="bib123">Kumar et al., 2021</xref>; <xref ref-type="bibr" rid="bib40">Dunlop et al., 2021</xref>). Similar to SLPI, reduced vaginal concentrations of β-defensin-2 are associated with vaginal CST IV and sPTB (<xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>). Taken together, these results suggest that the vaginal ecosystem of women who are destined to undergo early PPROM displays a suppressed AMP-driven host response; however, additional research is required to determine whether this decrease reflects an impaired or a dampened response.</p><p>A distinct finding is that VEGF, uniquely among the growth factors, was decreased in women who experienced sPTB. VEGF is one member of a family of pro-angiogenic, pro-vasculogenic growth factors with mild immunobiological functions including hematopoiesis (<xref ref-type="bibr" rid="bib67">Gerber and Ferrara, 2003</xref>; <xref ref-type="bibr" rid="bib66">Gerber et al., 2002</xref>) and vascular permeability (<xref ref-type="bibr" rid="bib28">Chen et al., 2012</xref>; <xref ref-type="bibr" rid="bib125">Lal et al., 2001</xref>). Indeed, disruption of VEGF proteins and their receptors is largely implicated in diseases associated with vascular malformations including obstetrical diseases such as preeclampsia (<xref ref-type="bibr" rid="bib184">Tarca et al., 2019</xref>; <xref ref-type="bibr" rid="bib186">Tarca et al., 2022</xref>; <xref ref-type="bibr" rid="bib23">Chaiworapongsa et al., 2004</xref>), a known etiology of iatrogenic preterm birth (<xref ref-type="bibr" rid="bib71">Goldenberg et al., 2008</xref>). Interestingly, while disrupted vascularization is an accepted risk factor of sPTB (<xref ref-type="bibr" rid="bib199">Visser et al., 2021</xref>), the evidence surrounding VEGF’s role remains limited. While one study implicated decreased amniotic fluid levels of VEGF in PPROM (<xref ref-type="bibr" rid="bib172">Savasan et al., 2010</xref>), another study found no association between preterm birth and VEGF in the cervico-vaginal space (<xref ref-type="bibr" rid="bib212">Yilmaz et al., 2014</xref>). Yet, more recently, we showed that vaginal concentrations of VEGF were negatively correlated with <italic>Gemella</italic> spp. in women who went on to experience preterm birth (<xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>). In the context of previous studies, our data suggest that a hostile vaginal milieu may lead to reduced VEGF levels and functions, such as angiogenesis, which could be implicated with early preterm birth regardless of the process of membrane rupture.</p><p>A major finding of the current study is that the vaginal immunoproteome sampled prior to 24 weeks of gestation can be utilized to generate noninvasive biomarkers with potential utility for the prediction of sPTB occurring before 30 weeks of gestation. This window of sampling is clinically relevant, given that ultrasound screening is performed between 20 and 24 weeks of gestation and improves the feasibility of implementing vaginal sampling for cytokine determinations as part of prenatal care. Another advantage of our model is its potential for the prediction of early sPTB, which is associated with more severe neonatal outcomes than those cases occurring after 34 weeks of gestation (<xref ref-type="bibr" rid="bib19">Callaghan et al., 2006</xref>; <xref ref-type="bibr" rid="bib33">Crump et al., 2019</xref>) and may provide the opportunity for personalized patient management to improve adverse perinatal outcomes. It is worth mentioning that the models generated herein showed the best predictive value for early PPROM, which highlights the importance of distinguishing between different subsets of sPTB (i.e., early and late sPTL and PPROM) to improve prediction. Indeed, for pregnancies resulting in early preterm birth, the immunoproteome provides improved predictive strength over previous biomarker models that utilized the vaginal microbiome (<xref ref-type="bibr" rid="bib170">Romero et al., 2022</xref>). Nonetheless, our results as well as those of previous studies suggest that the assessment of the immune response and its interactions with the microbiome (<xref ref-type="bibr" rid="bib55">Fettweis et al., 2019</xref>; <xref ref-type="bibr" rid="bib56">Flaviani et al., 2021</xref>; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>; <xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>) could be considered together with other prenatal screening tools to construct a comprehensive minimally invasive screening tool for preterm birth.</p><p>Herein, we also showed that overall maternal characteristics alone have a poor predictability for all subsets of preterm birth; yet, the combination of the vaginal immunoproteome and maternal characteristics improved such predictive capacity. Furthermore, while the predictability of the vaginal immunoproteome alone was not superior to that of the sonographic cervical length, the combination of the vaginal immunoproteome and cervical length improved the predictive value for early PPROM. This is important because there is an imperative need for finding noninvasive biomarkers to predict preterm birth in low-resource areas wherein there is a high risk for this pregnancy complication (<xref ref-type="bibr" rid="bib34">DeFranco et al., 2008</xref>; <xref ref-type="bibr" rid="bib177">Smith et al., 2007</xref>). Although sonographic cervical length remains an excellent predictor for preterm birth, the implementation of cervical length measurement as a universal screening modality for sPTB worldwide has been challenging. Indeed, even developed countries have not been able to enact widespread universal screening of cervical length due to logistic barriers as well as patient refusal to participate in this intrusive procedure (<xref ref-type="bibr" rid="bib189">Temming et al., 2016</xref>; <xref ref-type="bibr" rid="bib147">Pedretti et al., 2017</xref>). From a logistical standpoint, the accurate acquisition and interpretation of cervical length measurements require a highly trained maternal-fetal specialist (<xref ref-type="bibr" rid="bib105">Iams et al., 2013</xref>). As of 2018, only 1570 maternal-fetal medicine specialists were registered in the US workforce (<xref ref-type="bibr" rid="bib206">Wenstrom et al., 2018</xref>) and these specialists are neither distributed equally across the country nor the world, thereby representing a scarce resource. Also, the ultrasound equipment and facilities required to perform cervical length examinations have a prohibitive cost and are unavailable to many women, especially those who are medically underserved, reflecting widespread disparities in medicine (<xref ref-type="bibr" rid="bib96">Haviland et al., 2016</xref>). Furthermore, only 1–2% of pregnant mothers have the clinical finding of a sonographic short cervix in a mid-trimester transvaginal ultrasound screening (<xref ref-type="bibr" rid="bib58">Fonseca et al., 2007</xref>). Among these women, selective administration of vaginal progesterone will reduce the risk of delivery before 37 weeks by half (<xref ref-type="bibr" rid="bib58">Fonseca et al., 2007</xref>). Thus, while this pairing of predictive and preventive tools to sPTB has been modestly effective, the population of pregnant women for whom both cervical length and progesterone administration are beneficial represents a small fraction of the 10% of women who deliver preterm worldwide (<xref ref-type="bibr" rid="bib27">Chawanpaiboon et al., 2019</xref>; <xref ref-type="bibr" rid="bib131">Martin and Hamilton, 2021</xref>). Therefore, investigating biomarkers, including previously suggested immune mediators (e.g. SLPI; <xref ref-type="bibr" rid="bib57">Florova et al., 2021</xref>) and β-defensin-2 (<xref ref-type="bibr" rid="bib45">Elovitz et al., 2019</xref>), that can be easily collected and analyzed in a scalable manner could overcome these shortcomings. As shown here, the addition of the vaginal immunoproteome improved the predictability for specific subsets of preterm birth, specifically early PPROM. An advantage of vaginal sampling is that self-swabbing is now considered an effective way of vaginal fluid collection (<xref ref-type="bibr" rid="bib91">Haguenoer et al., 2014</xref>; <xref ref-type="bibr" rid="bib128">Lunny et al., 2015</xref>); therefore, a screening tool based on vaginal biomarkers may be developed for use in low-resource areas with a scarcity of healthcare providers. Herein, vaginal immune mediators were identified with distinct patterns between women who delivered at term and those who delivered preterm. Collectively, the identified vaginal immune mediators in this study could potentially be incorporated into a comprehensive molecular screening assay capable of supplementing sonographic short cervix screening, and even supplanting it in low-resource areas. Yet, further research is needed to investigate its utility.</p><p>A limitation of the current report is that, despite our comprehensive survey of the vaginal immunoproteome, the identification of causal mechanisms driving the changes in specific mediators associated with different subsets of preterm birth is yet to be elucidated. The incorporation of microbiome and other omics, as well as mechanistic approaches requiring the utilization of animal models, was outside the scope of the research question investigated herein. Yet, we consider that the substantial data generated in this study, together with our predictive models, can serve to spark new investigations focused on targeting key mediators and their relationships with local immune-microbiome interactions in the context of pregnancy complications. Lastly, the population included in this study was primarily composed of African-American women. Additional studies are required to ascertain the generalizability of these results to other populations.</p><p>The current study represents the largest longitudinal survey of the vaginal immunoproteome in a population at high risk for sPTB. We report that, throughout uncomplicated gestation, the vaginal immunoproteome harbors a cytokine network that represents a homeostatic profile similar to that observed in other body sites during the second phase of pregnancy. By contrast, the vaginal immunoproteome is skewed toward a pro-inflammatory state in women who ultimately undergo sPTL and PPROM. Such an inflammatory profile includes increased monocyte chemoattractants, cytokines associated with macrophage and T-cell activation, and the consistent reduction of antimicrobial proteins/peptides. Notably, our data show that the vaginal immunoproteome during the second trimester holds predictive value for PPROM before 30 weeks of gestation, indicating that the vaginal immune response can be leveraged as part of a noninvasive approach for the prediction of early sPTB, the leading cause of neonatal morbidity and mortality worldwide.</p><sec id="s3-1"><title>Resource availability</title><sec id="s3-1-1"><title>Lead contact</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Nardhy Gomez-Lopez (nardhy@wustl.edu).</p></sec></sec></sec><sec id="s4" sec-type="methods"><title>Methods</title><sec id="s4-1"><title>Experimental model and subject details</title><sec id="s4-1-1"><title>Human subjects, clinical specimens, and definitions</title><p>This was a retrospective longitudinal case–control study evaluating the associations between the vaginal immunoproteome across pregnancy and the incidence of sPTB (i.e., sPTL or PPROM resulting in delivery &lt;37 weeks). Term controls were defined as women who delivered ≥37 weeks of gestation. Patients with twins, fetal malformations, or those with less than three vaginal fluid samples collected throughout pregnancy were excluded. All cases meeting these specific criteria with samples in the biobank were included in the study. Cases were matched, based on ethnicity and maternal age, with term controls at a ratio of 1:2, and samples between these groups were further matched by gestational age at sampling. Samples were collected longitudinally across gestation from each subject under direct visualization from the posterior vaginal fornix using a Dacron swab (Medical Packaging Corp, Camarillo, CA) and a BD ESwab (COPAN ITALIA, Brescia, Italy/Beckton Dickinson, Loveton Circle Sparks, MD). No samples were collected after presentation to the clinic with signs of labor or rupture of membranes to avoid samples being affected by amniotic fluid leakage and/or treatment. Vaginal swabs/supernatants were stored at –80°C until cytokine, chemokine, or other biomarker concentrations were assessed. The study was conducted at the Perinatology Research Branch, an intramural program of the <italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, U.S. Department of Health and Human Services, Wayne State University (Detroit, MI), and the Detroit Medical Center (Detroit, MI). The collection and use of human materials for research purposes were approved by the Institutional Review Boards of the National Institute of Child Health and Human Development and Wayne State University (#110605MP2F(RCR)). All participating women provided written informed consent prior to sample collection.</p><p>Gestational age was determined by the last menstrual period and confirmed by ultrasound examination, or by ultrasound examination alone when the sonographic determination of gestational age was inconsistent with menstrual dating. sPTL was defined as the presence of regular uterine contractions with a frequency of at least two every 10  min and cervical changes between 20 and 36<sup>+6</sup> weeks of gestation with intact membranes (as determined by a lack of amniotic fluid pooling in the vagina, negative ferning, or a negative nitrazine test). PPROM was defined as amniorrhexis confirmed by vaginal pooling, ferning, or a positive nitrazine test prior to the onset of labor before 37 weeks of gestation (<xref ref-type="bibr" rid="bib194">Tricomi et al., 1966</xref>; <xref ref-type="bibr" rid="bib62">Friedman and McElin, 1969</xref>; <xref ref-type="bibr" rid="bib15">Bennett et al., 1993</xref>). This classification gave the following sample breakdown: (i) women who delivered at term (494 patients, 1907 samples); (ii) women who underwent sPTL (140 patients, 521 samples); and (iii) women who experienced PPROM (105 patients, 391 samples). All women included in the sPTL and PPROM groups delivered preterm (&lt;37 weeks of gestation). All samples were collected prior to patients presenting with signs of labor or membrane rupture.</p></sec></sec><sec id="s4-2"><title>Method details</title><sec id="s4-2-1"><title>Placental histopathological inflammation</title><p>Placentas were examined histologically by perinatal pathologists blinded to clinical diagnoses and obstetrical outcomes according to standardized Perinatology Research Branch protocols (<xref ref-type="bibr" rid="bib116">Kim et al., 2015a</xref>). Briefly, 3–9 sections of the placenta were examined, and at least one full-thickness section was taken from the center of the placenta; others were taken randomly from the placental disc. Acute inflammatory lesions of the placenta (maternal placental inflammatory response [defined as invasion of neutrophils into the chorioamniotic membranes] and fetal placental inflammatory response [acute lesions in the umbilical cord and/or chorionic plate, diagnosed by invasion of neutrophils into these tissues]) were diagnosed according to established criteria (<xref ref-type="bibr" rid="bib116">Kim et al., 2015a</xref>; <xref ref-type="bibr" rid="bib156">Redline, 2015</xref>).</p></sec><sec id="s4-2-2"><title>Determination of immune mediator concentrations in vaginal fluid supernatants</title><p>All vaginal swabs were processed and were centrifuged for 10 min at 1300 × <italic>g</italic> and 4°C. Supernatants from Dacron swabs were stored at −80°C until the determination of cytokine/chemokine concentrations. The V-PLEX Pro-Inflammatory Panel 1 (human), Cytokine Panel 1 (human), and the Chemokine Panel 1 (human) immunoassays (Meso Scale Discovery, Rockville, MD) were used to measure the concentrations of IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, and TNF (Pro-inflammatory Panel 1); or GM-CSF, IL-1α, IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, LT-α, and VEGF (VEGF-A) (Cytokine Panel 1); or CCL11 (Eotaxin), CCL26 (Eotaxin-3), CXCL8 (IL-8 (HA)), CXCL10 (IP-10), CCL2 (MCP-1), CCL13 (MCP-4), CCL22 (MDC), CCL3 (MIP-1α), CCL4 (MIP-1β), and CCL17 (TARC) (Chemokine Panel 1) in the cervicovaginal fluid according to the manufacturer’s instructions. A MESO QuickPlex SQ 120 (Meso Scale Discovery) was used to read the plates and analyte concentrations were calculated with the Discovery Workbench 4.0 (Meso Scale Discovery). The sensitivities of the assays were 0.368 pg/mL (IFN-γ), 0.152 pg/mL (IL-1β), 0.219 pg/mL (IL-2), 0.028 pg/mL (IL-4), 0.113 pg/mL (IL-6), 0.101 pg/mL (IL-8), 0.054 pg/mL (IL-10), 0.084 pg/mL (IL-12p70), 0.119 pg/mL (IL-13), 0.108 pg/mL (TNF), 0.200 pg/mL (GM-CSF), 0.089 pg/mL (IL-1α), 0.162 pg/mL (IL-5), 0.124 pg/mL (IL-7), 0.408 pg/mL (IL-12/IL-23p40), 0.111 pg/mL (IL-15), 0.478 pg/mL (IL-16), 0.381 pg/mL (IL-17A), 0.095 pg/mL (LT-α), 0.264 pg/mL (VEGF), 0.480 pg/mL (CCL11/Eotaxin), 1.099 pg/mL (CCL26/Eotaxin-3), 22.575 pg/mL (CXCL8/IL-8 (HA)), 0.119 pg/mL (CXCL10/IP-10), 0.072 pg/mL (CCL2/MCP-1), 0.230 pg/mL (CCL13/MCP-4), 1.740 pg/mL (CCL22/MDC), 0.319 pg/mL (CCL3/MIP-1α), 0.226 pg/mL (CCL4/MIP-1β), and 0.375 pg/mL (CCL17/TARC).</p><p>BD Eswabs were utilized to determine the vaginal fluid supernatant concentrations of SLPI and β-defensin-2 using the Quantikine ELISA human SLPI immunoassay (R&amp;D Systems, Minneapolis, MN) and the β-defensin-2 ELISA immunoassay (ALPCO, Salem, NH), according to the manufacturer’s instructions. A SpectraMax iD5 (Molecular Devices, San Jose, CA) was used to read the plates and analyte concentrations were calculated with the SoftMax Pro 7 (Molecular Devices). The sensitivities of the assays were 20.336 pg/mL (SLPI) and 0.007 ng/mL (β-defensin 2).</p><p>Vaginal fluid cytokine, chemokine, and other immune mediator concentrations were adjusted by total protein concentration, which were determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific, Rockford, IL), following the manufacturer’s instructions. All immunoassay kits were validated for vaginal swab determinations of the analytes.</p></sec></sec><sec id="s4-3"><title>Quantification and statistical analysis</title><p>Values below detection limit were imputed with 99% of the smallest detected value. Values larger than two times the 99th percentile were set to two times the 99th percentile. All analyses were performed in R (version 3.6.1; <xref ref-type="bibr" rid="bib155">R Development Core Team, 2010</xref>). Plots were generated with ggplot2 (version 3.3.5) and ggpubr (version 0.4.0.). Changes in immunoprotein abundance (log<sub>2</sub> thereof) with gestational age at sampling were assessed via linear mixed effects models (<xref ref-type="bibr" rid="bib12">Bates and Machler, 2015</xref>) to account for repeated observations from the same individuals using the lme4 package (version 1.1-26). The trends in scatterplots were estimated using generalized additive models with spline transformations of gestational age at sample collection using the mgcv package (version 1.8-35). Differences between sPTB, sPTL, or PPROM and controls were assessed based on data collected at &lt;37 weeks. Comparisons between early (delivery &lt;34 weeks) sPTL or PPROM and controls were based on data collected before 34 weeks. Violin plots for controls, sPTB, sPTL, PPROM, late sPTL, and late PPROM include data collected at &lt;37 weeks. Violin plots for early sPTL and early PPROM contain data &lt;34 weeks. Differences between cases and controls were assessed using linear mixed effects models with adjustment for gestational age at sampling, maternal age, BMI, parity, and history of preterm birth. p-Values for the significance of the coefficients in the linear mixed effects models were determined via <italic>t</italic>-statistics using Satterthwaite’s methods for degrees of freedom, which is the default method in the lmerTest package in R (version 3.1.3). To account for multiple testing, nominal p-values were adjusted using the false discovery rate method to obtain q-values. A 10% cutoff of false discovery rate was used in all analyses to infer significance. Prediction of preterm birth after 24 weeks was based on data collected prior to 24 weeks. Prediction of preterm birth after 28 weeks was based on data collected up to 28 weeks. Random forest models (<xref ref-type="bibr" rid="bib17">Breiman, 2001</xref>) (R package randomForest version 4.6–14) with 1000 trees were trained and evaluated via tenfold cross-validation, and AUC was calculated with DeLong 95% confidence intervals (R package pROC version 1.17.0.1). Models with an AUC 95% confidence interval with a lower bound above 0.5 were considered significant. The importance of individual immune mediators in these analyses was determined using the mean decrease in Gini coefficient.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Funding acquisition, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Visualization, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Software, Formal analysis, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Resources, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Investigation, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con11"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>The collection and use of human materials for research purposes were approved by the Institutional Review Boards of the National Institute of Child Health and Human Development and Wayne State University (#110605MP2F(RCR)). All participating women provided written informed consent prior to sample collection.</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-90943-mdarchecklist1-v1.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>The data generated during this study are available on <ext-link ext-link-type="uri" xlink:href="https://github.com/aditarca/ImmunoProteomePTB">GitHub</ext-link> (copy archived at <xref ref-type="bibr" rid="bib187">Tarca, 2024</xref>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the physicians, nurses, and research assistants from the Center for Advanced Obstetrical Care and Research, Intrapartum Unit, Perinatology Research Branch Clinical Laboratory, and Perinatology Research Branch Perinatal Translational Science Laboratory for help with collecting and processing samples. We also thank Rona Wang and Gregorio Martinez III for help with carrying out some of the assays, and Derek Miller for his critical feedback on the manuscript. This research was conducted by the Perinatology Research Branch, Division of Obstetrics and Maternal-Fetal Medicine, Division of Intramural Research, <italic>Eunice Kennedy Shriver</italic> National Institute of Child Health and Human Development, National Institutes of Health, US Department of Health and Human Services (NICHD/NIH/DHHS) under contract HHSN275201300006C. ALT, KRT, and NGL were supported by the Wayne State University Perinatal Initiative in Maternal, Perinatal and Child Health. RR contributed to this work as part of his official duties as an employee of the US federal government. Figures include art created with BioRender.com.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghaeepour</surname><given-names>N</given-names></name><name><surname>Ganio</surname><given-names>EA</given-names></name><name><surname>Mcilwain</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>AS</given-names></name><name><surname>Tingle</surname><given-names>M</given-names></name><name><surname>Van Gassen</surname><given-names>S</given-names></name><name><surname>Gaudilliere</surname><given-names>DK</given-names></name><name><surname>Baca</surname><given-names>Q</given-names></name><name><surname>McNeil</surname><given-names>L</given-names></name><name><surname>Okada</surname><given-names>R</given-names></name><name><surname>Ghaemi</surname><given-names>MS</given-names></name><name><surname>Furman</surname><given-names>D</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Winn</surname><given-names>VD</given-names></name><name><surname>Druzin</surname><given-names>ML</given-names></name><name><surname>El-Sayed</surname><given-names>YY</given-names></name><name><surname>Quaintance</surname><given-names>C</given-names></name><name><surname>Gibbs</surname><given-names>R</given-names></name><name><surname>Darmstadt</surname><given-names>GL</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Nolan</surname><given-names>GP</given-names></name><name><surname>Lewis</surname><given-names>DB</given-names></name><name><surname>Angst</surname><given-names>MS</given-names></name><name><surname>Gaudilliere</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>An immune clock of human pregnancy</article-title><source>Science Immunology</source><volume>2</volume><elocation-id>eaan2946</elocation-id><pub-id pub-id-type="doi">10.1126/sciimmunol.aan2946</pub-id><pub-id pub-id-type="pmid">28864494</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghaeepour</surname><given-names>N</given-names></name><name><surname>Lehallier</surname><given-names>B</given-names></name><name><surname>Baca</surname><given-names>Q</given-names></name><name><surname>Ganio</surname><given-names>EA</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Ghaemi</surname><given-names>MS</given-names></name><name><surname>Culos</surname><given-names>A</given-names></name><name><surname>El-Sayed</surname><given-names>YY</given-names></name><name><surname>Blumenfeld</surname><given-names>YJ</given-names></name><name><surname>Druzin</surname><given-names>ML</given-names></name><name><surname>Winn</surname><given-names>VD</given-names></name><name><surname>Gibbs</surname><given-names>RS</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Gaudilliere</surname><given-names>B</given-names></name><name><surname>Angst</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A proteomic clock of human pregnancy</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>218</volume><elocation-id>347</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2017.12.208</pub-id><pub-id pub-id-type="pmid">29277631</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amabebe</surname><given-names>E</given-names></name><name><surname>Chapman</surname><given-names>DR</given-names></name><name><surname>Stern</surname><given-names>VL</given-names></name><name><surname>Stafford</surname><given-names>G</given-names></name><name><surname>Anumba</surname><given-names>DOC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth</article-title><source>Journal of Reproductive Immunology</source><volume>126</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.jri.2018.01.001</pub-id><pub-id pub-id-type="pmid">29367099</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American College of Obstetricians and Gynecologists</collab></person-group><year iso-8601-date="2016">2016</year><article-title>Practice bulletin no. 171: management of preterm labor</article-title><source>Obstetrics &amp; Gynecology</source><volume>128</volume><fpage>e155</fpage><lpage>e164</lpage><pub-id pub-id-type="doi">10.1097/AOG.0000000000001711</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American College of Obstetricians and Gynecologists</collab></person-group><year iso-8601-date="2021">2021</year><article-title>Prediction and prevention of spontaneous preterm birth</article-title><source>Obstetrics &amp; Gynecology</source><volume>138</volume><fpage>e65</fpage><lpage>e90</lpage><pub-id pub-id-type="doi">10.1097/AOG.0000000000004479</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>HF</given-names></name><name><surname>Nugent</surname><given-names>CE</given-names></name><name><surname>Wanty</surname><given-names>SD</given-names></name><name><surname>Hayashi</surname><given-names>RH</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>163</volume><fpage>859</fpage><lpage>867</lpage><pub-id pub-id-type="doi">10.1016/0002-9378(90)91084-p</pub-id><pub-id pub-id-type="pmid">2206073</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apte</surname><given-names>RS</given-names></name><name><surname>Chen</surname><given-names>DS</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>VEGF in signaling and disease: beyond discovery and development</article-title><source>Cell</source><volume>176</volume><fpage>1248</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.01.021</pub-id><pub-id pub-id-type="pmid">30849371</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashford</surname><given-names>KB</given-names></name><name><surname>Chavan</surname><given-names>N</given-names></name><name><surname>Ebersole</surname><given-names>JL</given-names></name><name><surname>Wiggins</surname><given-names>AT</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>McCubbin</surname><given-names>A</given-names></name><name><surname>Barnett</surname><given-names>J</given-names></name><name><surname>O’Brien</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Patterns of systemic and cervicovaginal fluid inflammatory cytokines throughout pregnancy</article-title><source>American Journal of Perinatology</source><volume>35</volume><fpage>455</fpage><lpage>462</lpage><pub-id pub-id-type="doi">10.1055/s-0037-1608677</pub-id><pub-id pub-id-type="pmid">29132178</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Athayde</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Maymon</surname><given-names>E</given-names></name><name><surname>Gomez</surname><given-names>R</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Edwin</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>182</volume><fpage>135</fpage><lpage>141</lpage><pub-id pub-id-type="doi">10.1016/s0002-9378(00)70502-3</pub-id><pub-id pub-id-type="pmid">10649168</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baggia</surname><given-names>S</given-names></name><name><surname>Gravett</surname><given-names>MG</given-names></name><name><surname>Witkin</surname><given-names>SS</given-names></name><name><surname>Haluska</surname><given-names>GJ</given-names></name><name><surname>Novy</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Interleukin-1 beta intra-amniotic infusion induces tumor necrosis factor-alpha, prostaglandin production, and preterm contractions in pregnant rhesus monkeys</article-title><source>Journal of the Society for Gynecologic Investigation</source><volume>3</volume><fpage>121</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1177/107155769600300304</pub-id><pub-id pub-id-type="pmid">8796819</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barata</surname><given-names>JT</given-names></name><name><surname>Durum</surname><given-names>SK</given-names></name><name><surname>Seddon</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Flip the coin: IL-7 and IL-7R in health and disease</article-title><source>Nature Immunology</source><volume>20</volume><fpage>1584</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1038/s41590-019-0479-x</pub-id><pub-id pub-id-type="pmid">31745336</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>D</given-names></name><name><surname>Machler</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Fitting linear mixed-effects models using lme4</article-title><source>Journal of Statistical Software</source><volume>67</volume><fpage>1</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.18637/jss.v067.i01</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becher</surname><given-names>B</given-names></name><name><surname>Tugues</surname><given-names>S</given-names></name><name><surname>Greter</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>GM-CSF: from growth factor to central mediator of tissue inflammation</article-title><source>Immunity</source><volume>45</volume><fpage>963</fpage><lpage>973</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.026</pub-id><pub-id pub-id-type="pmid">27851925</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjelloun</surname><given-names>F</given-names></name><name><surname>Quillay</surname><given-names>H</given-names></name><name><surname>Cannou</surname><given-names>C</given-names></name><name><surname>Marlin</surname><given-names>R</given-names></name><name><surname>Madec</surname><given-names>Y</given-names></name><name><surname>Fernandez</surname><given-names>H</given-names></name><name><surname>Chrétien</surname><given-names>F</given-names></name><name><surname>Le Grand</surname><given-names>R</given-names></name><name><surname>Barré-Sinoussi</surname><given-names>F</given-names></name><name><surname>Nugeyre</surname><given-names>MT</given-names></name><name><surname>Menu</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Activation of toll-like receptors differentially modulates inflammation in the human reproductive tract: preliminary findings</article-title><source>Frontiers in Immunology</source><volume>11</volume><elocation-id>1655</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2020.01655</pub-id><pub-id pub-id-type="pmid">32849571</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>SL</given-names></name><name><surname>Cullen</surname><given-names>JB</given-names></name><name><surname>Sherer</surname><given-names>DM</given-names></name><name><surname>Woods</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The ferning and nitrazine tests of amniotic fluid between 12 and 41 weeks gestation</article-title><source>American Journal of Perinatology</source><volume>10</volume><fpage>101</fpage><lpage>104</lpage><pub-id pub-id-type="doi">10.1055/s-2007-994637</pub-id><pub-id pub-id-type="pmid">8476469</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blencowe</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>ACC</given-names></name><name><surname>Cousens</surname><given-names>S</given-names></name><name><surname>Bahalim</surname><given-names>A</given-names></name><name><surname>Narwal</surname><given-names>R</given-names></name><name><surname>Zhong</surname><given-names>N</given-names></name><name><surname>Chou</surname><given-names>D</given-names></name><name><surname>Say</surname><given-names>L</given-names></name><name><surname>Modi</surname><given-names>N</given-names></name><name><surname>Katz</surname><given-names>J</given-names></name><name><surname>Vos</surname><given-names>T</given-names></name><name><surname>Marlow</surname><given-names>N</given-names></name><name><surname>Lawn</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Preterm birth-associated neurodevelopmental impairment estimates at regional and global levels for 2010</article-title><source>Pediatric Research</source><volume>74 Suppl 1</volume><fpage>17</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1038/pr.2013.204</pub-id><pub-id pub-id-type="pmid">24366461</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Breiman</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Random forests</article-title><source>Machine Learning</source><volume>45</volume><fpage>5</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1023/A:1010933404324</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>CM</given-names></name><name><surname>Rogers</surname><given-names>JT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>25900</fpage><lpage>25912</lpage><pub-id pub-id-type="doi">10.1074/jbc.M707692200</pub-id><pub-id pub-id-type="pmid">18515365</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Callaghan</surname><given-names>WM</given-names></name><name><surname>MacDorman</surname><given-names>MF</given-names></name><name><surname>Rasmussen</surname><given-names>SA</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Lackritz</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The contribution of preterm birth to infant mortality rates in the United States</article-title><source>Pediatrics</source><volume>118</volume><fpage>1566</fpage><lpage>1573</lpage><pub-id pub-id-type="doi">10.1542/peds.2006-0860</pub-id><pub-id pub-id-type="pmid">17015548</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Camunas-Soler</surname><given-names>J</given-names></name><name><surname>Gee</surname><given-names>EPS</given-names></name><name><surname>Reddy</surname><given-names>M</given-names></name><name><surname>Mi</surname><given-names>JD</given-names></name><name><surname>Thao</surname><given-names>M</given-names></name><name><surname>Brundage</surname><given-names>T</given-names></name><name><surname>Siddiqui</surname><given-names>F</given-names></name><name><surname>Hezelgrave</surname><given-names>NL</given-names></name><name><surname>Shennan</surname><given-names>AH</given-names></name><name><surname>Namsaraev</surname><given-names>E</given-names></name><name><surname>Haverty</surname><given-names>C</given-names></name><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Elovitz</surname><given-names>MA</given-names></name><name><surname>Rasmussen</surname><given-names>M</given-names></name><name><surname>Tribe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Predictive RNA profiles for early and very early spontaneous preterm birth</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>227</volume><elocation-id>72</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2022.04.002</pub-id><pub-id pub-id-type="pmid">35398029</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capece</surname><given-names>A</given-names></name><name><surname>Vasieva</surname><given-names>O</given-names></name><name><surname>Meher</surname><given-names>S</given-names></name><name><surname>Alfirevic</surname><given-names>Z</given-names></name><name><surname>Alfirevic</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Pathway analysis of genetic factors associated with spontaneous preterm birth and pre-labor preterm rupture of membranes</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e108578</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0108578</pub-id><pub-id pub-id-type="pmid">25264875</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellino</surname><given-names>F</given-names></name><name><surname>Huang</surname><given-names>AY</given-names></name><name><surname>Altan-Bonnet</surname><given-names>G</given-names></name><name><surname>Stoll</surname><given-names>S</given-names></name><name><surname>Scheinecker</surname><given-names>C</given-names></name><name><surname>Germain</surname><given-names>RN</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction</article-title><source>Nature</source><volume>440</volume><fpage>890</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1038/nature04651</pub-id><pub-id pub-id-type="pmid">16612374</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Espinoza</surname><given-names>J</given-names></name><name><surname>Bujold</surname><given-names>E</given-names></name><name><surname>Mee Kim</surname><given-names>Y</given-names></name><name><surname>Gonçalves</surname><given-names>LF</given-names></name><name><surname>Gomez</surname><given-names>R</given-names></name><name><surname>Edwin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: young investigator award</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>190</volume><fpage>1541</fpage><lpage>1547</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2004.03.043</pub-id><pub-id pub-id-type="pmid">15284729</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Kundu</surname><given-names>S</given-names></name><name><surname>Teoh</surname><given-names>TG</given-names></name><name><surname>Adan</surname><given-names>M</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>RG</given-names></name><name><surname>David</surname><given-names>AL</given-names></name><name><surname>Lewis</surname><given-names>HV</given-names></name><name><surname>Gimeno-Molina</surname><given-names>B</given-names></name><name><surname>Norman</surname><given-names>JE</given-names></name><name><surname>Stock</surname><given-names>SJ</given-names></name><name><surname>Terzidou</surname><given-names>V</given-names></name><name><surname>Kropf</surname><given-names>P</given-names></name><name><surname>Botto</surname><given-names>M</given-names></name><name><surname>MacIntyre</surname><given-names>DA</given-names></name><name><surname>Sykes</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microbial-driven preterm labour involves crosstalk between the innate and adaptive immune response</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>975</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28620-1</pub-id><pub-id pub-id-type="pmid">35190561</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandiramani</surname><given-names>M</given-names></name><name><surname>Seed</surname><given-names>PT</given-names></name><name><surname>Orsi</surname><given-names>NM</given-names></name><name><surname>Ekbote</surname><given-names>UV</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name><name><surname>Shennan</surname><given-names>AH</given-names></name><name><surname>Tribe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Limited relationship between cervico-vaginal fluid cytokine profiles and cervical shortening in women at high risk of spontaneous preterm birth</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e52412</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0052412</pub-id><pub-id pub-id-type="pmid">22276149</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>D-H</given-names></name><name><surname>Shin</surname><given-names>J</given-names></name><name><surname>Rhee</surname><given-names>M-S</given-names></name><name><surname>Park</surname><given-names>K-R</given-names></name><name><surname>Cho</surname><given-names>B-K</given-names></name><name><surname>Lee</surname><given-names>S-K</given-names></name><name><surname>Kim</surname><given-names>B-C</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Vaginal microbiota profiles of native korean women and associations with high-risk pregnancy</article-title><source>Journal of Microbiology and Biotechnology</source><volume>30</volume><fpage>248</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.4014/jmb.1908.08016</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawanpaiboon</surname><given-names>S</given-names></name><name><surname>Vogel</surname><given-names>JP</given-names></name><name><surname>Moller</surname><given-names>AB</given-names></name><name><surname>Lumbiganon</surname><given-names>P</given-names></name><name><surname>Petzold</surname><given-names>M</given-names></name><name><surname>Hogan</surname><given-names>D</given-names></name><name><surname>Landoulsi</surname><given-names>S</given-names></name><name><surname>Jampathong</surname><given-names>N</given-names></name><name><surname>Kongwattanakul</surname><given-names>K</given-names></name><name><surname>Laopaiboon</surname><given-names>M</given-names></name><name><surname>Lewis</surname><given-names>C</given-names></name><name><surname>Rattanakanokchai</surname><given-names>S</given-names></name><name><surname>Teng</surname><given-names>DN</given-names></name><name><surname>Thinkhamrop</surname><given-names>J</given-names></name><name><surname>Watananirun</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Gülmezoglu</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis</article-title><source>The Lancet. Global Health</source><volume>7</volume><fpage>e37</fpage><lpage>e46</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(18)30451-0</pub-id><pub-id pub-id-type="pmid">30389451</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>XL</given-names></name><name><surname>Nam</surname><given-names>JO</given-names></name><name><surname>Jean</surname><given-names>C</given-names></name><name><surname>Lawson</surname><given-names>C</given-names></name><name><surname>Walsh</surname><given-names>CT</given-names></name><name><surname>Goka</surname><given-names>E</given-names></name><name><surname>Lim</surname><given-names>ST</given-names></name><name><surname>Tomar</surname><given-names>A</given-names></name><name><surname>Tancioni</surname><given-names>I</given-names></name><name><surname>Uryu</surname><given-names>S</given-names></name><name><surname>Guan</surname><given-names>JL</given-names></name><name><surname>Acevedo</surname><given-names>LM</given-names></name><name><surname>Weis</surname><given-names>SM</given-names></name><name><surname>Cheresh</surname><given-names>DA</given-names></name><name><surname>Schlaepfer</surname><given-names>DD</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>VEGF-induced vascular permeability is mediated by FAK</article-title><source>Developmental Cell</source><volume>22</volume><fpage>146</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.11.002</pub-id><pub-id pub-id-type="pmid">22264731</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chupp</surname><given-names>GL</given-names></name><name><surname>Wright</surname><given-names>EA</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Vallen-Mashikian</surname><given-names>M</given-names></name><name><surname>Cruikshank</surname><given-names>WW</given-names></name><name><surname>Center</surname><given-names>DM</given-names></name><name><surname>Kornfeld</surname><given-names>H</given-names></name><name><surname>Berman</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Tissue and T cell distribution of precursor and mature IL-16</article-title><source>Journal of Immunology</source><volume>161</volume><fpage>3114</fpage><lpage>3119</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.161.6.3114</pub-id><pub-id pub-id-type="pmid">9743378</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>AM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Innate host defense of human vaginal and cervical mucosae</article-title><source>Current Topics in Microbiology and Immunology</source><volume>306</volume><fpage>199</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">16909923</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>AM</given-names></name><name><surname>Cole</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense</article-title><source>American Journal of Reproductive Immunology</source><volume>59</volume><fpage>27</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0897.2007.00561.x</pub-id><pub-id pub-id-type="pmid">18154593</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Da Fonseca</surname><given-names>E</given-names></name><name><surname>O’Brien</surname><given-names>JM</given-names></name><name><surname>Cetingoz</surname><given-names>E</given-names></name><name><surname>Creasy</surname><given-names>GW</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Erez</surname><given-names>O</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>219</volume><fpage>10</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2018.03.028</pub-id><pub-id pub-id-type="pmid">29630885</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crump</surname><given-names>C</given-names></name><name><surname>Sundquist</surname><given-names>J</given-names></name><name><surname>Winkleby</surname><given-names>MA</given-names></name><name><surname>Sundquist</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Gestational age at birth and mortality from infancy into mid-adulthood: a national cohort study</article-title><source>The Lancet. Child &amp; Adolescent Health</source><volume>3</volume><fpage>408</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/S2352-4642(19)30108-7</pub-id><pub-id pub-id-type="pmid">30956154</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeFranco</surname><given-names>EA</given-names></name><name><surname>Lian</surname><given-names>M</given-names></name><name><surname>Muglia</surname><given-names>LA</given-names></name><name><surname>Schootman</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Area-level poverty and preterm birth risk: a population-based multilevel analysis</article-title><source>BMC Public Health</source><volume>8</volume><elocation-id>316</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2458-8-316</pub-id><pub-id pub-id-type="pmid">18793437</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delgado-Diaz</surname><given-names>DJ</given-names></name><name><surname>Jesaveluk</surname><given-names>B</given-names></name><name><surname>Hayward</surname><given-names>JA</given-names></name><name><surname>Tyssen</surname><given-names>D</given-names></name><name><surname>Alisoltani</surname><given-names>A</given-names></name><name><surname>Potgieter</surname><given-names>M</given-names></name><name><surname>Bell</surname><given-names>L</given-names></name><name><surname>Ross</surname><given-names>E</given-names></name><name><surname>Iranzadeh</surname><given-names>A</given-names></name><name><surname>Allali</surname><given-names>I</given-names></name><name><surname>Dabee</surname><given-names>S</given-names></name><name><surname>Barnabas</surname><given-names>S</given-names></name><name><surname>Gamieldien</surname><given-names>H</given-names></name><name><surname>Blackburn</surname><given-names>JM</given-names></name><name><surname>Mulder</surname><given-names>N</given-names></name><name><surname>Smith</surname><given-names>SB</given-names></name><name><surname>Edwards</surname><given-names>VL</given-names></name><name><surname>Burgener</surname><given-names>AD</given-names></name><name><surname>Bekker</surname><given-names>L-G</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Passmore</surname><given-names>J-AS</given-names></name><name><surname>Masson</surname><given-names>L</given-names></name><name><surname>Hearps</surname><given-names>AC</given-names></name><name><surname>Tachedjian</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression</article-title><source>Microbiome</source><volume>10</volume><elocation-id>141</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-022-01337-5</pub-id><pub-id pub-id-type="pmid">36045402</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiGiulio</surname><given-names>DB</given-names></name><name><surname>Callahan</surname><given-names>BJ</given-names></name><name><surname>McMurdie</surname><given-names>PJ</given-names></name><name><surname>Costello</surname><given-names>EK</given-names></name><name><surname>Lyell</surname><given-names>DJ</given-names></name><name><surname>Robaczewska</surname><given-names>A</given-names></name><name><surname>Sun</surname><given-names>CL</given-names></name><name><surname>Goltsman</surname><given-names>DSA</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Shaw</surname><given-names>G</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Holmes</surname><given-names>SP</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Temporal and spatial variation of the human microbiota during pregnancy</article-title><source>PNAS</source><volume>112</volume><fpage>11060</fpage><lpage>11065</lpage><pub-id pub-id-type="doi">10.1073/pnas.1502875112</pub-id><pub-id pub-id-type="pmid">26283357</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paola</surname><given-names>M</given-names></name><name><surname>Seravalli</surname><given-names>V</given-names></name><name><surname>Paccosi</surname><given-names>S</given-names></name><name><surname>Linari</surname><given-names>C</given-names></name><name><surname>Parenti</surname><given-names>A</given-names></name><name><surname>De Filippo</surname><given-names>C</given-names></name><name><surname>Tanturli</surname><given-names>M</given-names></name><name><surname>Vitali</surname><given-names>F</given-names></name><name><surname>Torcia</surname><given-names>MG</given-names></name><name><surname>Di Tommaso</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Identification of vaginal microbial communities associated with extreme cervical shortening in pregnant women</article-title><source>Journal of Clinical Medicine</source><volume>9</volume><elocation-id>3621</elocation-id><pub-id pub-id-type="doi">10.3390/jcm9113621</pub-id><pub-id pub-id-type="pmid">33182750</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donders</surname><given-names>GGG</given-names></name><name><surname>Vereecken</surname><given-names>A</given-names></name><name><surname>Bosmans</surname><given-names>E</given-names></name><name><surname>Spitz</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Vaginal cytokines in normal pregnancy</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>189</volume><fpage>1433</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1067/S0002-9378(03)00653-7</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donders</surname><given-names>G</given-names></name><name><surname>Van Calsteren</surname><given-names>K</given-names></name><name><surname>Bellen</surname><given-names>G</given-names></name><name><surname>Reybrouck</surname><given-names>R</given-names></name><name><surname>Van den Bosch</surname><given-names>T</given-names></name><name><surname>Riphagen</surname><given-names>I</given-names></name><name><surname>Van Lierde</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy</article-title><source>BJOG</source><volume>116</volume><fpage>1315</fpage><lpage>1324</lpage><pub-id pub-id-type="doi">10.1111/j.1471-0528.2009.02237.x</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>AL</given-names></name><name><surname>Satten</surname><given-names>GA</given-names></name><name><surname>Hu</surname><given-names>Y-J</given-names></name><name><surname>Knight</surname><given-names>AK</given-names></name><name><surname>Hill</surname><given-names>CC</given-names></name><name><surname>Wright</surname><given-names>ML</given-names></name><name><surname>Smith</surname><given-names>AK</given-names></name><name><surname>Read</surname><given-names>TD</given-names></name><name><surname>Pearce</surname><given-names>BD</given-names></name><name><surname>Corwin</surname><given-names>EJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vaginal microbiome composition in early pregnancy and risk of spontaneous preterm and early term birth among african american women</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>11</volume><elocation-id>641005</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.641005</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>EH</given-names></name><name><surname>Behnia</surname><given-names>F</given-names></name><name><surname>Boldogh</surname><given-names>I</given-names></name><name><surname>Saade</surname><given-names>GR</given-names></name><name><surname>Taylor</surname><given-names>BD</given-names></name><name><surname>Kacerovský</surname><given-names>M</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Oxidative stress damage-associated molecular signaling pathways differentiate spontaneous preterm birth and preterm premature rupture of the membranes</article-title><source>Molecular Human Reproduction</source><volume>22</volume><fpage>143</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1093/molehr/gav074</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dvorakova</surname><given-names>L</given-names></name><name><surname>Ivankova</surname><given-names>K</given-names></name><name><surname>Krofta</surname><given-names>L</given-names></name><name><surname>Hromadnikova</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Expression profile of heat shock proteins in placental tissues of patients with preterm prelabor rupture of membranes and spontaneous preterm labor with intact membranes</article-title><source>American Journal of Reproductive Immunology</source><volume>78</volume><elocation-id>2698</elocation-id><pub-id pub-id-type="doi">10.1111/aji.12698</pub-id><pub-id pub-id-type="pmid">28497897</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dvorakova</surname><given-names>L</given-names></name><name><surname>Ivankova</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Prelabor rupture of membranes</article-title><source>Obstetrics &amp; Gynecology</source><volume>135</volume><fpage>e80</fpage><lpage>e97</lpage><pub-id pub-id-type="doi">10.1097/AOG.0000000000003700</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dyer</surname><given-names>DP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Understanding the mechanisms that facilitate specificity, not redundancy, of chemokine-mediated leukocyte recruitment</article-title><source>Immunology</source><volume>160</volume><fpage>336</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1111/imm.13200</pub-id><pub-id pub-id-type="pmid">32285441</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elovitz</surname><given-names>MA</given-names></name><name><surname>Gajer</surname><given-names>P</given-names></name><name><surname>Riis</surname><given-names>V</given-names></name><name><surname>Brown</surname><given-names>AG</given-names></name><name><surname>Humphrys</surname><given-names>MS</given-names></name><name><surname>Holm</surname><given-names>JB</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1305</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09285-9</pub-id><pub-id pub-id-type="pmid">30899005</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ely</surname><given-names>DM</given-names></name><name><surname>Driscoll</surname><given-names>AK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Infant mortality in the united states, 2018: data from the period linked birth/infant death file</article-title><source>National Vital Statistics Reports</source><volume>69</volume><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">32730740</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erez</surname><given-names>O</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Than</surname><given-names>NG</given-names></name><name><surname>Vaisbuch</surname><given-names>E</given-names></name><name><surname>Draghici</surname><given-names>S</given-names></name><name><surname>Tromp</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Differential expression pattern of genes encoding for anti-microbial peptides in the fetal membranes of patients with spontaneous preterm labor and intact membranes and those with preterm prelabor rupture of the membranes</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>22</volume><fpage>1103</fpage><lpage>1115</lpage><pub-id pub-id-type="doi">10.3109/14767050902994796</pub-id><pub-id pub-id-type="pmid">19916708</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erlebacher</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Immunology of the maternal-fetal interface</article-title><source>Annual Review of Immunology</source><volume>31</volume><fpage>387</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032712-100003</pub-id><pub-id pub-id-type="pmid">23298207</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Espinoza</surname><given-names>J</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Edwin</surname><given-names>S</given-names></name><name><surname>Rathnasabapathy</surname><given-names>C</given-names></name><name><surname>Gomez</surname><given-names>R</given-names></name><name><surname>Bujold</surname><given-names>E</given-names></name><name><surname>Camacho</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Hassan</surname><given-names>S</given-names></name><name><surname>Blackwell</surname><given-names>S</given-names></name><name><surname>Whitty</surname><given-names>J</given-names></name><name><surname>Berman</surname><given-names>S</given-names></name><name><surname>Redman</surname><given-names>M</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Sorokin</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>13</volume><fpage>2</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1080/jmf.13.1.2.21</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ethuin</surname><given-names>F</given-names></name><name><surname>Delarche</surname><given-names>C</given-names></name><name><surname>Gougerot-Pocidalo</surname><given-names>MA</given-names></name><name><surname>Eurin</surname><given-names>B</given-names></name><name><surname>Jacob</surname><given-names>L</given-names></name><name><surname>Chollet-Martin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Regulation of interleukin 12 p40 and p70 production by blood and alveolar phagocytes during severe sepsis</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>83</volume><fpage>1353</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1097/01.lab.0000087589.37269.fc</pub-id><pub-id pub-id-type="pmid">13679443</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farias-Jofre</surname><given-names>M</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Arenas-Hernandez</surname><given-names>M</given-names></name><name><surname>Winters</surname><given-names>AD</given-names></name><name><surname>Berkowitz</surname><given-names>BA</given-names></name><name><surname>Podolsky</surname><given-names>RH</given-names></name><name><surname>Shen</surname><given-names>Y</given-names></name><name><surname>Kanninen</surname><given-names>T</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Glazier</surname><given-names>CR</given-names></name><name><surname>Pique-Regi</surname><given-names>R</given-names></name><name><surname>Theis</surname><given-names>KR</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Blockade of IL-6R prevents preterm birth and adverse neonatal outcomes</article-title><source>EBioMedicine</source><volume>98</volume><elocation-id>104865</elocation-id><pub-id pub-id-type="doi">10.1016/j.ebiom.2023.104865</pub-id><pub-id pub-id-type="pmid">37944273</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faro</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Schwenkel</surname><given-names>G</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Arenas-Hernandez</surname><given-names>M</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Intra-amniotic inflammation induces preterm birth by activating the NLRP3 inflammasome†</article-title><source>Biology of Reproduction</source><volume>100</volume><fpage>1290</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioy261</pub-id><pub-id pub-id-type="pmid">30590393</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehniger</surname><given-names>TA</given-names></name><name><surname>Caligiuri</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Interleukin 15: biology and relevance to human disease</article-title><source>Blood</source><volume>97</volume><fpage>14</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1182/blood.v97.1.14</pub-id><pub-id pub-id-type="pmid">11133738</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Gerber</surname><given-names>H-P</given-names></name><name><surname>LeCouter</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The biology of VEGF and its receptors</article-title><source>Nature Medicine</source><volume>9</volume><fpage>669</fpage><lpage>676</lpage><pub-id pub-id-type="doi">10.1038/nm0603-669</pub-id><pub-id pub-id-type="pmid">12778165</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fettweis</surname><given-names>JM</given-names></name><name><surname>Serrano</surname><given-names>MG</given-names></name><name><surname>Brooks</surname><given-names>JP</given-names></name><name><surname>Edwards</surname><given-names>DJ</given-names></name><name><surname>Girerd</surname><given-names>PH</given-names></name><name><surname>Parikh</surname><given-names>HI</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Arodz</surname><given-names>TJ</given-names></name><name><surname>Edupuganti</surname><given-names>L</given-names></name><name><surname>Glascock</surname><given-names>AL</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Jimenez</surname><given-names>NR</given-names></name><name><surname>Vivadelli</surname><given-names>SC</given-names></name><name><surname>Fong</surname><given-names>SS</given-names></name><name><surname>Sheth</surname><given-names>NU</given-names></name><name><surname>Jean</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>V</given-names></name><name><surname>Bokhari</surname><given-names>YA</given-names></name><name><surname>Lara</surname><given-names>AM</given-names></name><name><surname>Mistry</surname><given-names>SD</given-names></name><name><surname>Duckworth</surname><given-names>RA</given-names></name><name><surname>Bradley</surname><given-names>SP</given-names></name><name><surname>Koparde</surname><given-names>VN</given-names></name><name><surname>Orenda</surname><given-names>XV</given-names></name><name><surname>Milton</surname><given-names>SH</given-names></name><name><surname>Rozycki</surname><given-names>SK</given-names></name><name><surname>Matveyev</surname><given-names>AV</given-names></name><name><surname>Wright</surname><given-names>ML</given-names></name><name><surname>Huzurbazar</surname><given-names>SV</given-names></name><name><surname>Jackson</surname><given-names>EM</given-names></name><name><surname>Smirnova</surname><given-names>E</given-names></name><name><surname>Korlach</surname><given-names>J</given-names></name><name><surname>Tsai</surname><given-names>Y-C</given-names></name><name><surname>Dickinson</surname><given-names>MR</given-names></name><name><surname>Brooks</surname><given-names>JL</given-names></name><name><surname>Drake</surname><given-names>JI</given-names></name><name><surname>Chaffin</surname><given-names>DO</given-names></name><name><surname>Sexton</surname><given-names>AL</given-names></name><name><surname>Gravett</surname><given-names>MG</given-names></name><name><surname>Rubens</surname><given-names>CE</given-names></name><name><surname>Wijesooriya</surname><given-names>NR</given-names></name><name><surname>Hendricks-Muñoz</surname><given-names>KD</given-names></name><name><surname>Jefferson</surname><given-names>KK</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names></name><name><surname>Buck</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The vaginal microbiome and preterm birth</article-title><source>Nature Medicine</source><volume>25</volume><fpage>1012</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1038/s41591-019-0450-2</pub-id><pub-id pub-id-type="pmid">31142849</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flaviani</surname><given-names>F</given-names></name><name><surname>Hezelgrave</surname><given-names>NL</given-names></name><name><surname>Kanno</surname><given-names>T</given-names></name><name><surname>Prosdocimi</surname><given-names>EM</given-names></name><name><surname>Chin-Smith</surname><given-names>E</given-names></name><name><surname>Ridout</surname><given-names>AE</given-names></name><name><surname>von Maydell</surname><given-names>DK</given-names></name><name><surname>Mistry</surname><given-names>V</given-names></name><name><surname>Wade</surname><given-names>WG</given-names></name><name><surname>Shennan</surname><given-names>AH</given-names></name><name><surname>Dimitrakopoulou</surname><given-names>K</given-names></name><name><surname>Seed</surname><given-names>PT</given-names></name><name><surname>Mason</surname><given-names>AJ</given-names></name><name><surname>Tribe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cervicovaginal microbiota and metabolome predict preterm birth risk in an ethnically diverse cohort</article-title><source>JCI Insight</source><volume>6</volume><elocation-id>e149257</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.149257</pub-id><pub-id pub-id-type="pmid">34255744</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florova</surname><given-names>V</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Ahmad</surname><given-names>MM</given-names></name><name><surname>Hsu</surname><given-names>C-D</given-names></name><name><surname>Hsu</surname><given-names>R</given-names></name><name><surname>Tong</surname><given-names>A</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Theis</surname><given-names>KR</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vaginal host immune-microbiome interactions in a cohort of primarily African-American women who ultimately underwent spontaneous preterm birth or delivered at term</article-title><source>Cytokine</source><volume>137</volume><elocation-id>155316</elocation-id><pub-id pub-id-type="doi">10.1016/j.cyto.2020.155316</pub-id><pub-id pub-id-type="pmid">33032107</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>EB</given-names></name><name><surname>Celik</surname><given-names>E</given-names></name><name><surname>Parra</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>M</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Progesterone and the risk of preterm birth among women with a short cervix</article-title><source>New England Journal of Medicine</source><volume>357</volume><fpage>462</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa067815</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fortunato</surname><given-names>SJ</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name><name><surname>Lombardi</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture</article-title><source>Journal of Perinatal Medicine</source><volume>27</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1515/JPM.1999.049</pub-id><pub-id pub-id-type="pmid">10642956</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freitas</surname><given-names>AC</given-names></name><name><surname>Bocking</surname><given-names>A</given-names></name><name><surname>Hill</surname><given-names>JE</given-names></name><name><surname>Money</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Increased richness and diversity of the vaginal microbiota and spontaneous preterm birth</article-title><source>Microbiome</source><volume>6</volume><elocation-id>117</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-018-0502-8</pub-id><pub-id pub-id-type="pmid">29954448</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frey</surname><given-names>HA</given-names></name><name><surname>Stout</surname><given-names>MJ</given-names></name><name><surname>Pearson</surname><given-names>LN</given-names></name><name><surname>Tuuli</surname><given-names>MG</given-names></name><name><surname>Cahill</surname><given-names>AG</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names></name><name><surname>Gomez</surname><given-names>LM</given-names></name><name><surname>Parry</surname><given-names>S</given-names></name><name><surname>Allsworth</surname><given-names>JE</given-names></name><name><surname>Macones</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Genetic variation associated with preterm birth in African-American women</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>215</volume><elocation-id>235</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2016.03.008</pub-id><pub-id pub-id-type="pmid">26979631</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>ML</given-names></name><name><surname>McElin</surname><given-names>TW</given-names></name></person-group><year iso-8601-date="1969">1969</year><article-title>Diagnosis of ruptured fetal membranes: clinical study and review of the literature</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>104</volume><fpage>544</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/s0002-9378(16)34244-2</pub-id><pub-id pub-id-type="pmid">4182350</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Slutsky</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Para</surname><given-names>R</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Hsu</surname><given-names>C-D</given-names></name><name><surname>Kacerovsky</surname><given-names>M</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cellular immune responses in amniotic fluid of women with preterm prelabor rupture of membranes</article-title><source>Journal of Perinatal Medicine</source><volume>48</volume><fpage>222</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1515/jpm-2019-0395</pub-id><pub-id pub-id-type="pmid">32083453</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>K</given-names></name><name><surname>Gutierrez</surname><given-names>P</given-names></name><name><surname>Garza</surname><given-names>J</given-names></name><name><surname>Gray Wlazlo</surname><given-names>TJ</given-names></name><name><surname>Meiser</surname><given-names>RJ</given-names></name><name><surname>David</surname><given-names>S</given-names></name><name><surname>Carrillo</surname><given-names>M</given-names></name><name><surname>Narasimhan</surname><given-names>M</given-names></name><name><surname>Galloway</surname><given-names>M</given-names></name><name><surname>Ventolini</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Vaginal Lactobacillus species and inflammatory biomarkers in pregnancy</article-title><source>Minerva Ginecologica</source><volume>72</volume><fpage>299</fpage><lpage>309</lpage><pub-id pub-id-type="doi">10.23736/S0026-4784.20.04566-9</pub-id><pub-id pub-id-type="pmid">32403915</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganz</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Defensins: antimicrobial peptides of innate immunity</article-title><source>Nature Reviews Immunology</source><volume>3</volume><fpage>710</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.1038/nri1180</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>H-P</given-names></name><name><surname>Malik</surname><given-names>AK</given-names></name><name><surname>Solar</surname><given-names>GP</given-names></name><name><surname>Sherman</surname><given-names>D</given-names></name><name><surname>Liang</surname><given-names>XH</given-names></name><name><surname>Meng</surname><given-names>G</given-names></name><name><surname>Hong</surname><given-names>K</given-names></name><name><surname>Marsters</surname><given-names>JC</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism</article-title><source>Nature</source><volume>417</volume><fpage>954</fpage><lpage>958</lpage><pub-id pub-id-type="doi">10.1038/nature00821</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>H-P</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The role of VEGF in normal and neoplastic hematopoiesis</article-title><source>Journal of Molecular Medicine</source><volume>81</volume><fpage>20</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s00109-002-0397-4</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerson</surname><given-names>KD</given-names></name><name><surname>McCarthy</surname><given-names>C</given-names></name><name><surname>Elovitz</surname><given-names>MA</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Sammel</surname><given-names>MD</given-names></name><name><surname>Burris</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cervicovaginal microbial communities deficient in Lactobacillus species are associated with second trimester short cervix</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>222</volume><elocation-id>491</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2019.11.1283</pub-id><pub-id pub-id-type="pmid">31816307</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghaemi</surname><given-names>MS</given-names></name><name><surname>DiGiulio</surname><given-names>DB</given-names></name><name><surname>Contrepois</surname><given-names>K</given-names></name><name><surname>Callahan</surname><given-names>B</given-names></name><name><surname>Ngo</surname><given-names>TTM</given-names></name><name><surname>Lee-McMullen</surname><given-names>B</given-names></name><name><surname>Lehallier</surname><given-names>B</given-names></name><name><surname>Robaczewska</surname><given-names>A</given-names></name><name><surname>Mcilwain</surname><given-names>D</given-names></name><name><surname>Rosenberg-Hasson</surname><given-names>Y</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Quaintance</surname><given-names>C</given-names></name><name><surname>Culos</surname><given-names>A</given-names></name><name><surname>Stanley</surname><given-names>N</given-names></name><name><surname>Tanada</surname><given-names>A</given-names></name><name><surname>Tsai</surname><given-names>A</given-names></name><name><surname>Gaudilliere</surname><given-names>D</given-names></name><name><surname>Ganio</surname><given-names>E</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>McNeil</surname><given-names>L</given-names></name><name><surname>Tingle</surname><given-names>M</given-names></name><name><surname>Wise</surname><given-names>P</given-names></name><name><surname>Maric</surname><given-names>I</given-names></name><name><surname>Sirota</surname><given-names>M</given-names></name><name><surname>Wyss-Coray</surname><given-names>T</given-names></name><name><surname>Winn</surname><given-names>VD</given-names></name><name><surname>Druzin</surname><given-names>ML</given-names></name><name><surname>Gibbs</surname><given-names>R</given-names></name><name><surname>Darmstadt</surname><given-names>GL</given-names></name><name><surname>Lewis</surname><given-names>DB</given-names></name><name><surname>Partovi Nia</surname><given-names>V</given-names></name><name><surname>Agard</surname><given-names>B</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Nolan</surname><given-names>G</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Angst</surname><given-names>MS</given-names></name><name><surname>Gaudilliere</surname><given-names>B</given-names></name><name><surname>Aghaeepour</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multiomics modeling of the immunome, transcriptome, microbiome, proteome and metabolome adaptations during human pregnancy</article-title><source>Bioinformatics</source><volume>35</volume><fpage>95</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty537</pub-id><pub-id pub-id-type="pmid">30561547</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname><given-names>RL</given-names></name><name><surname>Hauth</surname><given-names>JC</given-names></name><name><surname>Andrews</surname><given-names>WW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Intrauterine infection and preterm delivery</article-title><source>New England Journal of Medicine</source><volume>342</volume><fpage>1500</fpage><lpage>1507</lpage><pub-id pub-id-type="doi">10.1056/NEJM200005183422007</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldenberg</surname><given-names>RL</given-names></name><name><surname>Culhane</surname><given-names>JF</given-names></name><name><surname>Iams</surname><given-names>JD</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Epidemiology and causes of preterm birth</article-title><source>Lancet</source><volume>371</volume><fpage>75</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(08)60074-4</pub-id><pub-id pub-id-type="pmid">18177778</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Guilbert</surname><given-names>LJ</given-names></name><name><surname>Olson</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Invasion of the leukocytes into the fetal-maternal interface during pregnancy</article-title><source>Journal of Leukocyte Biology</source><volume>88</volume><fpage>625</fpage><lpage>633</lpage><pub-id pub-id-type="doi">10.1189/jlb.1209796</pub-id><pub-id pub-id-type="pmid">20519637</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Plazyo</surname><given-names>O</given-names></name><name><surname>Unkel</surname><given-names>R</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Than</surname><given-names>NG</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Abrahams</surname><given-names>VM</given-names></name><name><surname>Yeo</surname><given-names>L</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A role for the inflammasome in spontaneous preterm labor with acute histologic chorioamnionitis</article-title><source>Reproductive Sciences</source><volume>24</volume><fpage>1382</fpage><lpage>1401</lpage><pub-id pub-id-type="doi">10.1177/1933719116687656</pub-id><pub-id pub-id-type="pmid">28122480</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Faro</surname><given-names>J</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Hsu</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inflammasome activation during spontaneous preterm labor with intra-amniotic infection or sterile intra-amniotic inflammation</article-title><source>American Journal of Reproductive Immunology</source><volume>80</volume><elocation-id>e13049</elocation-id><pub-id pub-id-type="doi">10.1111/aji.13049</pub-id><pub-id pub-id-type="pmid">30225853</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>Inflammasomes: their role in normal and complicated pregnancies</article-title><source>The Journal of Immunology</source><volume>203</volume><fpage>2757</fpage><lpage>2769</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1900901</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Hsu</surname><given-names>C-D</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Inhibition of the NLRP3 inflammasome can prevent sterile intra-amniotic inflammation, preterm labor/birth, and adverse neonatal outcomes†</article-title><source>Biology of Reproduction</source><volume>100</volume><fpage>1306</fpage><lpage>1318</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioy264</pub-id><pub-id pub-id-type="pmid">30596885</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Bhatti</surname><given-names>G</given-names></name><name><surname>Berry</surname><given-names>SM</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2019">2019c</year><article-title>The cellular transcriptome in the maternal circulation during normal pregnancy: a longitudinal study</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>2863</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02863</pub-id><pub-id pub-id-type="pmid">31921132</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Arenas-Hernandez</surname><given-names>M</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Hsu</surname><given-names>C-D</given-names></name><name><surname>Tse</surname><given-names>H</given-names></name><name><surname>Sanchez-Torres</surname><given-names>C</given-names></name><name><surname>Done</surname><given-names>B</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Regulatory t cells play a role in a subset of idiopathic preterm labor/birth and adverse neonatal outcomes</article-title><source>Cell Reports</source><volume>32</volume><elocation-id>107874</elocation-id><pub-id pub-id-type="doi">10.1016/j.celrep.2020.107874</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Chin</surname><given-names>PY</given-names></name><name><surname>Groome</surname><given-names>HM</given-names></name><name><surname>Bijland</surname><given-names>MT</given-names></name><name><surname>Diener</surname><given-names>KR</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Macrophages exert homeostatic actions in pregnancy to protect against preterm birth and fetal inflammatory injury</article-title><source>JCI Insight</source><volume>6</volume><elocation-id>e146089</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.146089</pub-id><pub-id pub-id-type="pmid">34622802</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Farias-Jofre</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Arenas-Hernandez</surname><given-names>M</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Shaffer</surname><given-names>Z</given-names></name><name><surname>Greenberg</surname><given-names>JM</given-names></name><name><surname>Theis</surname><given-names>KR</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>The immunobiology of preterm labor and birth: intra-amniotic inflammation or breakdown of maternal-fetal homeostasis</article-title><source>Reproduction</source><volume>164</volume><fpage>R11</fpage><lpage>R45</lpage><pub-id pub-id-type="doi">10.1530/REP-22-0046</pub-id><pub-id pub-id-type="pmid">35559791</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Bhatti</surname><given-names>G</given-names></name><name><surname>Done</surname><given-names>B</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Ghita</surname><given-names>C</given-names></name><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Farias-Jofre</surname><given-names>M</given-names></name><name><surname>Jung</surname><given-names>E</given-names></name><name><surname>Pique-Regi</surname><given-names>R</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>Transcriptome changes in maternal peripheral blood during term parturition mimic perturbations preceding spontaneous preterm birth†</article-title><source>Biology of Reproduction</source><volume>106</volume><fpage>185</fpage><lpage>199</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioab197</pub-id><pub-id pub-id-type="pmid">34686873</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gomez‐Lopez</surname><given-names>N</given-names></name><name><surname>Olson</surname><given-names>DM</given-names></name><name><surname>Robertson</surname><given-names>SA</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Interleukin‐6 controls uterine Th9 cells and CD8 <sup>+</sup> T regulatory cells to accelerate parturition in mice</article-title><source>Immunology &amp; Cell Biology</source><volume>94</volume><fpage>79</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/icb.2015.63</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González-Mesa</surname><given-names>E</given-names></name><name><surname>Blasco-Alonso</surname><given-names>M</given-names></name><name><surname>Benítez</surname><given-names>MJ</given-names></name><name><surname>Gómez-Muñoz</surname><given-names>C</given-names></name><name><surname>Sabonet-Morente</surname><given-names>L</given-names></name><name><surname>Gómez-Castellanos</surname><given-names>M</given-names></name><name><surname>Ulloa</surname><given-names>O</given-names></name><name><surname>González-Cazorla</surname><given-names>E</given-names></name><name><surname>Puertas-Prieto</surname><given-names>A</given-names></name><name><surname>Mozas-Moreno</surname><given-names>J</given-names></name><name><surname>Jiménez-López</surname><given-names>J</given-names></name><name><surname>Lubián-López</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Obstetric and perinatal outcomes after very early preterm premature rupture of membranes (PPROM)-a retrospective analysis over the period 2000-2020</article-title><source>Medicina</source><volume>57</volume><elocation-id>469</elocation-id><pub-id pub-id-type="doi">10.3390/medicina57050469</pub-id><pub-id pub-id-type="pmid">34064567</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>Taylor</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Monocyte and macrophage heterogeneity</article-title><source>Nature Reviews Immunology</source><volume>5</volume><fpage>953</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1038/nri1733</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goya</surname><given-names>M</given-names></name><name><surname>Bernabeu</surname><given-names>A</given-names></name><name><surname>García</surname><given-names>N</given-names></name><name><surname>Plata</surname><given-names>J</given-names></name><name><surname>Gonzalez</surname><given-names>F</given-names></name><name><surname>Merced</surname><given-names>C</given-names></name><name><surname>Llurba</surname><given-names>E</given-names></name><name><surname>Suy</surname><given-names>A</given-names></name><name><surname>Casellas</surname><given-names>M</given-names></name><name><surname>Carreras</surname><given-names>E</given-names></name><name><surname>Cabero</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Premature rupture of membranes before 34 weeks managed expectantly: maternal and perinatal outcomes in singletons</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>26</volume><fpage>290</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.3109/14767058.2012.733779</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gravett</surname><given-names>MG</given-names></name><name><surname>Witkin</surname><given-names>SS</given-names></name><name><surname>Haluska</surname><given-names>GJ</given-names></name><name><surname>Edwards</surname><given-names>JL</given-names></name><name><surname>Cook</surname><given-names>MJ</given-names></name><name><surname>Novy</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>An experimental model for intraamniotic infection and preterm labor in rhesus monkeys</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>171</volume><fpage>1660</fpage><lpage>1667</lpage><pub-id pub-id-type="doi">10.1016/0002-9378(94)90418-9</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grewal</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Brosens</surname><given-names>JJ</given-names></name><name><surname>Bourne</surname><given-names>T</given-names></name><name><surname>Al-Memar</surname><given-names>M</given-names></name><name><surname>Kundu</surname><given-names>S</given-names></name><name><surname>MacIntyre</surname><given-names>DA</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Chromosomally normal miscarriage is associated with vaginal dysbiosis and local inflammation</article-title><source>BMC Medicine</source><volume>20</volume><elocation-id>38</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-021-02227-7</pub-id><pub-id pub-id-type="pmid">35090453</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffith</surname><given-names>JW</given-names></name><name><surname>Sokol</surname><given-names>CL</given-names></name><name><surname>Luster</surname><given-names>AD</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Chemokines and chemokine receptors: positioning cells for host defense and immunity</article-title><source>Annual Review of Immunology</source><volume>32</volume><fpage>659</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120145</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gudicha</surname><given-names>DW</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Kabiri</surname><given-names>D</given-names></name><name><surname>Hernandez-Andrade</surname><given-names>E</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Erez</surname><given-names>O</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Jung</surname><given-names>E</given-names></name><name><surname>Paredes</surname><given-names>C</given-names></name><name><surname>Berry</surname><given-names>SM</given-names></name><name><surname>Yeo</surname><given-names>L</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Hsu</surname><given-names>CD</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Personalized assessment of cervical length improves prediction of spontaneous preterm birth: a standard and a percentile calculator</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>224</volume><elocation-id>288</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2020.09.002</pub-id><pub-id pub-id-type="pmid">32918893</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guilliams</surname><given-names>M</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Yona</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Developmental and functional heterogeneity of monocytes</article-title><source>Immunity</source><volume>49</volume><fpage>595</fpage><lpage>613</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2018.10.005</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haguenoer</surname><given-names>K</given-names></name><name><surname>Sengchanh</surname><given-names>S</given-names></name><name><surname>Gaudy-Graffin</surname><given-names>C</given-names></name><name><surname>Boyard</surname><given-names>J</given-names></name><name><surname>Fontenay</surname><given-names>R</given-names></name><name><surname>Marret</surname><given-names>H</given-names></name><name><surname>Goudeau</surname><given-names>A</given-names></name><name><surname>Pigneaux de Laroche</surname><given-names>N</given-names></name><name><surname>Rusch</surname><given-names>E</given-names></name><name><surname>Giraudeau</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Vaginal self-sampling is a cost-effective way to increase participation in a cervical cancer screening programme: a randomised trial</article-title><source>British Journal of Cancer</source><volume>111</volume><fpage>2187</fpage><lpage>2196</lpage><pub-id pub-id-type="doi">10.1038/bjc.2014.510</pub-id><pub-id pub-id-type="pmid">25247320</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Colony-stimulating factors in inflammation and autoimmunity</article-title><source>Nature Reviews. Immunology</source><volume>8</volume><fpage>533</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1038/nri2356</pub-id><pub-id pub-id-type="pmid">18551128</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harder</surname><given-names>J</given-names></name><name><surname>Bartels</surname><given-names>J</given-names></name><name><surname>Christophers</surname><given-names>E</given-names></name><name><surname>Schröder</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A peptide antibiotic from human skin</article-title><source>Nature</source><volume>387</volume><elocation-id>861</elocation-id><pub-id pub-id-type="doi">10.1038/43088</pub-id><pub-id pub-id-type="pmid">9202117</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Berry</surname><given-names>SM</given-names></name><name><surname>Dang</surname><given-names>K</given-names></name><name><surname>Blackwell</surname><given-names>SC</given-names></name><name><surname>Treadwell</surname><given-names>MC</given-names></name><name><surname>Wolfe</surname><given-names>HM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Patients with an ultrasonographic cervical length &lt; or =15 mm have nearly a 50% risk of early spontaneous preterm delivery</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>182</volume><fpage>1458</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1067/mob.2000.106851</pub-id><pub-id pub-id-type="pmid">10871466</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Vidyadhari</surname><given-names>D</given-names></name><name><surname>Fusey</surname><given-names>S</given-names></name><name><surname>Baxter</surname><given-names>JK</given-names></name><name><surname>Khandelwal</surname><given-names>M</given-names></name><name><surname>Vijayaraghavan</surname><given-names>J</given-names></name><name><surname>Trivedi</surname><given-names>Y</given-names></name><name><surname>Soma-Pillay</surname><given-names>P</given-names></name><name><surname>Sambarey</surname><given-names>P</given-names></name><name><surname>Dayal</surname><given-names>A</given-names></name><name><surname>Potapov</surname><given-names>V</given-names></name><name><surname>O’Brien</surname><given-names>J</given-names></name><name><surname>Astakhov</surname><given-names>V</given-names></name><name><surname>Yuzko</surname><given-names>O</given-names></name><name><surname>Kinzler</surname><given-names>W</given-names></name><name><surname>Dattel</surname><given-names>B</given-names></name><name><surname>Sehdev</surname><given-names>H</given-names></name><name><surname>Mazheika</surname><given-names>L</given-names></name><name><surname>Manchulenko</surname><given-names>D</given-names></name><name><surname>Gervasi</surname><given-names>MT</given-names></name><name><surname>Sullivan</surname><given-names>L</given-names></name><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name><name><surname>Phillips</surname><given-names>JA</given-names></name><name><surname>Creasy</surname><given-names>GW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial</article-title><source>Ultrasound in Obstetrics &amp; Gynecology</source><volume>38</volume><fpage>18</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1002/uog.9017</pub-id><pub-id pub-id-type="pmid">21472815</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haviland</surname><given-names>MJ</given-names></name><name><surname>Shainker</surname><given-names>SA</given-names></name><name><surname>Hacker</surname><given-names>MR</given-names></name><name><surname>Burris</surname><given-names>HH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Racial and ethnic disparities in universal cervical length screening with transvaginal ultrasound</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>29</volume><fpage>4078</fpage><lpage>4081</lpage><pub-id pub-id-type="doi">10.3109/14767058.2016.1157577</pub-id><pub-id pub-id-type="pmid">26987873</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazuda</surname><given-names>DJ</given-names></name><name><surname>Lee</surname><given-names>JC</given-names></name><name><surname>Young</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>The kinetics of interleukin 1 secretion from activated monocytes: differences between interleukin 1 alpha and interleukin 1 beta</article-title><source>Journal of Biological Chemistry</source><volume>263</volume><fpage>8473</fpage><lpage>8479</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)68502-3</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heath</surname><given-names>VCF</given-names></name><name><surname>Southall</surname><given-names>TR</given-names></name><name><surname>Souka</surname><given-names>AP</given-names></name><name><surname>Elisseou</surname><given-names>A</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Cervical length at 23 weeks of gestation: prediction of spontaneous preterm delivery</article-title><source>Ultrasound in Obstetrics &amp; Gynecology</source><volume>12</volume><fpage>312</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1046/j.1469-0705.1998.12050312.x</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>M</given-names></name><name><surname>Valore</surname><given-names>EV</given-names></name><name><surname>Helmig</surname><given-names>RB</given-names></name><name><surname>Uldbjerg</surname><given-names>N</given-names></name><name><surname>Ganz</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Antimicrobial factors in the cervical mucus plug</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>187</volume><fpage>137</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1067/mob.2002.123034</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henney</surname><given-names>CS</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Interleukin 7: effects on early events in lymphopoiesis</article-title><source>Immunology Today</source><volume>10</volume><fpage>170</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/0167-5699(89)90175-8</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hezelgrave</surname><given-names>NL</given-names></name><name><surname>Seed</surname><given-names>PT</given-names></name><name><surname>Chin-Smith</surname><given-names>EC</given-names></name><name><surname>Ridout</surname><given-names>AE</given-names></name><name><surname>Shennan</surname><given-names>AH</given-names></name><name><surname>Tribe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cervicovaginal natural antimicrobial expression in pregnancy and association with spontaneous preterm birth</article-title><source>Scientific Reports</source><volume>10</volume><elocation-id>12018</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-68329-z</pub-id><pub-id pub-id-type="pmid">32694552</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hočevar</surname><given-names>K</given-names></name><name><surname>Maver</surname><given-names>A</given-names></name><name><surname>Vidmar Šimic</surname><given-names>M</given-names></name><name><surname>Hodžić</surname><given-names>A</given-names></name><name><surname>Haslberger</surname><given-names>A</given-names></name><name><surname>Premru Seršen</surname><given-names>T</given-names></name><name><surname>Peterlin</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Vaginal microbiome signature is associated with spontaneous preterm delivery</article-title><source>Frontiers in Medicine</source><volume>6</volume><elocation-id>201</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2019.00201</pub-id><pub-id pub-id-type="pmid">31552254</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugues</surname><given-names>S</given-names></name><name><surname>Scholer</surname><given-names>A</given-names></name><name><surname>Boissonnas</surname><given-names>A</given-names></name><name><surname>Nussbaum</surname><given-names>A</given-names></name><name><surname>Combadière</surname><given-names>C</given-names></name><name><surname>Amigorena</surname><given-names>S</given-names></name><name><surname>Fetler</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses</article-title><source>Nature Immunology</source><volume>8</volume><fpage>921</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1038/ni1495</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iams</surname><given-names>JD</given-names></name><name><surname>Goldenberg</surname><given-names>RL</given-names></name><name><surname>Meis</surname><given-names>PJ</given-names></name><name><surname>Mercer</surname><given-names>BM</given-names></name><name><surname>Moawad</surname><given-names>A</given-names></name><name><surname>Das</surname><given-names>A</given-names></name><name><surname>Thom</surname><given-names>E</given-names></name><name><surname>McNellis</surname><given-names>D</given-names></name><name><surname>Copper</surname><given-names>RL</given-names></name><name><surname>Johnson</surname><given-names>F</given-names></name><name><surname>Roberts</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The length of the cervix and the risk of spontaneous premature delivery</article-title><source>New England Journal of Medicine</source><volume>334</volume><fpage>567</fpage><lpage>573</lpage><pub-id pub-id-type="doi">10.1056/NEJM199602293340904</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iams</surname><given-names>JD</given-names></name><name><surname>Grobman</surname><given-names>WA</given-names></name><name><surname>Lozitska</surname><given-names>A</given-names></name><name><surname>Spong</surname><given-names>CY</given-names></name><name><surname>Saade</surname><given-names>G</given-names></name><name><surname>Mercer</surname><given-names>BM</given-names></name><name><surname>Tita</surname><given-names>AT</given-names></name><name><surname>Rouse</surname><given-names>DJ</given-names></name><name><surname>Sorokin</surname><given-names>Y</given-names></name><name><surname>Wapner</surname><given-names>RJ</given-names></name><name><surname>Leveno</surname><given-names>KJ</given-names></name><name><surname>Blackwell</surname><given-names>SC</given-names></name><name><surname>Esplin</surname><given-names>MS</given-names></name><name><surname>Tolosa</surname><given-names>JE</given-names></name><name><surname>Thorp</surname><given-names>JM</given-names></name><name><surname>Caritis</surname><given-names>SN</given-names></name><name><surname>Van Dorsten</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adherence to criteria for transvaginal ultrasound imaging and measurement of cervical length</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>209</volume><elocation-id>365</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2013.07.032</pub-id><pub-id pub-id-type="pmid">23958649</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imseis</surname><given-names>HM</given-names></name><name><surname>Greig</surname><given-names>PC</given-names></name><name><surname>Livengood</surname><given-names>CH</given-names></name><name><surname>Shunior</surname><given-names>E</given-names></name><name><surname>Durda</surname><given-names>P</given-names></name><name><surname>Erikson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Characterization of the inflammatory cytokines in the vagina during pregnancy and labor and with bacterial vaginosis</article-title><source>Journal of the Society for Gynecologic Investigation</source><volume>4</volume><fpage>90</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">9101468</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itaoka</surname><given-names>N</given-names></name><name><surname>Nagamatsu</surname><given-names>T</given-names></name><name><surname>Schust</surname><given-names>DJ</given-names></name><name><surname>Ichikawa</surname><given-names>M</given-names></name><name><surname>Sayama</surname><given-names>S</given-names></name><name><surname>Iwasawa-Kawai</surname><given-names>Y</given-names></name><name><surname>Kawana</surname><given-names>K</given-names></name><name><surname>Yamashita</surname><given-names>T</given-names></name><name><surname>Osuga</surname><given-names>Y</given-names></name><name><surname>Fujii</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cervical expression of elafin and slpi in pregnancy and their association with preterm labor</article-title><source>American Journal of Reproductive Immunology</source><volume>73</volume><fpage>536</fpage><lpage>544</lpage><pub-id pub-id-type="doi">10.1111/aji.12354</pub-id><pub-id pub-id-type="pmid">25559229</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>VG</given-names></name><name><surname>Monangi</surname><given-names>N</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Muglia</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Genetics, epigenetics, and transcriptomics of preterm birth</article-title><source>American Journal of Reproductive Immunology</source><volume>88</volume><elocation-id>e13600</elocation-id><pub-id pub-id-type="doi">10.1111/aji.13600</pub-id><pub-id pub-id-type="pmid">35818963</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jehan</surname><given-names>F</given-names></name><name><surname>Sazawal</surname><given-names>S</given-names></name><name><surname>Baqui</surname><given-names>AH</given-names></name><name><surname>Nisar</surname><given-names>MI</given-names></name><name><surname>Dhingra</surname><given-names>U</given-names></name><name><surname>Khanam</surname><given-names>R</given-names></name><name><surname>Ilyas</surname><given-names>M</given-names></name><name><surname>Dutta</surname><given-names>A</given-names></name><name><surname>Mitra</surname><given-names>DK</given-names></name><name><surname>Mehmood</surname><given-names>U</given-names></name><name><surname>Deb</surname><given-names>S</given-names></name><name><surname>Mahmud</surname><given-names>A</given-names></name><name><surname>Hotwani</surname><given-names>A</given-names></name><name><surname>Ali</surname><given-names>SM</given-names></name><name><surname>Rahman</surname><given-names>S</given-names></name><name><surname>Nizar</surname><given-names>A</given-names></name><name><surname>Ame</surname><given-names>SM</given-names></name><name><surname>Moin</surname><given-names>MI</given-names></name><name><surname>Muhammad</surname><given-names>S</given-names></name><name><surname>Chauhan</surname><given-names>A</given-names></name><name><surname>Begum</surname><given-names>N</given-names></name><name><surname>Khan</surname><given-names>W</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Ahmed</surname><given-names>S</given-names></name><name><surname>Hasan</surname><given-names>T</given-names></name><name><surname>Khalid</surname><given-names>J</given-names></name><name><surname>Rizvi</surname><given-names>SJR</given-names></name><name><surname>Juma</surname><given-names>MH</given-names></name><name><surname>Chowdhury</surname><given-names>NH</given-names></name><name><surname>Kabir</surname><given-names>F</given-names></name><name><surname>Aftab</surname><given-names>F</given-names></name><name><surname>Quaiyum</surname><given-names>A</given-names></name><name><surname>Manu</surname><given-names>A</given-names></name><name><surname>Yoshida</surname><given-names>S</given-names></name><name><surname>Bahl</surname><given-names>R</given-names></name><name><surname>Rahman</surname><given-names>A</given-names></name><name><surname>Pervin</surname><given-names>J</given-names></name><name><surname>Winston</surname><given-names>J</given-names></name><name><surname>Musonda</surname><given-names>P</given-names></name><name><surname>Stringer</surname><given-names>JSA</given-names></name><name><surname>Litch</surname><given-names>JA</given-names></name><name><surname>Ghaemi</surname><given-names>MS</given-names></name><name><surname>Moufarrej</surname><given-names>MN</given-names></name><name><surname>Contrepois</surname><given-names>K</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Stelzer</surname><given-names>IA</given-names></name><name><surname>Stanley</surname><given-names>N</given-names></name><name><surname>Chang</surname><given-names>AL</given-names></name><name><surname>Hammad</surname><given-names>GB</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Quaintance</surname><given-names>CC</given-names></name><name><surname>Culos</surname><given-names>A</given-names></name><name><surname>Espinosa</surname><given-names>C</given-names></name><name><surname>Xenochristou</surname><given-names>M</given-names></name><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Fallahzadeh</surname><given-names>R</given-names></name><name><surname>Ganio</surname><given-names>E</given-names></name><name><surname>Tsai</surname><given-names>AS</given-names></name><name><surname>Gaudilliere</surname><given-names>D</given-names></name><name><surname>Tsai</surname><given-names>ES</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Tingle</surname><given-names>M</given-names></name><name><surname>Maric</surname><given-names>I</given-names></name><name><surname>Wise</surname><given-names>PH</given-names></name><name><surname>Winn</surname><given-names>VD</given-names></name><name><surname>Druzin</surname><given-names>ML</given-names></name><name><surname>Gibbs</surname><given-names>RS</given-names></name><name><surname>Darmstadt</surname><given-names>GL</given-names></name><name><surname>Murray</surname><given-names>JC</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name><name><surname>Angst</surname><given-names>MS</given-names></name><name><surname>Gaudilliere</surname><given-names>B</given-names></name><name><surname>Aghaeepour</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multiomics characterization of preterm birth in low- and middle-income countries</article-title><source>JAMA Network Open</source><volume>3</volume><elocation-id>e2029655</elocation-id><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2020.29655</pub-id><pub-id pub-id-type="pmid">33337494</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>SA</given-names></name><name><surname>Jenkins</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer</article-title><source>Nature Reviews Immunology</source><volume>18</volume><fpage>773</fpage><lpage>789</lpage><pub-id pub-id-type="doi">10.1038/s41577-018-0066-7</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>EY</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Ryu</surname><given-names>A</given-names></name><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Cho</surname><given-names>SH</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Prediction of impending preterm delivery based on sonographic cervical length and different cytokine levels in cervicovaginal fluid in preterm labor</article-title><source>The Journal of Obstetrics and Gynaecology Research</source><volume>42</volume><fpage>158</fpage><lpage>165</lpage><pub-id pub-id-type="doi">10.1111/jog.12882</pub-id><pub-id pub-id-type="pmid">26556477</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kacerovsky</surname><given-names>M</given-names></name><name><surname>Musilova</surname><given-names>I</given-names></name><name><surname>Jacobsson</surname><given-names>B</given-names></name><name><surname>Drahosova</surname><given-names>M</given-names></name><name><surname>Hornychova</surname><given-names>H</given-names></name><name><surname>Janku</surname><given-names>P</given-names></name><name><surname>Prochazka</surname><given-names>M</given-names></name><name><surname>Simetka</surname><given-names>O</given-names></name><name><surname>Andrys</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Vaginal fluid IL-6 and IL-8 levels in pregnancies complicated by preterm prelabor membrane ruptures</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>28</volume><fpage>392</fpage><lpage>398</lpage><pub-id pub-id-type="doi">10.3109/14767058.2014.917625</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalinka</surname><given-names>J</given-names></name><name><surname>Sobala</surname><given-names>W</given-names></name><name><surname>Wasiela</surname><given-names>M</given-names></name><name><surname>Brzezińska‐Błaszczyk</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Decreased proinflammatory cytokines in cervicovaginal fluid, as measured in midgestation, are associated with preterm delivery</article-title><source>American Journal of Reproductive Immunology</source><volume>54</volume><fpage>70</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0897.2005.00289.x</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Shimozato</surname><given-names>O</given-names></name><name><surname>Hoshi</surname><given-names>K</given-names></name><name><surname>Wakimoto</surname><given-names>H</given-names></name><name><surname>Hamada</surname><given-names>H</given-names></name><name><surname>Yagita</surname><given-names>H</given-names></name><name><surname>Okumura</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection</article-title><source>PNAS</source><volume>93</volume><fpage>9085</fpage><lpage>9089</lpage><pub-id pub-id-type="doi">10.1073/pnas.93.17.9085</pub-id><pub-id pub-id-type="pmid">8799158</pub-id></element-citation></ref><ref id="bib115"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Yoo</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Topping</surname><given-names>V</given-names></name><name><surname>Gotsch</surname><given-names>F</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Chi</surname><given-names>JG</given-names></name><name><surname>Kim</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The frequency, clinical significance, and pathological features of chronic chorioamnionitis: a lesion associated with spontaneous preterm birth</article-title><source>Modern Pathology</source><volume>23</volume><fpage>1000</fpage><lpage>1011</lpage><pub-id pub-id-type="doi">10.1038/modpathol.2010.73</pub-id><pub-id pub-id-type="pmid">20348884</pub-id></element-citation></ref><ref id="bib116"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Chaemsaithong</surname><given-names>P</given-names></name><name><surname>Chaiyasit</surname><given-names>N</given-names></name><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>213</volume><fpage>S29</fpage><lpage>S52</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2015.08.040</pub-id><pub-id pub-id-type="pmid">26428501</pub-id></element-citation></ref><ref id="bib117"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Chaemsaithong</surname><given-names>P</given-names></name><name><surname>Kim</surname><given-names>J-S</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>213</volume><fpage>S53</fpage><lpage>S69</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2015.08.041</pub-id><pub-id pub-id-type="pmid">26428503</pub-id></element-citation></ref><ref id="bib118"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Lee</surname><given-names>JJ</given-names></name><name><surname>Tak</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>ST</given-names></name><name><surname>Song</surname><given-names>JE</given-names></name><name><surname>Son</surname><given-names>GH</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Expression of antimicrobial peptides in the amniotic fluid of women with cervical insufficiency</article-title><source>American Journal of Reproductive Immunology</source><volume>88</volume><elocation-id>e13577</elocation-id><pub-id pub-id-type="doi">10.1111/aji.13577</pub-id><pub-id pub-id-type="pmid">35567598</pub-id></element-citation></ref><ref id="bib119"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kindinger</surname><given-names>LM</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Marchesi</surname><given-names>JR</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Cacciatore</surname><given-names>S</given-names></name><name><surname>Holmes</surname><given-names>E</given-names></name><name><surname>Nicholson</surname><given-names>JK</given-names></name><name><surname>Teoh</surname><given-names>TG</given-names></name><name><surname>MacIntyre</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk</article-title><source>Microbiome</source><volume>5</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.1186/s40168-016-0223-9</pub-id><pub-id pub-id-type="pmid">28103952</pub-id></element-citation></ref><ref id="bib120"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>AE</given-names></name><name><surname>Critchley</surname><given-names>HOD</given-names></name><name><surname>Kelly</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Innate immune defences in the human endometrium</article-title><source>Reproductive Biology and Endocrinology</source><volume>1</volume><elocation-id>116</elocation-id><pub-id pub-id-type="doi">10.1186/1477-7827-1-116</pub-id><pub-id pub-id-type="pmid">14641912</pub-id></element-citation></ref><ref id="bib121"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname><given-names>AE</given-names></name><name><surname>Paltoo</surname><given-names>A</given-names></name><name><surname>Kelly</surname><given-names>RW</given-names></name><name><surname>Sallenave</surname><given-names>J-M</given-names></name><name><surname>Bocking</surname><given-names>AD</given-names></name><name><surname>Challis</surname><given-names>JRG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Expression of natural antimicrobials by human placenta and fetal membranes</article-title><source>Placenta</source><volume>28</volume><fpage>161</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2006.01.006</pub-id></element-citation></ref><ref id="bib122"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostura</surname><given-names>MJ</given-names></name><name><surname>Tocci</surname><given-names>MJ</given-names></name><name><surname>Limjuco</surname><given-names>G</given-names></name><name><surname>Chin</surname><given-names>J</given-names></name><name><surname>Cameron</surname><given-names>P</given-names></name><name><surname>Hillman</surname><given-names>AG</given-names></name><name><surname>Chartrain</surname><given-names>NA</given-names></name><name><surname>Schmidt</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Identification of a monocyte specific pre-interleukin 1 beta convertase activity</article-title><source>PNAS</source><volume>86</volume><fpage>5227</fpage><lpage>5231</lpage><pub-id pub-id-type="doi">10.1073/pnas.86.14.5227</pub-id><pub-id pub-id-type="pmid">2787508</pub-id></element-citation></ref><ref id="bib123"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Murugesan</surname><given-names>S</given-names></name><name><surname>Singh</surname><given-names>P</given-names></name><name><surname>Saadaoui</surname><given-names>M</given-names></name><name><surname>Elhag</surname><given-names>DA</given-names></name><name><surname>Terranegra</surname><given-names>A</given-names></name><name><surname>Kabeer</surname><given-names>BSA</given-names></name><name><surname>Marr</surname><given-names>AK</given-names></name><name><surname>Kino</surname><given-names>T</given-names></name><name><surname>Brummaier</surname><given-names>T</given-names></name><name><surname>McGready</surname><given-names>R</given-names></name><name><surname>Nosten</surname><given-names>F</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name><name><surname>Al Khodor</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vaginal microbiota and cytokine levels predict preterm delivery in asian women</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>11</volume><elocation-id>639665</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.639665</pub-id><pub-id pub-id-type="pmid">33747983</pub-id></element-citation></ref><ref id="bib124"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuziel</surname><given-names>WA</given-names></name><name><surname>Morgan</surname><given-names>SJ</given-names></name><name><surname>Dawson</surname><given-names>TC</given-names></name><name><surname>Griffin</surname><given-names>S</given-names></name><name><surname>Smithies</surname><given-names>O</given-names></name><name><surname>Ley</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>N</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2</article-title><source>PNAS</source><volume>94</volume><fpage>12053</fpage><lpage>12058</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.22.12053</pub-id><pub-id pub-id-type="pmid">9342361</pub-id></element-citation></ref><ref id="bib125"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lal</surname><given-names>BK</given-names></name><name><surname>Varma</surname><given-names>S</given-names></name><name><surname>Pappas</surname><given-names>PJ</given-names></name><name><surname>Hobson</surname><given-names>RW</given-names></name><name><surname>Durán</surname><given-names>WN</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways</article-title><source>Microvascular Research</source><volume>62</volume><fpage>252</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1006/mvre.2001.2338</pub-id><pub-id pub-id-type="pmid">11678628</pub-id></element-citation></ref><ref id="bib126"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>CJ</given-names></name><name><surname>Kim</surname><given-names>D-J</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Immune cells in the female reproductive tract</article-title><source>Immune Network</source><volume>15</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.4110/in.2015.15.1.16</pub-id></element-citation></ref><ref id="bib127"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lichtenstein</surname><given-names>A</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Mechanism of mammalian cell lysis mediated by peptide defensins: evidence for an initial alteration of the plasma membrane</article-title><source>The Journal of Clinical Investigation</source><volume>88</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1172/JCI115310</pub-id><pub-id pub-id-type="pmid">2056135</pub-id></element-citation></ref><ref id="bib128"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunny</surname><given-names>C</given-names></name><name><surname>Taylor</surname><given-names>D</given-names></name><name><surname>Hoang</surname><given-names>L</given-names></name><name><surname>Wong</surname><given-names>T</given-names></name><name><surname>Gilbert</surname><given-names>M</given-names></name><name><surname>Lester</surname><given-names>R</given-names></name><name><surname>Krajden</surname><given-names>M</given-names></name><name><surname>Ogilvie</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Self-collected versus clinician-collected sampling for chlamydia and gonorrhea screening: a systemic review and meta-analysis</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0132776</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0132776</pub-id><pub-id pub-id-type="pmid">26168051</pub-id></element-citation></ref><ref id="bib129"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maisetta</surname><given-names>G</given-names></name><name><surname>Batoni</surname><given-names>G</given-names></name><name><surname>Esin</surname><given-names>S</given-names></name><name><surname>Luperini</surname><given-names>F</given-names></name><name><surname>Pardini</surname><given-names>M</given-names></name><name><surname>Bottai</surname><given-names>D</given-names></name><name><surname>Florio</surname><given-names>W</given-names></name><name><surname>Giuca</surname><given-names>MR</given-names></name><name><surname>Gabriele</surname><given-names>M</given-names></name><name><surname>Campa</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>47</volume><fpage>3349</fpage><lpage>3351</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.10.3349-3351.2003</pub-id><pub-id pub-id-type="pmid">14506056</pub-id></element-citation></ref><ref id="bib130"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JA</given-names></name><name><surname>Osterman</surname><given-names>MJK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Describing the increase in preterm births in the United States, 2014-2016</article-title><source>NCHS Data Brief</source><volume>01</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">30044213</pub-id></element-citation></ref><ref id="bib131"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JA</given-names></name><name><surname>Hamilton</surname><given-names>BE</given-names></name></person-group><year iso-8601-date="2021">2021</year><source>Births in the United States</source><publisher-name>NCHS Data Brief</publisher-name></element-citation></ref><ref id="bib132"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattner</surname><given-names>F</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><name><surname>Guckes</surname><given-names>S</given-names></name><name><surname>Jin</surname><given-names>S</given-names></name><name><surname>Kaulen</surname><given-names>H</given-names></name><name><surname>Schmitt</surname><given-names>E</given-names></name><name><surname>Rüde</surname><given-names>E</given-names></name><name><surname>Germann</surname><given-names>T</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer</article-title><source>European Journal of Immunology</source><volume>23</volume><fpage>2202</fpage><lpage>2208</lpage><pub-id pub-id-type="doi">10.1002/eji.1830230923</pub-id><pub-id pub-id-type="pmid">8103745</pub-id></element-citation></ref><ref id="bib133"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>W</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>K</given-names></name><name><surname>Huang</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The unique microbiome and innate immunity during pregnancy</article-title><source>Frontiers in Immunology</source><volume>10</volume><elocation-id>2886</elocation-id><pub-id pub-id-type="doi">10.3389/fimmu.2019.02886</pub-id><pub-id pub-id-type="pmid">31921149</pub-id></element-citation></ref><ref id="bib134"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menon</surname><given-names>R</given-names></name><name><surname>Richardson</surname><given-names>LS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Preterm prelabor rupture of the membranes: a disease of the fetal membranes</article-title><source>Seminars in Perinatology</source><volume>41</volume><fpage>409</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1053/j.semperi.2017.07.012</pub-id><pub-id pub-id-type="pmid">28807394</pub-id></element-citation></ref><ref id="bib135"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mikołajczyk</surname><given-names>M</given-names></name><name><surname>Wirstlein</surname><given-names>P</given-names></name><name><surname>Adamczyk</surname><given-names>M</given-names></name><name><surname>Skrzypczak</surname><given-names>J</given-names></name><name><surname>Wender-Ożegowska</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Value of cervicovaginal fluid cytokines in prediction of fetal inflammatory response syndrome in pregnancies complicated with preterm premature rupture of membranes (pPROM)</article-title><source>Journal of Perinatal Medicine</source><volume>48</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1515/jpm-2019-0280</pub-id></element-citation></ref><ref id="bib136"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modi</surname><given-names>BP</given-names></name><name><surname>Teves</surname><given-names>ME</given-names></name><name><surname>Pearson</surname><given-names>LN</given-names></name><name><surname>Parikh</surname><given-names>HI</given-names></name><name><surname>Haymond-Thornburg</surname><given-names>H</given-names></name><name><surname>Tucker</surname><given-names>JL</given-names></name><name><surname>Chaemsaithong</surname><given-names>P</given-names></name><name><surname>GomezLopez</surname><given-names>N</given-names></name><name><surname>York</surname><given-names>TP</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mutations in fetal genes involved in innate immunity and host defense against microbes increase risk of preterm premature rupture of membranes (PPROM)</article-title><source>Molecular Genetics &amp; Genomic Medicine</source><volume>5</volume><fpage>720</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1002/mgg3.330</pub-id><pub-id pub-id-type="pmid">29178652</pub-id></element-citation></ref><ref id="bib137"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modi</surname><given-names>BP</given-names></name><name><surname>Parikh</surname><given-names>HI</given-names></name><name><surname>Teves</surname><given-names>ME</given-names></name><name><surname>Kulkarni</surname><given-names>R</given-names></name><name><surname>Liyu</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>York</surname><given-names>TP</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Discovery of rare ancestry-specific variants in the fetal genome that confer risk of preterm premature rupture of membranes (PPROM) and preterm birth</article-title><source>BMC Medical Genetics</source><volume>19</volume><elocation-id>181</elocation-id><pub-id pub-id-type="doi">10.1186/s12881-018-0696-4</pub-id><pub-id pub-id-type="pmid">30290772</pub-id></element-citation></ref><ref id="bib138"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monin</surname><given-names>L</given-names></name><name><surname>Whettlock</surname><given-names>EM</given-names></name><name><surname>Male</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Immune responses in the human female reproductive tract</article-title><source>Immunology</source><volume>160</volume><fpage>106</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.1111/imm.13136</pub-id><pub-id pub-id-type="pmid">31630394</pub-id></element-citation></ref><ref id="bib139"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Slutsky</surname><given-names>R</given-names></name><name><surname>Levenson</surname><given-names>D</given-names></name><name><surname>GomezLopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The alarmin interleukin-1α causes preterm birth through the NLRP3 inflammasome</article-title><source>Molecular Human Reproduction</source><volume>26</volume><fpage>712</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1093/molehr/gaaa054</pub-id><pub-id pub-id-type="pmid">32647859</pub-id></element-citation></ref><ref id="bib140"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Plazyo</surname><given-names>O</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Gershater</surname><given-names>M</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>GomezLopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The alarmin S100A12 causes sterile inflammation of the human chorioamniotic membranes as well as preterm birth and neonatal mortality in mice†</article-title><source>Biology of Reproduction</source><volume>105</volume><fpage>1494</fpage><lpage>1509</lpage><pub-id pub-id-type="doi">10.1093/biolre/ioab188</pub-id><pub-id pub-id-type="pmid">34632484</pub-id></element-citation></ref><ref id="bib141"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motomura</surname><given-names>K</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Tao</surname><given-names>L</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Done</surname><given-names>B</given-names></name><name><surname>Arenas-Hernandez</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Gutierrez-Contreras</surname><given-names>P</given-names></name><name><surname>Farias-Jofre</surname><given-names>M</given-names></name><name><surname>Aras</surname><given-names>S</given-names></name><name><surname>Grossman</surname><given-names>LI</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Fetal and maternal NLRP3 signaling is required for preterm labor and birth</article-title><source>JCI Insight</source><volume>7</volume><elocation-id>e158238</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.158238</pub-id><pub-id pub-id-type="pmid">35993366</pub-id></element-citation></ref><ref id="bib142"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname><given-names>TTM</given-names></name><name><surname>Moufarrej</surname><given-names>MN</given-names></name><name><surname>Rasmussen</surname><given-names>M-LH</given-names></name><name><surname>Camunas-Soler</surname><given-names>J</given-names></name><name><surname>Pan</surname><given-names>W</given-names></name><name><surname>Okamoto</surname><given-names>J</given-names></name><name><surname>Neff</surname><given-names>NF</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Downes</surname><given-names>K</given-names></name><name><surname>Tibshirani</surname><given-names>R</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Skotte</surname><given-names>L</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Biggio</surname><given-names>JR</given-names></name><name><surname>Elovitz</surname><given-names>MA</given-names></name><name><surname>Melbye</surname><given-names>M</given-names></name><name><surname>Quake</surname><given-names>SR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Noninvasive blood tests for fetal development predict gestational age and preterm delivery</article-title><source>Science</source><volume>360</volume><fpage>1133</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1126/science.aar3819</pub-id><pub-id pub-id-type="pmid">29880692</pub-id></element-citation></ref><ref id="bib143"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odogwu</surname><given-names>NM</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Onebunne</surname><given-names>CA</given-names></name><name><surname>Jeraldo</surname><given-names>P</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Johnson</surname><given-names>S</given-names></name><name><surname>Ayeni</surname><given-names>FA</given-names></name><name><surname>Walther-Antonio</surname><given-names>MRS</given-names></name><name><surname>Olayemi</surname><given-names>OO</given-names></name><name><surname>Chia</surname><given-names>N</given-names></name><name><surname>Omigbodun</surname><given-names>AO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Predominance of atopobium vaginae at midtrimester: a potential indicator of preterm birth risk in a nigerian cohort</article-title><source>mSphere</source><volume>6</volume><elocation-id>e01261-20</elocation-id><pub-id pub-id-type="doi">10.1128/mSphere.01261-20</pub-id><pub-id pub-id-type="pmid">33504666</pub-id></element-citation></ref><ref id="bib144"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>JE</given-names></name><name><surname>Iijima</surname><given-names>N</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Lu</surname><given-names>P</given-names></name><name><surname>Klein</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Kleinstein</surname><given-names>SH</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Migrant memory B cells secrete luminal antibody in the vagina</article-title><source>Nature</source><volume>571</volume><fpage>122</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1285-1</pub-id><pub-id pub-id-type="pmid">31189952</pub-id></element-citation></ref><ref id="bib145"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osman</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Leukocyte density and pro-inflammatory cytokine expression in human fetal membranes, decidua, cervix and myometrium before and during labour at term</article-title><source>Molecular Human Reproduction</source><volume>9</volume><fpage>41</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1093/molehr/gag001</pub-id></element-citation></ref><ref id="bib146"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Payne</surname><given-names>MS</given-names></name><name><surname>Newnham</surname><given-names>JP</given-names></name><name><surname>Doherty</surname><given-names>DA</given-names></name><name><surname>Furfaro</surname><given-names>LL</given-names></name><name><surname>Pendal</surname><given-names>NL</given-names></name><name><surname>Loh</surname><given-names>DE</given-names></name><name><surname>Keelan</surname><given-names>JA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A specific bacterial DNA signature in the vagina of Australian women in midpregnancy predicts high risk of spontaneous preterm birth (the Predict1000 study)</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>224</volume><elocation-id>206</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2020.08.034</pub-id><pub-id pub-id-type="pmid">32861687</pub-id></element-citation></ref><ref id="bib147"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pedretti</surname><given-names>MK</given-names></name><name><surname>Kazemier</surname><given-names>BM</given-names></name><name><surname>Dickinson</surname><given-names>JE</given-names></name><name><surname>Mol</surname><given-names>BWJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Implementing universal cervical length screening in asymptomatic women with singleton pregnancies: challenges and opportunities</article-title><source>The Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology</source><volume>57</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1111/ajo.12586</pub-id><pub-id pub-id-type="pmid">28295170</pub-id></element-citation></ref><ref id="bib148"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>LS</given-names></name><name><surname>Stelzer</surname><given-names>IA</given-names></name><name><surname>Tsai</surname><given-names>AS</given-names></name><name><surname>Ghaemi</surname><given-names>MS</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Winn</surname><given-names>VD</given-names></name><name><surname>Martinez</surname><given-names>NR</given-names></name><name><surname>Contrepois</surname><given-names>K</given-names></name><name><surname>Moufarrej</surname><given-names>MN</given-names></name><name><surname>Quake</surname><given-names>S</given-names></name><name><surname>Relman</surname><given-names>DA</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Arck</surname><given-names>P</given-names></name><name><surname>Angst</surname><given-names>MS</given-names></name><name><surname>Aghaeepour</surname><given-names>N</given-names></name><name><surname>Gaudilliere</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Multiomic immune clockworks of pregnancy</article-title><source>Seminars in Immunopathology</source><volume>42</volume><fpage>397</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.1007/s00281-019-00772-1</pub-id><pub-id pub-id-type="pmid">32020337</pub-id></element-citation></ref><ref id="bib149"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinto</surname><given-names>S</given-names></name><name><surname>Malheiro</surname><given-names>MF</given-names></name><name><surname>Vaz</surname><given-names>A</given-names></name><name><surname>Rodrigues</surname><given-names>T</given-names></name><name><surname>Montenegro</surname><given-names>N</given-names></name><name><surname>Guimarães</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neonatal outcome in preterm deliveries before 34-week gestation – the influence of the mechanism of labor onset</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>32</volume><fpage>3655</fpage><lpage>3661</lpage><pub-id pub-id-type="doi">10.1080/14767058.2018.1481038</pub-id></element-citation></ref><ref id="bib150"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plazyo</surname><given-names>O</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Unkel</surname><given-names>R</given-names></name><name><surname>Balancio</surname><given-names>A</given-names></name><name><surname>Mial</surname><given-names>TN</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HMGB1 induces an inflammatory response in the chorioamniotic membranes that is partially mediated by the inflammasome</article-title><source>Biology of Reproduction</source><volume>95</volume><elocation-id>130</elocation-id><pub-id pub-id-type="doi">10.1095/biolreprod.116.144139</pub-id><pub-id pub-id-type="pmid">27806943</pub-id></element-citation></ref><ref id="bib151"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polettini</surname><given-names>J</given-names></name><name><surname>Silva</surname><given-names>MG</given-names></name><name><surname>Kacerovsky</surname><given-names>M</given-names></name><name><surname>Syed</surname><given-names>TA</given-names></name><name><surname>Saade</surname><given-names>G</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Expression profiles of fetal membrane nicotinamide adenine dinucleotide phosphate oxidases (NOX) 2 and 3 differentiates spontaneous preterm birth and pPROM pathophysiologies</article-title><source>Placenta</source><volume>35</volume><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.placenta.2013.12.012</pub-id><pub-id pub-id-type="pmid">24439294</pub-id></element-citation></ref><ref id="bib152"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Presicce</surname><given-names>P</given-names></name><name><surname>Senthamaraikannan</surname><given-names>P</given-names></name><name><surname>Alvarez</surname><given-names>M</given-names></name><name><surname>Rueda</surname><given-names>CM</given-names></name><name><surname>Cappelletti</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>LA</given-names></name><name><surname>Jobe</surname><given-names>AH</given-names></name><name><surname>Chougnet</surname><given-names>CA</given-names></name><name><surname>Kallapur</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neutrophil recruitment and activation in decidua with intra-amniotic IL-1beta in the preterm rhesus macaque</article-title><source>Biology of Reproduction</source><volume>92</volume><elocation-id>56</elocation-id><pub-id pub-id-type="doi">10.1095/biolreprod.114.124420</pub-id><pub-id pub-id-type="pmid">25537373</pub-id></element-citation></ref><ref id="bib153"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pruski</surname><given-names>P</given-names></name><name><surname>Correia</surname><given-names>GDS</given-names></name><name><surname>Lewis</surname><given-names>HV</given-names></name><name><surname>Capuccini</surname><given-names>K</given-names></name><name><surname>Inglese</surname><given-names>P</given-names></name><name><surname>Chan</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>RG</given-names></name><name><surname>Kindinger</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Marchesi</surname><given-names>J</given-names></name><name><surname>McDonald</surname><given-names>JAK</given-names></name><name><surname>Cameron</surname><given-names>S</given-names></name><name><surname>Alexander-Hardiman</surname><given-names>K</given-names></name><name><surname>David</surname><given-names>AL</given-names></name><name><surname>Stock</surname><given-names>SJ</given-names></name><name><surname>Norman</surname><given-names>JE</given-names></name><name><surname>Terzidou</surname><given-names>V</given-names></name><name><surname>Teoh</surname><given-names>TG</given-names></name><name><surname>Sykes</surname><given-names>L</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name><name><surname>Takats</surname><given-names>Z</given-names></name><name><surname>MacIntyre</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Direct on-swab metabolic profiling of vaginal microbiome host interactions during pregnancy and preterm birth</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>5967</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26215-w</pub-id><pub-id pub-id-type="pmid">34645809</pub-id></element-citation></ref><ref id="bib154"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Gajer</surname><given-names>P</given-names></name><name><surname>Abdo</surname><given-names>Z</given-names></name><name><surname>Schneider</surname><given-names>GM</given-names></name><name><surname>Koenig</surname><given-names>SSK</given-names></name><name><surname>McCulle</surname><given-names>SL</given-names></name><name><surname>Karlebach</surname><given-names>S</given-names></name><name><surname>Gorle</surname><given-names>R</given-names></name><name><surname>Russell</surname><given-names>J</given-names></name><name><surname>Tacket</surname><given-names>CO</given-names></name><name><surname>Brotman</surname><given-names>RM</given-names></name><name><surname>Davis</surname><given-names>CC</given-names></name><name><surname>Ault</surname><given-names>K</given-names></name><name><surname>Peralta</surname><given-names>L</given-names></name><name><surname>Forney</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Vaginal microbiome of reproductive-age women</article-title><source>PNAS</source><volume>108 Suppl 1</volume><fpage>4680</fpage><lpage>4687</lpage><pub-id pub-id-type="doi">10.1073/pnas.1002611107</pub-id><pub-id pub-id-type="pmid">20534435</pub-id></element-citation></ref><ref id="bib155"><element-citation publication-type="software"><person-group person-group-type="author"><collab>R Development Core Team</collab></person-group><year iso-8601-date="2010">2010</year><data-title>R: A language and environment for statistical Compuiting</data-title><publisher-loc>Vienna, Austria</publisher-loc><publisher-name>R Foundation for Statistical Computing</publisher-name><ext-link ext-link-type="uri" xlink:href="https://www.r-project.org">https://www.r-project.org</ext-link></element-citation></ref><ref id="bib156"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>RW</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Classification of placental lesions</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>213</volume><fpage>S21</fpage><lpage>S28</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2015.05.056</pub-id></element-citation></ref><ref id="bib157"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robertson</surname><given-names>SA</given-names></name><name><surname>Christiaens</surname><given-names>I</given-names></name><name><surname>Dorian</surname><given-names>CL</given-names></name><name><surname>Zaragoza</surname><given-names>DB</given-names></name><name><surname>Care</surname><given-names>AS</given-names></name><name><surname>Banks</surname><given-names>AM</given-names></name><name><surname>Olson</surname><given-names>DM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Interleukin-6 is an essential determinant of on-time parturition in the mouse</article-title><source>Endocrinology</source><volume>151</volume><fpage>3996</fpage><lpage>4006</lpage><pub-id pub-id-type="doi">10.1210/en.2010-0063</pub-id></element-citation></ref><ref id="bib158"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>CZ</given-names></name><name><surname>Glass</surname><given-names>CK</given-names></name><name><surname>Pollard</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Monocyte regulation in homeostasis and malignancy</article-title><source>Trends in Immunology</source><volume>42</volume><fpage>104</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.it.2020.12.001</pub-id><pub-id pub-id-type="pmid">33446416</pub-id></element-citation></ref><ref id="bib159"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Brody</surname><given-names>DT</given-names></name><name><surname>Oyarzun</surname><given-names>E</given-names></name><name><surname>Mazor</surname><given-names>M</given-names></name><name><surname>King Wu</surname><given-names>Y</given-names></name><name><surname>Hobbins</surname><given-names>JC</given-names></name><name><surname>Durum</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Infection and labor</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>160</volume><fpage>1117</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1016/0002-9378(89)90172-5</pub-id></element-citation></ref><ref id="bib160"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Mazor</surname><given-names>M</given-names></name><name><surname>Brandt</surname><given-names>F</given-names></name><name><surname>Sepulveda</surname><given-names>W</given-names></name><name><surname>Avila</surname><given-names>C</given-names></name><name><surname>Cotton</surname><given-names>DB</given-names></name><name><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><year iso-8601-date="1992">1992a</year><article-title>Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition</article-title><source>American Journal of Reproductive Immunology</source><volume>27</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0897.1992.tb00737.x</pub-id><pub-id pub-id-type="pmid">1418402</pub-id></element-citation></ref><ref id="bib161"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Tartakovsky</surname><given-names>B</given-names></name></person-group><year iso-8601-date="1992">1992b</year><article-title>The natural interleukin-1 receptor antagonist prevents interleukin-l-induced preterm delivery in mice</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>167</volume><fpage>1041</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1016/S0002-9378(12)80035-4</pub-id></element-citation></ref><ref id="bib162"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Espinoza</surname><given-names>J</given-names></name><name><surname>Gonçalves</surname><given-names>LF</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Friel</surname><given-names>LA</given-names></name><name><surname>Nien</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2006">2006a</year><article-title>Inflammation in preterm and term labour and delivery</article-title><source>Seminars in Fetal &amp; Neonatal Medicine</source><volume>11</volume><fpage>317</fpage><lpage>326</lpage><pub-id pub-id-type="doi">10.1016/j.siny.2006.05.001</pub-id><pub-id pub-id-type="pmid">16839830</pub-id></element-citation></ref><ref id="bib163"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Espinoza</surname><given-names>J</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Gotsch</surname><given-names>F</given-names></name><name><surname>Hassan</surname><given-names>S</given-names></name><name><surname>Erez</surname><given-names>O</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Mazor</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2006">2006b</year><article-title>The preterm parturition syndrome</article-title><source>BJOG</source><volume>113 Suppl 3</volume><fpage>17</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1111/j.1471-0528.2006.01120.x</pub-id><pub-id pub-id-type="pmid">17206962</pub-id></element-citation></ref><ref id="bib164"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Espinoza</surname><given-names>J</given-names></name><name><surname>Gonçalves</surname><given-names>LF</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Friel</surname><given-names>L</given-names></name><name><surname>Hassan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>The role of inflammation and infection in preterm birth</article-title><source>Seminars in Reproductive Medicine</source><volume>25</volume><fpage>21</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1055/s-2006-956773</pub-id><pub-id pub-id-type="pmid">17205421</pub-id></element-citation></ref><ref id="bib165"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Dey</surname><given-names>SK</given-names></name><name><surname>Fisher</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Preterm labor: one syndrome, many causes</article-title><source>Science</source><volume>345</volume><fpage>760</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1126/science.1251816</pub-id><pub-id pub-id-type="pmid">25124429</pub-id></element-citation></ref><ref id="bib166"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Yeo</surname><given-names>L</given-names></name><name><surname>Chaemsaithong</surname><given-names>P</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Progesterone to prevent spontaneous preterm birth</article-title><source>Seminars in Fetal &amp; Neonatal Medicine</source><volume>19</volume><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.siny.2013.10.004</pub-id><pub-id pub-id-type="pmid">24315687</pub-id></element-citation></ref><ref id="bib167"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name><name><surname>O’Brien</surname><given-names>JM</given-names></name><name><surname>Cetingoz</surname><given-names>E</given-names></name><name><surname>Da Fonseca</surname><given-names>E</given-names></name><name><surname>Creasy</surname><given-names>GW</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Vaginal progesterone decreases preterm birth ≤ 34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study</article-title><source>Ultrasound in Obstetrics &amp; Gynecology</source><volume>48</volume><fpage>308</fpage><lpage>317</lpage><pub-id pub-id-type="doi">10.1002/uog.15953</pub-id><pub-id pub-id-type="pmid">27444208</pub-id></element-citation></ref><ref id="bib168"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name><name><surname>El-Refaie</surname><given-names>W</given-names></name><name><surname>Rode</surname><given-names>L</given-names></name><name><surname>Brizot</surname><given-names>ML</given-names></name><name><surname>Cetingoz</surname><given-names>E</given-names></name><name><surname>Serra</surname><given-names>V</given-names></name><name><surname>Da Fonseca</surname><given-names>E</given-names></name><name><surname>Abdelhafez</surname><given-names>MS</given-names></name><name><surname>Tabor</surname><given-names>A</given-names></name><name><surname>Perales</surname><given-names>A</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data</article-title><source>Ultrasound in Obstetrics &amp; Gynecology</source><volume>49</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="doi">10.1002/uog.17397</pub-id><pub-id pub-id-type="pmid">28067007</pub-id></element-citation></ref><ref id="bib169"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Conde-Agudelo</surname><given-names>A</given-names></name><name><surname>Da Fonseca</surname><given-names>E</given-names></name><name><surname>O’Brien</surname><given-names>JM</given-names></name><name><surname>Cetingoz</surname><given-names>E</given-names></name><name><surname>Creasy</surname><given-names>GW</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Nicolaides</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>218</volume><fpage>161</fpage><lpage>180</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2017.11.576</pub-id><pub-id pub-id-type="pmid">29157866</pub-id></element-citation></ref><ref id="bib170"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Tarca</surname><given-names>A</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Winters</surname><given-names>A</given-names></name><name><surname>Panzer</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Gudicha</surname><given-names>D</given-names></name><name><surname>Galaz</surname><given-names>J</given-names></name><name><surname>Farias-Jofre</surname><given-names>M</given-names></name><name><surname>Kracht</surname><given-names>D</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Jung</surname><given-names>E</given-names></name><name><surname>Gotsch</surname><given-names>F</given-names></name><name><surname>Suksai</surname><given-names>M</given-names></name><name><surname>Berry</surname><given-names>S</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name><name><surname>Peddada</surname><given-names>S</given-names></name><name><surname>Theis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>The vaginal microbiota in early pregnancy identifies a subset of women at risk for early preterm prelabor rupture of membranes and preterm birth</article-title><source>In Review</source><volume>01</volume><elocation-id>e402/v1</elocation-id><pub-id pub-id-type="doi">10.21203/rs.3.rs-2359402/v1</pub-id></element-citation></ref><ref id="bib171"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sadowsky</surname><given-names>DW</given-names></name><name><surname>Adams</surname><given-names>KM</given-names></name><name><surname>Gravett</surname><given-names>MG</given-names></name><name><surname>Witkin</surname><given-names>SS</given-names></name><name><surname>Novy</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Preterm labor is induced by intraamniotic infusions of interleukin-1β and tumor necrosis factor-α but not by interleukin-6 or interleukin-8 in a nonhuman primate model</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>195</volume><fpage>1578</fpage><lpage>1589</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2006.06.072</pub-id></element-citation></ref><ref id="bib172"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Savasan</surname><given-names>ZA</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Kim</surname><given-names>SK</given-names></name><name><surname>Mazaki-Tovi</surname><given-names>S</given-names></name><name><surname>Vaisbuch</surname><given-names>E</given-names></name><name><surname>Mittal</surname><given-names>P</given-names></name><name><surname>Ogge</surname><given-names>G</given-names></name><name><surname>Madan</surname><given-names>I</given-names></name><name><surname>Dong</surname><given-names>Z</given-names></name><name><surname>Yeo</surname><given-names>L</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>23</volume><fpage>828</fpage><lpage>841</lpage><pub-id pub-id-type="doi">10.3109/14767050903440471</pub-id><pub-id pub-id-type="pmid">20158393</pub-id></element-citation></ref><ref id="bib173"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Monocyte recruitment during infection and inflammation</article-title><source>Nature Reviews. Immunology</source><volume>11</volume><fpage>762</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1038/nri3070</pub-id><pub-id pub-id-type="pmid">21984070</pub-id></element-citation></ref><ref id="bib174"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimoya</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Temma</surname><given-names>K</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name><name><surname>Tsujie</surname><given-names>T</given-names></name><name><surname>Tsutsui</surname><given-names>T</given-names></name><name><surname>Wasada</surname><given-names>K</given-names></name><name><surname>Kanzaki</surname><given-names>T</given-names></name><name><surname>Koyama</surname><given-names>M</given-names></name><name><surname>Murata</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women</article-title><source>Maturitas</source><volume>54</volume><fpage>141</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2004.02.019</pub-id></element-citation></ref><ref id="bib175"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>CS</given-names></name><name><surname>Quinlan</surname><given-names>R</given-names></name><name><surname>Bennett</surname><given-names>P</given-names></name><name><surname>Shattock</surname><given-names>RJ</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Optimising the collection of female genital tract fluid for cytokine analysis in pregnant women</article-title><source>Journal of Immunological Methods</source><volume>458</volume><fpage>15</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.jim.2018.03.014</pub-id><pub-id pub-id-type="pmid">29625077</pub-id></element-citation></ref><ref id="bib176"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Short</surname><given-names>C-ES</given-names></name><name><surname>Quinlan</surname><given-names>RA</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Preda</surname><given-names>VG</given-names></name><name><surname>Smith</surname><given-names>A</given-names></name><name><surname>Marchesi</surname><given-names>JR</given-names></name><name><surname>Lee</surname><given-names>YS</given-names></name><name><surname>MacIntyre</surname><given-names>DA</given-names></name><name><surname>Bennett</surname><given-names>PR</given-names></name><name><surname>Taylor</surname><given-names>GP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Vaginal microbiota, genital inflammation and extracellular matrix remodelling collagenase: mmp-9 in pregnant women with hiv, a potential preterm birth mechanism warranting further exploration</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>11</volume><elocation-id>750103</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2021.750103</pub-id><pub-id pub-id-type="pmid">34912728</pub-id></element-citation></ref><ref id="bib177"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>LK</given-names></name><name><surname>Draper</surname><given-names>ES</given-names></name><name><surname>Manktelow</surname><given-names>BN</given-names></name><name><surname>Dorling</surname><given-names>JS</given-names></name><name><surname>Field</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Socioeconomic inequalities in very preterm birth rates</article-title><source>Archives of Disease in Childhood. Fetal and Neonatal Edition</source><volume>92</volume><fpage>F11</fpage><lpage>F14</lpage><pub-id pub-id-type="doi">10.1136/adc.2005.090308</pub-id><pub-id pub-id-type="pmid">16595590</pub-id></element-citation></ref><ref id="bib178"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SB</given-names></name><name><surname>Ravel</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>The vaginal microbiota, host defence and reproductive physiology</article-title><source>The Journal of Physiology</source><volume>595</volume><fpage>451</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1113/JP271694</pub-id><pub-id pub-id-type="pmid">27373840</pub-id></element-citation></ref><ref id="bib179"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soto</surname><given-names>E</given-names></name><name><surname>Espinoza</surname><given-names>J</given-names></name><name><surname>Nien</surname><given-names>JK</given-names></name><name><surname>Kusanovic</surname><given-names>JP</given-names></name><name><surname>Erez</surname><given-names>O</given-names></name><name><surname>Richani</surname><given-names>K</given-names></name><name><surname>Santolaya-Forgas</surname><given-names>J</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Human beta-defensin-2: a natural antimicrobial peptide present in amniotic fluid participates in the host response to microbial invasion of the amniotic cavity</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>20</volume><fpage>15</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1080/14767050601036212</pub-id><pub-id pub-id-type="pmid">17437194</pub-id></element-citation></ref><ref id="bib180"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzer</surname><given-names>IA</given-names></name><name><surname>Ghaemi</surname><given-names>MS</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Ando</surname><given-names>K</given-names></name><name><surname>Hédou</surname><given-names>JJ</given-names></name><name><surname>Feyaerts</surname><given-names>D</given-names></name><name><surname>Peterson</surname><given-names>LS</given-names></name><name><surname>Rumer</surname><given-names>KK</given-names></name><name><surname>Tsai</surname><given-names>ES</given-names></name><name><surname>Ganio</surname><given-names>EA</given-names></name><name><surname>Gaudillière</surname><given-names>DK</given-names></name><name><surname>Tsai</surname><given-names>AS</given-names></name><name><surname>Choisy</surname><given-names>B</given-names></name><name><surname>Gaigne</surname><given-names>LP</given-names></name><name><surname>Verdonk</surname><given-names>F</given-names></name><name><surname>Jacobsen</surname><given-names>D</given-names></name><name><surname>Gavasso</surname><given-names>S</given-names></name><name><surname>Traber</surname><given-names>GM</given-names></name><name><surname>Ellenberger</surname><given-names>M</given-names></name><name><surname>Stanley</surname><given-names>N</given-names></name><name><surname>Becker</surname><given-names>M</given-names></name><name><surname>Culos</surname><given-names>A</given-names></name><name><surname>Fallahzadeh</surname><given-names>R</given-names></name><name><surname>Wong</surname><given-names>RJ</given-names></name><name><surname>Darmstadt</surname><given-names>GL</given-names></name><name><surname>Druzin</surname><given-names>ML</given-names></name><name><surname>Winn</surname><given-names>VD</given-names></name><name><surname>Gibbs</surname><given-names>RS</given-names></name><name><surname>Ling</surname><given-names>XB</given-names></name><name><surname>Sylvester</surname><given-names>K</given-names></name><name><surname>Carvalho</surname><given-names>B</given-names></name><name><surname>Snyder</surname><given-names>MP</given-names></name><name><surname>Shaw</surname><given-names>GM</given-names></name><name><surname>Stevenson</surname><given-names>DK</given-names></name><name><surname>Contrepois</surname><given-names>K</given-names></name><name><surname>Angst</surname><given-names>MS</given-names></name><name><surname>Aghaeepour</surname><given-names>N</given-names></name><name><surname>Gaudillière</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integrated trajectories of the maternal metabolome, proteome, and immunome predict labor onset</article-title><source>Science Translational Medicine</source><volume>13</volume><elocation-id>eabd9898</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abd9898</pub-id><pub-id pub-id-type="pmid">33952678</pub-id></element-citation></ref><ref id="bib181"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>JF</given-names></name><name><surname>Pearson</surname><given-names>LN</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Spontaneous preterm birth: advances toward the discovery of genetic predisposition</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>218</volume><fpage>294</fpage><lpage>314</lpage></element-citation></ref><ref id="bib182"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>KV</given-names></name><name><surname>Deng</surname><given-names>M</given-names></name><name><surname>Ting</surname><given-names>JP-Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The NLRP3 inflammasome: molecular activation and regulation to therapeutics</article-title><source>Nature Reviews. Immunology</source><volume>19</volume><fpage>477</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1038/s41577-019-0165-0</pub-id><pub-id pub-id-type="pmid">31036962</pub-id></element-citation></ref><ref id="bib183"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabatabaei</surname><given-names>N</given-names></name><name><surname>Eren</surname><given-names>AM</given-names></name><name><surname>Barreiro</surname><given-names>LB</given-names></name><name><surname>Yotova</surname><given-names>V</given-names></name><name><surname>Dumaine</surname><given-names>A</given-names></name><name><surname>Allard</surname><given-names>C</given-names></name><name><surname>Fraser</surname><given-names>WD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case-control study</article-title><source>BJOG</source><volume>126</volume><fpage>349</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1111/1471-0528.15299</pub-id><pub-id pub-id-type="pmid">29791775</pub-id></element-citation></ref><ref id="bib184"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Benshalom-Tirosh</surname><given-names>N</given-names></name><name><surname>Than</surname><given-names>NG</given-names></name><name><surname>Gudicha</surname><given-names>DW</given-names></name><name><surname>Done</surname><given-names>B</given-names></name><name><surname>Pacora</surname><given-names>P</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Panaitescu</surname><given-names>B</given-names></name><name><surname>Tirosh</surname><given-names>D</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Draghici</surname><given-names>S</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Erez</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The prediction of early preeclampsia: Results from a longitudinal proteomics study</article-title><source>PLOS ONE</source><volume>14</volume><elocation-id>e0217273</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0217273</pub-id><pub-id pub-id-type="pmid">31163045</pub-id></element-citation></ref><ref id="bib185"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Pataki</surname><given-names>BÁ</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Sirota</surname><given-names>M</given-names></name><name><surname>Guan</surname><given-names>Y</given-names></name><name><surname>Kutum</surname><given-names>R</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name><name><surname>Done</surname><given-names>B</given-names></name><name><surname>Bhatti</surname><given-names>G</given-names></name><name><surname>Yu</surname><given-names>T</given-names></name><name><surname>Andreoletti</surname><given-names>G</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><collab>DREAM Preterm Birth Prediction Challenge Consortium</collab><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Hsu</surname><given-names>CD</given-names></name><name><surname>Aghaeepour</surname><given-names>N</given-names></name><name><surname>Stolovitzky</surname><given-names>G</given-names></name><name><surname>Csabai</surname><given-names>I</given-names></name><name><surname>Costello</surname><given-names>JC</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Crowdsourcing assessment of maternal blood multi-omics for predicting gestational age and preterm birth</article-title><source>Cell Reports. Medicine</source><volume>2</volume><elocation-id>100323</elocation-id><pub-id pub-id-type="doi">10.1016/j.xcrm.2021.100323</pub-id><pub-id pub-id-type="pmid">34195686</pub-id></element-citation></ref><ref id="bib186"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Taran</surname><given-names>A</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Jung</surname><given-names>E</given-names></name><name><surname>Paredes</surname><given-names>C</given-names></name><name><surname>Bhatti</surname><given-names>G</given-names></name><name><surname>Ghita</surname><given-names>C</given-names></name><name><surname>Chaiworapongsa</surname><given-names>T</given-names></name><name><surname>Than</surname><given-names>NG</given-names></name><name><surname>Hsu</surname><given-names>C-D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>226</volume><elocation-id>126</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2021.01.020</pub-id><pub-id pub-id-type="pmid">34998477</pub-id></element-citation></ref><ref id="bib187"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Tarca</surname><given-names>AL</given-names></name></person-group><year iso-8601-date="2024">2024</year><data-title>ImmunoProteomePTB</data-title><version designator="swh:1:rev:3052ec8cdd0e60b722e841ab6749056754a86f08">swh:1:rev:3052ec8cdd0e60b722e841ab6749056754a86f08</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:b8eaafb28e4b1dad20647984998be8db7edd7ce5;origin=https://github.com/aditarca/ImmunoProteomePTB;visit=swh:1:snp:26c45d365ff307071f4ee9baf9b61a24cedc29d1;anchor=swh:1:rev:3052ec8cdd0e60b722e841ab6749056754a86f08">https://archive.softwareheritage.org/swh:1:dir:b8eaafb28e4b1dad20647984998be8db7edd7ce5;origin=https://github.com/aditarca/ImmunoProteomePTB;visit=swh:1:snp:26c45d365ff307071f4ee9baf9b61a24cedc29d1;anchor=swh:1:rev:3052ec8cdd0e60b722e841ab6749056754a86f08</ext-link></element-citation></ref><ref id="bib188"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>BD</given-names></name><name><surname>Holzman</surname><given-names>CB</given-names></name><name><surname>Fichorova</surname><given-names>RN</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Jones</surname><given-names>NM</given-names></name><name><surname>Fu</surname><given-names>W</given-names></name><name><surname>Senagore</surname><given-names>PK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Inflammation biomarkers in vaginal fluid and preterm delivery</article-title><source>Human Reproduction</source><volume>28</volume><fpage>942</fpage><lpage>952</lpage><pub-id pub-id-type="doi">10.1093/humrep/det019</pub-id><pub-id pub-id-type="pmid">23416276</pub-id></element-citation></ref><ref id="bib189"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Temming</surname><given-names>LA</given-names></name><name><surname>Durst</surname><given-names>JK</given-names></name><name><surname>Tuuli</surname><given-names>MG</given-names></name><name><surname>Stout</surname><given-names>MJ</given-names></name><name><surname>Dicke</surname><given-names>JM</given-names></name><name><surname>Macones</surname><given-names>GA</given-names></name><name><surname>Cahill</surname><given-names>AG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Universal cervical length screening: implementation and outcomes</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>214</volume><elocation-id>523</elocation-id><pub-id pub-id-type="doi">10.1016/j.ajog.2016.02.002</pub-id><pub-id pub-id-type="pmid">26874299</pub-id></element-citation></ref><ref id="bib190"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>RC</given-names></name><name><surname>Ohlsson</surname><given-names>K</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase</article-title><source>PNAS</source><volume>83</volume><fpage>6692</fpage><lpage>6696</lpage><pub-id pub-id-type="doi">10.1073/pnas.83.18.6692</pub-id><pub-id pub-id-type="pmid">3462719</pub-id></element-citation></ref><ref id="bib191"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tiensuu</surname><given-names>H</given-names></name><name><surname>Haapalainen</surname><given-names>AM</given-names></name><name><surname>Tissarinen</surname><given-names>P</given-names></name><name><surname>Pasanen</surname><given-names>A</given-names></name><name><surname>Määttä</surname><given-names>TA</given-names></name><name><surname>Huusko</surname><given-names>JM</given-names></name><name><surname>Ohlmeier</surname><given-names>S</given-names></name><name><surname>Bergmann</surname><given-names>U</given-names></name><name><surname>Ojaniemi</surname><given-names>M</given-names></name><name><surname>Muglia</surname><given-names>LJ</given-names></name><name><surname>Hallman</surname><given-names>M</given-names></name><name><surname>Rämet</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Human placental proteomics and exon variant studies link AAT/SERPINA1 with spontaneous preterm birth</article-title><source>BMC Medicine</source><volume>20</volume><elocation-id>141</elocation-id><pub-id pub-id-type="doi">10.1186/s12916-022-02339-8</pub-id><pub-id pub-id-type="pmid">35477570</pub-id></element-citation></ref><ref id="bib192"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Timmons</surname><given-names>BC</given-names></name><name><surname>Fairhurst</surname><given-names>A-M</given-names></name><name><surname>Mahendroo</surname><given-names>MS</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Temporal changes in myeloid cells in the cervix during pregnancy and parturition</article-title><source>Journal of Immunology</source><volume>182</volume><fpage>2700</fpage><lpage>2707</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0803138</pub-id><pub-id pub-id-type="pmid">19234164</pub-id></element-citation></ref><ref id="bib193"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tribe</surname><given-names>RM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Small peptides with a big role: antimicrobial peptides in the pregnant female reproductive tract</article-title><source>American Journal of Reproductive Immunology</source><volume>74</volume><fpage>123</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1111/aji.12379</pub-id><pub-id pub-id-type="pmid">25773319</pub-id></element-citation></ref><ref id="bib194"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tricomi</surname><given-names>V</given-names></name><name><surname>Hall</surname><given-names>JE</given-names></name><name><surname>Bittar</surname><given-names>A</given-names></name><name><surname>Chambers</surname><given-names>D</given-names></name></person-group><year iso-8601-date="1966">1966</year><article-title>Arborization test for the detection of ruptured fetal membranes: clinical evaluation</article-title><source>Obstetrics and Gynecology</source><volume>27</volume><fpage>275</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">5930011</pub-id></element-citation></ref><ref id="bib195"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinchieri</surname><given-names>G</given-names></name><name><surname>Pflanz</surname><given-names>S</given-names></name><name><surname>Kastelein</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses</article-title><source>Immunity</source><volume>19</volume><fpage>641</fpage><lpage>644</lpage><pub-id pub-id-type="doi">10.1016/s1074-7613(03)00296-6</pub-id><pub-id pub-id-type="pmid">14614851</pub-id></element-citation></ref><ref id="bib196"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vadillo-Ortega</surname><given-names>F</given-names></name><name><surname>Sadowsky</surname><given-names>DW</given-names></name><name><surname>Haluska</surname><given-names>GJ</given-names></name><name><surname>Hernandez-Guerrero</surname><given-names>C</given-names></name><name><surname>Guevara-Silva</surname><given-names>R</given-names></name><name><surname>Gravett</surname><given-names>MG</given-names></name><name><surname>Novy</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1β infusion in pregnant rhesus monkeys</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>186</volume><fpage>128</fpage><lpage>138</lpage><pub-id pub-id-type="doi">10.1067/mob.2002.118916</pub-id></element-citation></ref><ref id="bib197"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van de Veerdonk</surname><given-names>FL</given-names></name><name><surname>Netea</surname><given-names>MG</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Diversity: a hallmark of monocyte society</article-title><source>Immunity</source><volume>33</volume><fpage>289</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2010.09.007</pub-id></element-citation></ref><ref id="bib198"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignali</surname><given-names>DAA</given-names></name><name><surname>Kuchroo</surname><given-names>VK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>IL-12 family cytokines: immunological playmakers</article-title><source>Nature Immunology</source><volume>13</volume><fpage>722</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1038/ni.2366</pub-id><pub-id pub-id-type="pmid">22814351</pub-id></element-citation></ref><ref id="bib199"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Visser</surname><given-names>L</given-names></name><name><surname>van Buggenum</surname><given-names>H</given-names></name><name><surname>van der Voorn</surname><given-names>JP</given-names></name><name><surname>Heestermans</surname><given-names>LAPH</given-names></name><name><surname>Hollander</surname><given-names>KWP</given-names></name><name><surname>Wouters</surname><given-names>MGAJ</given-names></name><name><surname>de Groot</surname><given-names>CJM</given-names></name><name><surname>de Boer</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Maternal vascular malperfusion in spontaneous preterm birth placentas related to clinical outcome of subsequent pregnancy</article-title><source>The Journal of Maternal-Fetal &amp; Neonatal Medicine</source><volume>34</volume><fpage>2759</fpage><lpage>2764</lpage><pub-id pub-id-type="doi">10.1080/14767058.2019.1670811</pub-id></element-citation></ref><ref id="bib200"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waitzman</surname><given-names>NJ</given-names></name><name><surname>Jalali</surname><given-names>A</given-names></name><name><surname>Grosse</surname><given-names>SD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Preterm birth lifetime costs in the United States in 2016: An update</article-title><source>Seminars in Perinatology</source><volume>45</volume><elocation-id>151390</elocation-id><pub-id pub-id-type="doi">10.1016/j.semperi.2021.151390</pub-id><pub-id pub-id-type="pmid">33541716</pub-id></element-citation></ref><ref id="bib201"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakabayashi</surname><given-names>A</given-names></name><name><surname>Sawada</surname><given-names>K</given-names></name><name><surname>Nakayama</surname><given-names>M</given-names></name><name><surname>Toda</surname><given-names>A</given-names></name><name><surname>Kimoto</surname><given-names>A</given-names></name><name><surname>Mabuchi</surname><given-names>S</given-names></name><name><surname>Kinose</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Kurachi</surname><given-names>H</given-names></name><name><surname>Kimura</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation</article-title><source>MHR</source><volume>19</volume><fpage>718</fpage><lpage>726</lpage><pub-id pub-id-type="doi">10.1093/molehr/gat057</pub-id></element-citation></ref><ref id="bib202"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The immune landscape during the tumorigenesis of cervical cancer</article-title><source>Cancer Medicine</source><volume>10</volume><fpage>2380</fpage><lpage>2395</lpage><pub-id pub-id-type="doi">10.1002/cam4.3833</pub-id><pub-id pub-id-type="pmid">33694292</pub-id></element-citation></ref><ref id="bib203"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>C</given-names></name><name><surname>Weber</surname><given-names>KSC</given-names></name><name><surname>Klier</surname><given-names>C</given-names></name><name><surname>Gu</surname><given-names>S</given-names></name><name><surname>Wank</surname><given-names>R</given-names></name><name><surname>Horuk</surname><given-names>R</given-names></name><name><surname>Nelson</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+T cells</article-title><source>Blood</source><volume>97</volume><fpage>1144</fpage><lpage>1146</lpage><pub-id pub-id-type="doi">10.1182/blood.V97.4.1144</pub-id></element-citation></ref><ref id="bib204"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>S-Q</given-names></name><name><surname>Fraser</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>Z-C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Inflammatory cytokines and spontaneous preterm birth in asymptomatic women</article-title><source>Obstetrics &amp; Gynecology</source><volume>116</volume><fpage>393</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.1097/AOG.0b013e3181e6dbc0</pub-id></element-citation></ref><ref id="bib205"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wennerholm</surname><given-names>UB</given-names></name><name><surname>Holm</surname><given-names>B</given-names></name><name><surname>Mattsby-Baltzer</surname><given-names>I</given-names></name><name><surname>Nielsen</surname><given-names>T</given-names></name><name><surname>Platz-Christensen</surname><given-names>JJ</given-names></name><name><surname>Sundell</surname><given-names>G</given-names></name><name><surname>Hagberg</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Interleukin-1alpha, interleukin-6 and interleukin-8 in cervico/vaginal secretion for screening of preterm birth in twin gestation</article-title><source>Acta Obstetricia et Gynecologica Scandinavica</source><volume>77</volume><fpage>508</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">9654172</pub-id></element-citation></ref><ref id="bib206"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenstrom</surname><given-names>K</given-names></name><name><surname>D’Alton</surname><given-names>M</given-names></name><name><surname>O’Keefe</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Maternal–fetal medicine workforce survey: are we ready for regionalized levels of maternal care?</article-title><source>American Journal of Perinatology</source><volume>35</volume><fpage>1044</fpage><lpage>1049</lpage><pub-id pub-id-type="doi">10.1055/s-0038-1635093</pub-id></element-citation></ref><ref id="bib207"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witkin</surname><given-names>SS</given-names></name><name><surname>Gravett</surname><given-names>MG</given-names></name><name><surname>Haluska</surname><given-names>GJ</given-names></name><name><surname>Novy</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Induction of interleukin-1 receptor antagonist in rhesus monkeys after intraamniotic infection with group B streptococci or interleukin-1 infusion</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>171</volume><fpage>1668</fpage><lpage>1672</lpage><pub-id pub-id-type="doi">10.1016/0002-9378(94)90419-7</pub-id></element-citation></ref><ref id="bib208"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witkin</surname><given-names>SS</given-names></name><name><surname>Moron</surname><given-names>AF</given-names></name><name><surname>Ridenhour</surname><given-names>BJ</given-names></name><name><surname>Minis</surname><given-names>E</given-names></name><name><surname>Hatanaka</surname><given-names>A</given-names></name><name><surname>Sarmento</surname><given-names>SGP</given-names></name><name><surname>Franca</surname><given-names>MS</given-names></name><name><surname>Carvalho</surname><given-names>FHC</given-names></name><name><surname>Hamamoto</surname><given-names>TK</given-names></name><name><surname>Mattar</surname><given-names>R</given-names></name><name><surname>Sabino</surname><given-names>E</given-names></name><name><surname>Linhares</surname><given-names>IM</given-names></name><name><surname>Rudge</surname><given-names>MVC</given-names></name><name><surname>Forney</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Vaginal biomarkers that predict cervical length and dominant bacteria in the vaginal microbiomes of pregnant women</article-title><source>mBio</source><volume>10</volume><elocation-id>e02242-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02242-19</pub-id><pub-id pub-id-type="pmid">31641087</pub-id></element-citation></ref><ref id="bib209"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Kadam</surname><given-names>L</given-names></name><name><surname>Mial</surname><given-names>TN</given-names></name><name><surname>Plazyo</surname><given-names>O</given-names></name><name><surname>Garcia-Flores</surname><given-names>V</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Tarca</surname><given-names>AL</given-names></name><name><surname>Drewlo</surname><given-names>S</given-names></name><name><surname>Gomez-Lopez</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>An m1-like macrophage polarization in decidual tissue during spontaneous preterm labor that is attenuated by rosiglitazone treatment</article-title><source>The Journal of Immunology</source><volume>196</volume><fpage>2476</fpage><lpage>2491</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1502055</pub-id></element-citation></ref><ref id="bib210"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Biragyn</surname><given-names>A</given-names></name><name><surname>Kwak</surname><given-names>LW</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Mammalian defensins in immunity: more than just microbicidal</article-title><source>Trends in Immunology</source><volume>23</volume><fpage>291</fpage><lpage>296</lpage><pub-id pub-id-type="doi">10.1016/S1471-4906(02)02246-9</pub-id></element-citation></ref><ref id="bib211"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarbrough</surname><given-names>VL</given-names></name><name><surname>Winkle</surname><given-names>S</given-names></name><name><surname>Herbst-Kralovetz</surname><given-names>MM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications</article-title><source>Human Reproduction Update</source><volume>21</volume><fpage>353</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1093/humupd/dmu065</pub-id></element-citation></ref><ref id="bib212"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yilmaz</surname><given-names>E</given-names></name><name><surname>Ustunyurt</surname><given-names>E</given-names></name><name><surname>Kucukkomurcu</surname><given-names>S</given-names></name><name><surname>Budak</surname><given-names>F</given-names></name><name><surname>Ozkaya</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Assessment of cervicovaginal vascular endothelial growth factor in predicting preterm delivery</article-title><source>The Journal of Obstetrics and Gynaecology Research</source><volume>40</volume><fpage>1846</fpage><lpage>1852</lpage><pub-id pub-id-type="doi">10.1111/jog.12438</pub-id><pub-id pub-id-type="pmid">25056461</pub-id></element-citation></ref><ref id="bib213"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>H-N</given-names></name><name><surname>Park</surname><given-names>KH</given-names></name><name><surname>Jung</surname><given-names>EY</given-names></name><name><surname>Kim</surname><given-names>YM</given-names></name><name><surname>Kook</surname><given-names>SY</given-names></name><name><surname>Jeon</surname><given-names>SJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Non-invasive prediction of preterm birth in women with cervical insufficiency or an asymptomatic short cervix (≤25 mm) by measurement of biomarkers in the cervicovaginal fluid</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0180878</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0180878</pub-id><pub-id pub-id-type="pmid">28700733</pub-id></element-citation></ref><ref id="bib214"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoon</surname><given-names>BH</given-names></name><name><surname>Romero</surname><given-names>R</given-names></name><name><surname>Moon</surname><given-names>JB</given-names></name><name><surname>Shim</surname><given-names>S-S</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>G</given-names></name><name><surname>Jun</surname><given-names>JK</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes</article-title><source>American Journal of Obstetrics and Gynecology</source><volume>185</volume><fpage>1130</fpage><lpage>1136</lpage><pub-id pub-id-type="doi">10.1067/mob.2001.117680</pub-id></element-citation></ref><ref id="bib215"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshimura</surname><given-names>K</given-names></name><name><surname>Hirsch</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Effect of stimulation and antagonism of interleukin-1 signaling on preterm delivery in mice</article-title><source>Journal of the Society for Gynecologic Investigation</source><volume>12</volume><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1016/j.jsgi.2005.06.006</pub-id><pub-id pub-id-type="pmid">16202930</pub-id></element-citation></ref><ref id="bib216"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>H</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Perinatal outcomes of pregnancies complicated by preterm premature rupture of the membranes before 34 weeks of gestation in a tertiary center in China: a retrospective review</article-title><source>Bioscience Trends</source><volume>9</volume><fpage>35</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.5582/bst.2014.01058</pub-id><pub-id pub-id-type="pmid">25787907</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90943.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Simon</surname><given-names>Carlos</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043nxc105</institution-id><institution>Foundation Carlos Simon and Valencia University</institution></institution-wrap><country>Spain</country></aff></contrib></contrib-group></front-stub><body><p>This study presents important findings about the vaginal immunoproteome throughout pregnancy in cases of term or preterm birth, showing dynamic differences over time and between birth groups. The findings are solid and convincing in demonstrating the clinical usefulness as informative biomarker material to monitor pregnancy health and risk for preterm birth</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90943.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Simon</surname><given-names>Carlos</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043nxc105</institution-id><institution>Foundation Carlos Simon and Valencia University</institution></institution-wrap><country>Spain</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Simon</surname><given-names>Carlos</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/043nxc105</institution-id><institution>Foundation Carlos Simon and Valencia University</institution></institution-wrap><country>Spain</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;The vaginal immunoproteome for the prediction of spontaneous preterm birth: a retrospective longitudinal study&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Wei Yan as the Senior Editor.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions (for the authors):</p><p>1) Based on the findings reported please elaborate on a potentially shared pathobiology of late PTB and early PPROM (line 497-498).</p><p>2) sPTL and PPROM are significantly higher in women with a history of sPTB. Can the authors discuss about the meaning of this association?</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>Summary</p><p>The authors describe here the dynamics of vaginal immunoproteome during pregnancy by analyzing 31 immune mediators in cervicovaginal samples in women with uncomplicated pregnancies (n=494) and women with sPTB, with a separate analysis for spontaneous preterm labor (sPTL, n=140) and preterm prelabor rupture of membranes (PPROM, n=105). The results show how the vaginal cytokine profile changes as pregnancy progress, contributing to physiological homeostasis in an uncomplicated pregnancy. In contrast, patients undergoing sPTL or PPROM presented deviations from these dynamics towards an inflammatory state through increased monocyte, macrophage, and T-cell activation, and reduction of antimicrobial peptides.</p><p>Strengths</p><p>This is a comprehensive study of the immunoproteome during pregnancy. It involves a high number of patients, analyzes a wide spectrum of cytokines, chemokines, etc., and contemplates a longitudinal collection of samples covering the three trimesters of pregnancy.</p><p>The study is well designed and potential bias has been controlled by matching cases and controls based on ethnicity, maternal age, and gestational age at sampling.</p><p>The results are clearly presented, well-interpreted, and discussed in light of the vast literature available about immunity and the onset of labor.</p><p>The data presented here could be used for the early prediction of sPTB (before 30 weeks) either alone or in combination with other non-invasive biomarkers or measurements.</p><p>Improving early prediction of sPTL and PPROM is an important mission to fight the health and economic burdens of preterm births worldwide.</p><p>Weaknesses</p><p>The majority of the patients included in this work belong to the African-American community; however, it has been reported that the vaginal microbiota composition differs between races, and these variations may affect the vaginal immune profile in other racial populations. Further studies would be necessary to validate or redefine the sPTB immunoproteome signature in women other than African-American. This limitation has been acknowledged by the authors in the Discussion section.</p><p>Some suggestions for the authors that may improve the understanding of the paper:</p><p>– Line 151: the authors have analysed 31 immune mediators. How were these 31 molecules selected? Can the authors elaborate on why they chose these 31 and no others?</p><p>– Lines 154-159: the 31 molecules are divided into 6 groups, which are the molecules belonging to each of the groups. This information can be found later in the manuscript when results are presented in a subsection, but it would be nice to have this information at the beginning of the section.</p><p>– Line 458: change &quot;Interleukin-6&quot; by &quot;IL-6&quot;.</p><p>– Table 1: sPTL and PPROM are significantly higher in women with a history of sPTB. Can the authors discuss the meaning of this association?</p><p><italic>Reviewer #2 (Recommendations for the authors):</italic></p><p>The authors present a longitudinal analysis of the vaginal immunoproteome (31 absolute concentrations of a hypothesis-driven selection of cytokines, chemokines, growth factors, and anti-microbial peptides) at four timepoints throughout pregnancy in N = 739 women, n = 2,819 samples who delivered a term or preterm birth (PTB) infant following either spontaneous preterm labor (sPTL), or premature preterm rupture of the membranes (PPROM). Aiming to identify proteins associated with preterm birth, the study reveals proinflammatory signatures present in PTB, such as elevated levels of IL1b, IL6, CCL2, CCL3, and decreased levels of VEGF, b-defensin-2, and SLPI, with specific signatures associated with early/late sPTL/PPROM. Longitudinal modeling of the term immunoproteome shows subtle but significant changes in protein levels across term pregnancies, indicative of a precisely-timed regulation of vaginal changes with pregnancy progression. Furthermore, protein measurements before 24, or 28 weeks gestation are informative for classification models to predict PTB vs. term birth, with the strongest predictive performance for PPROM before 34 weeks, and when combined with maternal demographic characteristics, and cervical length measurements.</p><p>Overall, this study demonstrates the clinical usefulness of sampling the vaginal microenvironment as accessible, informative material for biomarkers to monitor pregnancy progression and risk for preterm birth. The study can serve as a resource for future investigations and incentivizes to further investigate other pillars of the immune and non-immune environment of the vagina throughout pregnancy, which were outside of the scope of the current study.</p><p>This is a neat manuscript.</p><p>1. The differences in term vs. preterm, stratified by type and time of PTB, are pointing towards an overlap of late PTB and early PPROM vaginal immunoproteome signature. The authors touch on this finding in the discussion, however, do not further explain it. Please elaborate on a potentially shared pathobiology of late PTB and early PPROM (line 497-498).</p><p>2. What do the authors mean by maternal or fetal inflammation (demographics Table 1)? Was there a difference in the immunoproteome based on the presence/absence of an inflammatory state? (see also Discussion line 487-488).</p><p>3. The authors report random forest classifiers but do not report which proteins informed the model, and contributed to its performance (despite mentioning that models built using the top univariately different proteins reach a similar performance). Have the authors tried to identify biomarker candidates by using other types of regression models more conducive to feature selection?</p><p>4. Comparisons between term and subgroups of PTB cases were assessed based on data collected at &lt;37 or &lt;34 weeks (methods line 786-788). Which term data are shown in the right column for the term group in Figure 3-6, as here, both &lt;37 and &lt;34 weeks comparisons are displayed in the same figure. Furthermore, this information, in addition to in the methods, should be included in text and legends describing the results.</p><p>5. Did the authors observe any differences in immunoproteome when stratifying by other demographic categories, e.g., BMI (normal weight, overweight, obese) in healthy term pregnancies?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.90943.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions (for the authors):</p><p>1) Based on the findings reported please elaborate on a potentially shared pathobiology of late PTB and early PPROM (line 497-498).</p></disp-quote><p>We thank the Reviewer for pointing out the potential for a shared pathobiology underlying late PTB and early PPROM, despite there being differences in the timing during gestation of such changes. It is important to first emphasize that spontaneous preterm birth (sPTB) encompasses both spontaneous preterm labor with intact membranes (sPTL) and preterm prelabor rupture of membranes (PPROM) (1). Both sPTL and PPROM are frequently accompanied by a local (i.e., intra-amniotic) inflammatory response triggered by ascending infection or sterile inflammation (2, 3). Regardless of its nature, such an intra-amniotic inflammatory response comprises elevated concentrations of numerous cytokines (4), including IL-6, IL-1α, and IL-1β, of which IL-6 is used clinically as a biomarker to diagnose intra-amniotic inflammation (5) and IL-1/IL-1β are both causally linked to the onset of labor (6, 7). Importantly, the local inflammation in the amniotic cavity can be reflected in the vaginal fluid (8, 9). Thus, the concept that sPTL and PPROM culminating in sPTB are both accompanied by a vaginal immune response is consistent with the existence of a “common pathway of labor” (10) encompassing those molecular and mechanical processes necessary for labor to occur. We consider that our findings support the existence of a shared vaginal immune response between late sPTL and early PPROM that may also be a component (or reflection) of such a common pathway.</p><p>Lines amended in the document: Lines 525-533</p><p>Amended text: “Regardless of the differing mechanisms that can drive sPTL and PPROM, our data support a shared vaginal immune signature that accompanies inflammation-associated sPTB, potentially reflecting the inflammatory status of the amniotic cavity. This observation is consistent with the concept of a “common pathway of labor” (10), and indicates that care should be taken to distinguish between changes in vaginal immune mediators that are driven by labor and those that are specific to the disease subset (i.e., sPTL vs. PPROM).”</p><disp-quote content-type="editor-comment"><p>2) sPTL and PPROM are significantly higher in women with a history of sPTB. Can the authors discuss about the meaning of this association?</p></disp-quote><p>We thank the Reviewer for raising this important point. Spontaneous preterm birth (sPTB) encompasses both preterm labor with intact membranes (sPTL) and preterm prelabor rupture of membranes (PPROM) (1). It is well established that a history of preterm birth in prior pregnancy is an important risk factor for the current pregnancy, ranging from 15% to over 50%, depending on the number and gestational age of previous deliveries (1). Although the exact mechanisms for recurrence are not well known, it has been proposed that persistent or recurrent intra-uterine infections may play a role on such increased risk (1, 11). Therefore, the higher prevalence of history of spontaneous preterm birth in the sPTL and PPROM groups compared to the term delivery group is expected.</p><p>Lines amended in the document: Lines 153-155</p><p>Amended text: “As expected (1), the prevalence of sPTL or PPROM was higher in women with a history of sPTB.”</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>Summary</p><p>The authors describe here the dynamics of vaginal immunoproteome during pregnancy by analyzing 31 immune mediators in cervicovaginal samples in women with uncomplicated pregnancies (n=494) and women with sPTB, with a separate analysis for spontaneous preterm labor (sPTL, n=140) and preterm prelabor rupture of membranes (PPROM, n=105). The results show how the vaginal cytokine profile changes as pregnancy progress, contributing to physiological homeostasis in an uncomplicated pregnancy. In contrast, patients undergoing sPTL or PPROM presented deviations from these dynamics towards an inflammatory state through increased monocyte, macrophage, and T-cell activation, and reduction of antimicrobial peptides.</p><p>Strengths</p><p>This is a comprehensive study of the immunoproteome during pregnancy. It involves a high number of patients, analyzes a wide spectrum of cytokines, chemokines, etc., and contemplates a longitudinal collection of samples covering the three trimesters of pregnancy.</p><p>The study is well designed and potential bias has been controlled by matching cases and controls based on ethnicity, maternal age, and gestational age at sampling.</p><p>The results are clearly presented, well-interpreted, and discussed in light of the vast literature available about immunity and the onset of labor.</p><p>The data presented here could be used for the early prediction of sPTB (before 30 weeks) either alone or in combination with other non-invasive biomarkers or measurements.</p><p>Improving early prediction of sPTL and PPROM is an important mission to fight the health and economic burdens of preterm births worldwide.</p><p>Weaknesses</p><p>The majority of the patients included in this work belong to the African-American community; however, it has been reported that the vaginal microbiota composition differs between races, and these variations may affect the vaginal immune profile in other racial populations. Further studies would be necessary to validate or redefine the sPTB immunoproteome signature in women other than African-American. This limitation has been acknowledged by the authors in the Discussion section.</p><p>Some suggestions for the authors that may improve the understanding of the paper:</p><p>– Line 151: the authors have analysed 31 immune mediators. How were these 31 molecules selected? Can the authors elaborate on why they chose these 31 and no others?</p></disp-quote><p>We thank the Reviewer for requesting this clarification. There were both scientific and technical factors to be taken into consideration for the selected immunoassays. The overarching goal was to comprehensively evaluate soluble factors that could be assigned potential functions based on prior literature. To cover some of the best studied cytokines/growth factors (IFN-γ, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IL-13, TNF, GM-CSF, IL-1α, IL-5, IL-7, IL-12/IL-23p40, IL-15, IL-16, IL-17A, LT-α, and VEGF), we utilized two MSD kits (Pro-Inflammatory Panel 1 and Cytokine Panel 1), which allowed us to measure these mediators with much less sample volume than would be required for conventional ELISA. Similarly, to cover some of the better known chemokines (CCL11, CCL26, CXCL8, CXCL10, CCL2, CCL13, CCL22, CCL3, CCL4, and CCL17), we used the MSD Chemokine Panel 1. For bacterial defensins, multiplex kits are largely unavailable, and thus we needed to be more selective of our targets. The two defensins measured in this study, β-defensin-2 and SLPI, have both been demonstrated to be important vaginal antimicrobial peptides (12, 13, 14, 15, 16). Moreover, prior research had shown that vaginal concentrations of β-defensin-2 were reduced in women with sPTB (16). Thus, we considered that β-defensin-2 and SLPI represented viable targets that would potentially undergo modulation in different sPTB subsets.</p><p>In summary, the 31 analytes examined in the current study were selected for their biological relevance, to build upon our prior data, and to allow for efficient use of our samples.</p><disp-quote content-type="editor-comment"><p>– Lines 154-159: the 31 molecules are divided into 6 groups, which are the molecules belonging to each of the groups. This information can be found later in the manuscript when results are presented in a subsection, but it would be nice to have this information at the beginning of the section.</p></disp-quote><p>We thank the reviewer for this suggestion. We have added the immune mediator information to the suggested area.</p><p>Lines amended in the document: 165-173</p><p>Amended text: “proinflammatory cytokines (IL-6, IL-1β, IL-16, CXCL8, TNF, IFN-γ, IL-1α, and LT-α), chemoattractants of monocytes (herein referred to as monocyte chemokines; CCL2, CCL3, and CCL4), macrophage cytokines (IL-12/IL-23p40, IL-12p70, and IL-15), T-cell cytokines and chemokines (IL-2, IL-4, IL-17A, IL-10, IL-13, IL-5, CXCL10, and CCL17), anti-microbial peptides (β-defensin-2 and SLPI), and growth factors (VEGF and GM-CSF).”</p><disp-quote content-type="editor-comment"><p>– Line 458: change &quot;Interleukin-6&quot; by &quot;IL-6&quot;.</p></disp-quote><p>We thank the Reviewer for this suggestion. In this instance, ‘Interleukin-6’ was at the start of the sentence so we wrote it out rather than abbreviate it.</p><disp-quote content-type="editor-comment"><p>– Table 1: sPTL and PPROM are significantly higher in women with a history of sPTB. Can the authors discuss the meaning of this association?</p></disp-quote><p>We thank the Reviewer for this question. An in-depth response to this question can be seen in the essential revisions component of this document above. In brief, previous preterm delivery is an established risk factor for sPTB in subsequent pregnancies. The association of sPTL and PPROM with a history of PTB in this study reflects this increased risk.</p><p>Lines amended in the document: Lines 153-155</p><p>Amended text: As expected (1), the prevalence of sPTL or PPROM was higher in women with a history of sPTB.</p><disp-quote content-type="editor-comment"><p>Reviewer #2 (Recommendations for the authors):</p><p>The authors present a longitudinal analysis of the vaginal immunoproteome (31 absolute concentrations of a hypothesis-driven selection of cytokines, chemokines, growth factors, and anti-microbial peptides) at four timepoints throughout pregnancy in N = 739 women, n = 2,819 samples who delivered a term or preterm birth (PTB) infant following either spontaneous preterm labor (sPTL), or premature preterm rupture of the membranes (PPROM). Aiming to identify proteins associated with preterm birth, the study reveals proinflammatory signatures present in PTB, such as elevated levels of IL1b, IL6, CCL2, CCL3, and decreased levels of VEGF, b-defensin-2, and SLPI, with specific signatures associated with early/late sPTL/PPROM. Longitudinal modeling of the term immunoproteome shows subtle but significant changes in protein levels across term pregnancies, indicative of a precisely-timed regulation of vaginal changes with pregnancy progression. Furthermore, protein measurements before 24, or 28 weeks gestation are informative for classification models to predict PTB vs. term birth, with the strongest predictive performance for PPROM before 34 weeks, and when combined with maternal demographic characteristics, and cervical length measurements.</p><p>Overall, this study demonstrates the clinical usefulness of sampling the vaginal microenvironment as accessible, informative material for biomarkers to monitor pregnancy progression and risk for preterm birth. The study can serve as a resource for future investigations and incentivizes to further investigate other pillars of the immune and non-immune environment of the vagina throughout pregnancy, which were outside of the scope of the current study.</p><p>This is a neat manuscript.</p><p>1. The differences in term vs. preterm, stratified by type and time of PTB, are pointing towards an overlap of late PTB and early PPROM vaginal immunoproteome signature. The authors touch on this finding in the discussion, however, do not further explain it. Please elaborate on a potentially shared pathobiology of late PTB and early PPROM (line 497-498).</p></disp-quote><p>We thank the Reviewer for this question. An in-depth response to this question can be found in the essential revisions component of this document above. In brief, sPTL and PPROM can both result in sPTB and are both associated with inflammation in the amniotic cavity. The overlap between the findings for these two pathologies is reflected in their shared inflammatory signatures.</p><p>Lines amended in the document: Lines 525-533</p><p>Amended text: “Regardless of the differing mechanisms that can drive sPTL and PPROM, our data support a shared vaginal immune signature that accompanies inflammation-associated sPTB, potentially reflecting the inflammatory status of the amniotic cavity. This observation is consistent with the concept of a “common pathway of labor” (10), and indicates that care should be taken to distinguish between changes in vaginal immune mediators that are driven by labor and those that are specific to the disease subset (i.e., sPTL vs. PPROM).”</p><disp-quote content-type="editor-comment"><p>2. What do the authors mean by maternal or fetal inflammation (demographics Table 1)? Was there a difference in the immunoproteome based on the presence/absence of an inflammatory state? (see also Discussion line 487-488).</p></disp-quote><p>We thank the Reviewer for pointing this out. We apologize for our oversight in omitting the definition of maternal or fetal placental inflammatory responses in the methods section of our manuscript. These terms are based on the diagnosis conducted through histopathological examination of the placenta, carried out by perinatal pathologists who were blinded to clinical diagnoses and obstetrical outcomes, in accordance with standardized Perinatology Research Branch protocols (17). Maternal placental inflammatory response refers to acute inflammatory lesions of the placenta, and is defined as the invasion of maternal neutrophils into the chorioamniotic membranes (17). Fetal placental inflammatory response refers to the presence of acute lesions (i.e., neutrophil invasion) in the umbilical cord (funisitis) or chorionic plate (chorionic vasculitis) (17, 18). This information has now been added in the methods section of the revised manuscript.</p><p>With respect to whether there is a difference in the vaginal immunoproteome based on the presence/absence of an inflammatory state, when the PTL and PPROM groups were further divided by the presence/absence of maternal or fetal placental inflammatory lesions (instead of by gestational age at delivery) all resulting subgroups demonstrated at least some differences in immune mediators relative to controls (see Appendix Table 1). However, disaggregation by gestational age at delivery better accounted for the vaginal imunoproteomic changes than disaggregation by the presence of maternal or fetal placental inflammatory lesions. Therefore, we have remained reporting it as such.</p><p>Lines amended in the document: Lines 765-775</p><p>Amended text: “Placental histopathological inflammation – Placentas were examined histologically by perinatal pathologists blinded to clinical diagnoses and obstetrical outcomes according to standardized Perinatology Research Branch protocols (17). Briefly, three to nine sections of the placenta were examined, and at least one full-thickness section was taken from the center of the placenta; others were taken randomly from the placental disc. Acute inflammatory lesions of the placenta [maternal placental inflammatory response (defined as invasion of neutrophils into the chorioamniotic membranes) and fetal placental inflammatory response (acute lesions in the umbilical cord and/or chorionic plate, diagnosed by invasion of neutrophils into these tissues)] were diagnosed according to established criteria (17, 19)</p><disp-quote content-type="editor-comment"><p>3. The authors report random forest classifiers but do not report which proteins informed the model, and contributed to its performance (despite mentioning that models built using the top univariately different proteins reach a similar performance). Have the authors tried to identify biomarker candidates by using other types of regression models more conducive to feature selection?</p></disp-quote><p>We thank the Reviewer for this suggestion. Within the manuscript, we have now identified the principal immune mediators informing key models for early PPROM (VEGF, Il1β) and early sPTL (IL1β, IL16, and IL13). Nevertheless, many immune mediators contributed to these analyses (see Appendix Figure 1 A-E). These immune mediators were identified using the mean decrease in Gini coefficient (i.e., a metric of importance), and these analyses complement the univariate analyses in earlier sections of the Results. A similar conclusion regarding the non-dominance of a single or very few biomarkers was reached using lasso regression with hyperparameter λ being determined by cross-validation. For all outcomes considered, at least 21 of the 28 proteins had non-zero coefficients in the lasso regression models suggesting shared predictive value among proteins.</p><p>Lines amended in the document: 374-376; 380-381; 842-844</p><p>Amended text: “When considering the vaginal concentrations of cytokines, chemokines, growth factors, and defensins without including maternal characteristics (black line), the vaginal immunoproteome has the highest potential predictive value for early PPROM &lt;34 (AUC = 0.787) (Figure 7E), with the two most informative immune mediators for the prediction of early PPROM being VEGF and IL-1β.”</p><p>“Nonetheless, the combination of all analytes determined in the vaginal fluid resulted in a model with a lower predictive strength for early sPTL &lt;34 (AUC = 0.637) (Figure 7C) compared to early PPROM. For early sPTL, concentrations of IL-1β, IL-16, and IL-13 were most informative.”</p><p>“The importance of individual immune mediators in these analyses was determined using the mean decrease in Gini coefficient.”</p><disp-quote content-type="editor-comment"><p>4. Comparisons between term and subgroups of PTB cases were assessed based on data collected at &lt;37 or &lt;34 weeks (methods line 786-788). Which term data are shown in the right column for the term group in Figure 3-6, as here, both &lt;37 and &lt;34 weeks comparisons are displayed in the same figure. Furthermore, this information, in addition to in the methods, should be included in text and legends describing the results.</p></disp-quote><p>We thank the Reviewer for this suggestion. To clarify, the left-most column in each panel of Figures 3-6 shows the control group including data &lt;37 weeks. Term group data collected at &lt;34 weeks was used for the comparisons with early sPTL and early PPROM but was not shown independently on the violin plot.</p><p>Lines amended in the document: 827-829</p><p>Amended text: “Violin plots for controls, sPTB, sPTL, PPROM, late sPTL, and late PPROM include data collected at &lt;37 weeks. Violin plots for early sPTL and early PPROM contain data &lt;34 weeks.”</p><disp-quote content-type="editor-comment"><p>5. Did the authors observe any differences in immunoproteome when stratifying by other demographic categories, e.g., BMI (normal weight, overweight, obese) in healthy term pregnancies?</p></disp-quote><p>We thank the Reviewer for this suggestion. We did assess possible interactions between BMI (categorical variable with three levels as suggested by the Reviewer) and group (sPTBvsControl) on immune mediator levels, while adjusting for gestational age and nulliparity. The q-value was &gt;0.2 for all immune mediators and hence we concluded a lack of significant interactions. We have also assessed the interaction between group and history of preterm birth on immune mediator levels and the results were again negative (q&gt;0.8 for all).</p><p><bold>References</bold></p><p>1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84.</p><p>2. Romero R, Miranda J, Chaiworapongsa T, Korzeniewski SJ, Chaemsaithong P, Gotsch F, et al. Prevalence and clinical significance of sterile intra-amniotic inflammation in patients with preterm labor and intact membranes. Am J Reprod Immunol. 2014;72(5):458-74.</p><p>3. Romero R, Miranda J, Chaemsaithong P, Chaiworapongsa T, Kusanovic JP, Dong Z, et al. Sterile and microbial-associated intra-amniotic inflammation in preterm prelabor rupture of membranes. J Matern Fetal Neonatal Med. 2015;28(12):1394-409.</p><p>4. Romero R, Grivel JC, Tarca AL, Chaemsaithong P, Xu Z, Fitzgerald W, et al. Evidence of perturbations of the cytokine network in preterm labor. Am J Obstet Gynecol. 2015;213(6):836.e1-.e18.</p><p>5. Yoon BH, Romero R, Moon JB, Shim SS, Kim M, Kim G, et al. Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. American journal of obstetrics and gynecology. 2001;185(5):1130-6.</p><p>6. Romero R, Brody DT, Oyarzun E, Mazor M, Wu YK, Hobbins JC, et al. Infection and labor. III. Interleukin-1: a signal for the onset of parturition. Am J Obstet Gynecol. 1989;160(5 Pt 1):1117-23.</p><p>7. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, et al. Interleukin-1 α and interleukin-1 β in preterm and term human parturition. American journal of reproductive immunology (New York, NY : 1989). 1992;27(3-4):117-23.</p><p>8. Wei SQ, Fraser W, Luo ZC. Inflammatory cytokines and spontaneous preterm birth in asymptomatic women: a systematic review. Obstet Gynecol. 2010;116(2 Pt 1):393-401.</p><p>9. Musilova I, Bestvina T, Hudeckova M, Michalec I, Cobo T, Jacobsson B, et al. Vaginal fluid IL-6 concentrations as a point-of-care test is of value in women with preterm PROM. Am J Obstet Gynecol. 2016.</p><p>10. Romero R, Dey SK, Fisher SJ. Preterm labor: one syndrome, many causes. Science. 2014;345(6198):760-5.</p><p>11. Mazaki-Tovi S, Romero R, Kusanovic JP, Erez O, Pineles BL, Gotsch F, et al. Recurrent preterm birth. Semin Perinatol. 2007;31(3):142-58.</p><p>12. Florova V, Romero R, Tarca AL, Galaz J, Motomura K, Ahmad MM, et al. Vaginal host immune-microbiome interactions in a cohort of primarily African-American women who ultimately underwent spontaneous preterm birth or delivered at term. Cytokine. 2021;137:155316.</p><p>13. Cole AM. Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol. 2006;306:199-230.</p><p>14. Shimoya K, Zhang Q, Temma K, Kimura T, Tsujie T, Tsutsui T, et al. Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women. Maturitas. 2006;54(2):141-8.</p><p>15. Cole AM, Cole AL. Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reprod Immunol. 2008;59(1):27-34.</p><p>16. Elovitz MA, Gajer P, Riis V, Brown AG, Humphrys MS, Holm JB, et al. Cervicovaginal microbiota and local immune response modulate the risk of spontaneous preterm delivery. Nat Commun. 2019;10(1):1305.</p><p>17. Kim CJ, Romero R, Chaemsaithong P, Chaiyasit N, Yoon BH, Kim YM. Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance. Am J Obstet Gynecol. 2015;213(4 Suppl):S29-52.</p><p>18. Pacora P, Chaiworapongsa T, Maymon E, Kim YM, Gomez R, Yoon BH, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med. 2002;11(1):18-25.</p><p>19. Redline RW. Classification of placental lesions. Am J Obstet Gynecol. 2015;213(4 Suppl):S21-8.</p></body></sub-article></article>